Verint Systems (VRNT) 10-K 29 Mar 23 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Mar. 15, 2023	Jul. 31, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jan. 31, 2023
Current Fiscal Year End Date	--01-31
Document Transition Report	false
Entity File Number	001-34807
Entity Registrant Name	Verint Systems Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3200514
Entity Address, Address Line One	175 Broadhollow Road
Entity Address, City or Town	Melville,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11747
City Area Code	(631)
Local Phone Number	962-9600
Title of 12(b) Security	Common Stock, $.001 par value per share
Trading Symbol	VRNT
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 2,910,948
Entity Common Stock, Shares Outstanding		65,105,922
Documents Incorporated by Reference	The information required by Part III of this report, to the extent not set forth herein, is incorporated herein by reference from the registrant’s definitive proxy statement relating to the Annual Meeting of Stockholders to be held in 2023, which definitive proxy statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
Entity Central Index Key	0001166388
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Jan. 31, 2023
Audit Information [Abstract]
Auditor Location	New York, New York
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Firm ID	34

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Current Assets:
Cash and cash equivalents	$ 282,099	$ 358,805
Short-term investments	697	765
Accounts receivable, net of allowance for credit losses of $1.3 million and $1.3 million, respectively	188,414	193,831
Contract assets, net	60,444	42,688
Inventories	12,628	5,337
Prepaid expenses and other current assets	75,374	53,752
Total current assets	619,656	655,178
Property and equipment, net	64,810	64,090
Operating lease right-of-use assets	37,649	35,433
Goodwill	1,347,213	1,353,421
Intangible assets, net	85,272	118,254
Long-term deferred income taxes	10,719	8,091
Other assets	148,282	126,638
Total assets	2,313,601	2,361,105
Current Liabilities:
Accounts payable	43,631	39,501
Accrued expenses and other current liabilities	155,944	168,694
Contract liabilities	271,476	271,271
Total current liabilities	471,051	479,466
Long-term debt	408,908	406,954
Long-term contract liabilities	18,047	15,872
Operating lease liabilities	40,744	28,457
Long-term deferred income taxes	11,749	17,460
Other liabilities	68,632	21,996
Total liabilities	1,019,131	970,205
Commitments and Contingencies
Temporary Equity:
Total temporary equity	436,321	436,321
Stockholders' Equity:
Common stock — $0.001 par value; authorized 240,000,000 and 120,000,000 shares; issued 65,404,000 and 66,211,000; outstanding 65,404,000 and 66,211,000 shares at January 31, 2023 and 2022, respectively.	65	66
Additional paid-in capital	1,055,157	1,125,152
Accumulated deficit	(45,333)	(54,509)
Accumulated other comprehensive loss	(154,099)	(118,515)
Total Verint Systems Inc. stockholders' equity	855,790	952,194
Noncontrolling interests	2,359	2,385
Total stockholders' equity	858,149	954,579
Total liabilities, temporary equity, and stockholders' equity	2,313,601	2,361,105
Series A Preferred Stock
Temporary Equity:
Preferred Stock	200,628	200,628
Series B Preferred Stock
Temporary Equity:
Preferred Stock	$ 235,693	$ 235,693

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Allowance for credit losses	$ 1,300	$ 1,300
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	2,207,000	2,207,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	240,000,000	120,000,000
Common stock, issued (in shares)	65,404,000	66,211,000
Common stock, outstanding (in shares)	65,404,000	66,211,000
Series A Preferred Stock
Preferred stock, issued (in shares)	200,000	200,000
Preferred stock, outstanding (in shares)	200,000	200,000
Preferred stock, liquidation preference value	$ 206,067	$ 206,067
Preferred stock, redemption value	$ 206,067	$ 206,067
Series B Preferred Stock
Preferred stock, issued (in shares)	200,000	200,000
Preferred stock, outstanding (in shares)	200,000	200,000
Preferred stock, liquidation preference value	$ 206,067	$ 206,067
Preferred stock, redemption value	$ 206,067	$ 206,067

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Revenue:
Total revenue	$ 902,245	$ 874,509	$ 830,247
Cost of revenue:
Amortization of acquired technology	13,191	17,777	17,962
Total cost of revenue	295,068	298,572	287,551
Gross profit	607,177	575,937	542,696
Operating expenses:
Research and development, net	130,644	123,291	128,152
Selling, general and administrative	392,939	376,808	327,345
Amortization of other acquired intangible assets	26,238	28,995	29,777
Total operating expenses	549,821	529,094	485,274
Operating income	57,356	46,843	57,422
Other income (expense), net:
Interest income	3,301	233	1,461
Interest expense	(7,877)	(10,325)	(39,803)
Losses on early retirements of debt	0	(2,474)	(143)
Other income (expense), net	1,982	5,227	(60,601)
Total other expense, net	(2,594)	(7,339)	(99,086)
Income (loss) from continuing operations before provision for income taxes	54,762	39,504	(41,664)
Provision for income taxes	39,103	23,853	6,937
Net income (loss) from continuing operations	15,659	15,651	(48,601)
Net income from discontinued operations	0	0	48,494
Net income (loss)	15,659	15,651	(107)
Net income (loss) attributable to Verint Systems Inc.	14,898	14,413	(7,267)
Dividends on preferred stock	(20,800)	(18,922)	(7,656)
Net loss attributable to Verint Systems Inc. common shares	(5,902)	(4,509)	(14,923)
Net (loss) income attributable to Verint Systems Inc. common shares:
Net loss from continuing operations attributable to Verint Systems Inc. common shares	(5,902)	(4,509)	(57,310)
Net income from discontinued operations attributable to Verint Systems Inc. common shares	$ 0	$ 0	$ 42,387
Basic net (loss) income per common share attributable to Verint Systems Inc.:
Continuing operations (in dollars per share)	$ (0.09)	$ (0.07)	$ (0.88)
Discontinued operations (in dollars per share)	0	0	0.65
Total basic net loss per common share attributable to Verint Systems Inc. (in dollars per share)	(0.09)	(0.07)	(0.23)
Diluted net (loss) income per common share attributable to Verint Systems Inc.:
Continuing operations (in dollars per share)	(0.09)	(0.07)	(0.88)
Discontinued operations (in dollars per share)	0	0	0.65
Total diluted net loss per common share attributable to Verint Systems Inc. (in dollars per share)	$ (0.09)	$ (0.07)	$ (0.23)
Weighted-average common shares outstanding:
Basic (in shares)	65,332	65,591	65,173
Diluted (in shares)	65,332	65,591	65,173
Continuing Operations
Other income (expense), net:
Net income attributable to noncontrolling interests	$ 761	$ 1,238	$ 1,053
Discontinued Operations
Other income (expense), net:
Net income attributable to noncontrolling interests	0	0	6,107
Recurring
Revenue:
Total revenue	685,537	633,129	575,624
Cost of revenue:
Cost of revenue	162,347	156,569	139,044
Nonrecurring
Revenue:
Total revenue	216,708	241,380	254,623
Cost of revenue:
Cost of revenue	$ 119,530	$ 124,226	$ 130,545

Consolidated Statements of Comp

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 15,659	$ 15,651	$ (107)
Other comprehensive (loss) income, net of reclassification adjustments:
Foreign currency translation adjustments	(35,545)	(11,668)	17,794
Distribution of Cognyte Software Ltd.	0	17,123	0
Net (decrease) increase from foreign exchange contracts designated as hedges	(47)	(147)	37
Net increase (decrease) from interest rate swap designated as a hedge	0	1,014	(3,168)
Net increase from settlement of interest rate swap due to partial early retirement of Term Loan	0	12,017	0
Benefit from income taxes on net increase from foreign exchange contracts and interest rate swap designated as hedges	8	24	636
Other comprehensive (loss) income	(35,584)	18,363	15,299
Comprehensive (loss) income	(19,925)	34,014	15,192
Comprehensive income attributable to noncontrolling interests	761	1,238	7,472
Comprehensive (loss) income attributable to Verint Systems Inc.	$ (20,686)	$ 32,776	$ 7,720

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Total Verint Systems Inc. Stockholders’ Equity	Total Verint Systems Inc. Stockholders’ Equity Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Non-controlling Interests
Beginning balances (in shares) at Jan. 31, 2020					64,738,000
Beginning balances at Jan. 31, 2020	$ 1,242,437	$ (940)	$ 1,229,368	$ (940)	$ 68	$ 1,660,889		$ (174,134)	$ (105,590)	$ (940)	$ (151,865)	$ 13,069
Increase (Decrease) in Stockholders' Equity
Net (loss) income	(107)		(7,267)						(7,267)			7,160
Other comprehensive (loss) income	15,299		14,987								14,987	312
Stock-based compensation — equity-classified awards	63,005		63,005			63,005
Common stock issued for stock awards and stock bonuses (in shares)					1,646,000
Common stock issued for stock awards and stock bonuses	14,110		14,110		$ 2	14,108
Exercises of stock options (in shares)					2,000
Exercises of stock options	12		12			12
Treasury stock acquired (in shares)					(613,000)
Treasury stock acquired	(33,990)		(33,990)					(33,990)
Dividends or distribution to noncontrolling interests	(5,414)											(5,414)
Preferred stock dividends	(6,789)		(6,789)			(6,789)
Reacquisition of equity component from convertible notes repurchases, net of taxes	(218)		(218)			(218)
Temporary equity reclassification	$ (4,841)		(4,841)			(4,841)
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Ending balances (in shares) at Jan. 31, 2021					65,773,000
Ending balances at Jan. 31, 2021	$ 1,282,564	$ 1,430	1,267,437	$ 1,430	$ 70	1,726,166	$ (43,445)	(208,124)	(113,797)	$ 44,875	(136,878)	15,127
Increase (Decrease) in Stockholders' Equity
Net (loss) income	15,651		14,413						14,413			1,238
Other comprehensive (loss) income	18,363
Stock-based compensation — equity-classified awards	58,679		58,679			58,679
Common stock issued for stock awards and stock bonuses (in shares)					1,800,000
Common stock issued for stock awards and stock bonuses	0				$ 2	(2)
Treasury stock acquired (in shares)					(555,000)
Treasury stock acquired	(26,375)		(26,375)					(26,375)
Dividends or distribution to noncontrolling interests	(1,110)											(1,110)
Preferred stock dividends	(18,056)		(18,056)			(18,056)
Other comprehensive income, excluding the distribution of Cognyte Software Ltd.	1,240		1,240								1,240
Distribution of Cognyte Software Ltd.	$ (277,412)		(264,542)			(281,665)					17,123	(12,870)
Common stock repurchased and retired (in shares)	(5,000,786)				(1,058,000)
Common stock repurchased and retired	$ (49,581)		(49,581)		$ (1)	(49,580)
Settlement of conversion premium upon maturity of 2014 Notes (in shares)					1,250,000
Settlement of conversion premium upon maturity of 2014 Notes	(8)		(8)			(59,139)		59,131
Common stock received from exercise of Note Hedges (in shares)					(1,250,000)
Common stock received from exercise of Note Hedges	3		3			57,695		(57,692)
Common stock received from exercise of Note Hedges related to repurchased 2014 Notes (in shares)					(42,000)
Common stock received from exercise of Note Hedges related to repurchased 2014 Notes	0					1,959		(1,959)
Common stock issued upon settlement of Warrants (in shares)					293,000
Common stock issued upon settlement of Warrants	(5)		(5)			(25)		20
Purchases of capped calls, net of taxes	(32,441)		(32,441)			(32,441)
Treasury stock retired	0				$ (5)	(234,994)		234,999
Ending balances (in shares) at Jan. 31, 2022					66,211,000
Ending balances at Jan. 31, 2022	954,579		952,194		$ 66	1,125,152		0	(54,509)		(118,515)	2,385
Increase (Decrease) in Stockholders' Equity
Net (loss) income	15,659		14,898						14,898			761
Other comprehensive (loss) income	(35,584)		(35,584)								(35,584)
Stock-based compensation — equity-classified awards	68,257		68,257			68,257
Common stock issued for stock awards and stock bonuses (in shares)					1,853,000
Common stock issued for stock awards and stock bonuses	6,427		6,427		$ 2	6,425
Treasury stock acquired (in shares)					(2,011,000)
Treasury stock acquired	(106,146)		(106,146)					(106,146)
Dividends or distribution to noncontrolling interests	(787)											(787)
Preferred stock dividends	$ (20,800)		(20,800)			(20,800)
Common stock repurchased and retired (in shares)	(2,659,000)				(649,000)
Common stock repurchased and retired	$ (23,456)		(23,456)		$ (1)	(23,455)
Treasury stock retired	0				$ (2)	(106,144)		106,146
Other reclasses	0					5,722			(5,722)
Ending balances (in shares) at Jan. 31, 2023					65,404,000
Ending balances at Jan. 31, 2023	$ 858,149		$ 855,790		$ 65	$ 1,055,157		$ 0	$ (45,333)		$ (154,099)	$ 2,359

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 15,659	$ 15,651	$ (107)
(Income) from discontinued operations, net of income taxes	0	0	(48,494)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:
Depreciation and amortization	67,960	75,449	85,380
Provision for credit losses	629	1,396	1,959
Stock-based compensation, excluding cash-settled awards	76,051	65,246	45,208
Change in fair value of future tranche right	0	(15,810)	56,146
Amortization of discount on convertible notes	0	0	12,883
Benefit from deferred income taxes	(9,544)	(11,323)	(1,398)
Non-cash losses on derivative financial instruments, net	0	14,374	1,267
Losses on early retirements of debt	0	2,474	143
Other non-cash items, net	9,652	7,416	(1,804)
Changes in operating assets and liabilities, net of effects of business combinations and divestitures:
Accounts receivable	3,060	11,712	(3,896)
Contract assets	(18,762)	(6,391)	(63)
Inventories	(7,753)	(713)	599
Prepaid expenses and other assets	(44,247)	(33,107)	(28,166)
Accounts payable and accrued expenses	6,394	(1,772)	33,380
Contract liabilities	5,395	7,820	5,438
Other liabilities	40,852	(2,321)	534
Other, net	(5,530)	4,553	644
Net cash provided by operating activities — continuing operations	139,816	134,654	159,653
Net cash (used in) provided by operating activities — discontinued operations	0	(9,055)	94,193
Net cash provided by operating activities	139,816	125,599	253,846
Cash flows from investing activities:
Cash paid for business combinations, including adjustments, net of cash acquired	(21,928)	(57,024)	0
Purchases of property and equipment	(27,950)	(16,962)	(14,035)
Purchases of investments	(10,627)	(751)	(102,531)
Maturities and sales of investments	10,709	46,299	69,763
Cash paid for capitalized software development costs	(7,595)	(7,560)	(7,312)
Other investing activities	808	98	100
Net cash used in investing activities — continuing operations	(56,583)	(35,900)	(54,015)
Net cash provided by investing activities — discontinued operations	0	0	16,772
Net cash used in investing activities	(56,583)	(35,900)	(37,243)
Cash flows from financing activities:
Proceeds from issuance of preferred stock and future tranche right, net of issuance costs	0	198,731	197,254
Proceeds from borrowings	0	315,000	155,000
Repayments of borrowings and other financing obligations	(3,658)	(313,354)	(207,165)
Payments to repurchase convertible notes	0	0	(13,032)
Settlement of 2014 Notes	0	(386,887)	0
Purchases of capped calls	0	(41,060)	0
Payments of equity issuance, debt issuance, and other debt-related costs	(224)	(10,708)	(2,287)
Distributions paid to noncontrolling interest	(787)	(1,110)	(5,414)
Purchases of treasury stock and common stock for retirement	(128,985)	(75,955)	(36,836)
Preferred stock dividend payments	(20,800)	(12,856)	(1,589)
Payment for termination of interest rate swap	0	(16,502)	0
Net cash transferred to Cognyte Software Ltd.	0	(114,657)	0
Dividend and other settlements received from Cognyte Software Ltd.	0	38,280	0
Payments of deferred purchase price and contingent consideration for business combinations (financing portion) and other financing activities	(3,453)	(9,045)	(9,121)
Net cash (used in) provided by financing activities — continuing operations	(157,907)	(430,123)	76,810
Net cash used in financing activities — discontinued operations	0	0	(4,877)
Net cash (used in) provided by financing activities	(157,907)	(430,123)	71,933
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents	(2,033)	(841)	(60)
Net (decrease) increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	(76,707)	(341,265)	288,476
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year	358,868	700,133	411,657
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year	$ 282,161	$ 358,868	$ 700,133

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash and cash equivalents	$ 282,099	$ 358,805	$ 663,843
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	282,161	358,868	700,133
Restricted cash and cash equivalents, and restricted bank time deposits
Restricted cash and cash equivalents	0	0	25,910
Prepaid expenses and other current assets
Restricted cash and cash equivalents	5	6	0
Other assets
Restricted cash and cash equivalents	$ 57	$ 57	$ 10,380

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business Unless the context otherwise requires, the terms “Verint”, “we”, “us”, and “our” in these notes to consolidated financial statements refer to Verint Systems Inc. and its consolidated subsidiaries. Verint helps brands provide Boundless Customer Engagement™. For more than two decades, the world’s most iconic brands – including more than 85 of the Fortune 100 companies – have trusted Verint to provide the technology and domain expertise they require to effectively build enduring customer relationships. Through the Verint Customer Engagement Cloud Platform, we offer our customers and partners solutions that are based on artificial intelligence (“AI”) and are developed specifically for customer engagement. These solutions automate workflows across enterprise silos to optimize the workforce expense and at the same time drive an elevated consumer experience. Our solutions are used by approximately 10,000 organizations in over 175 countries across a diverse set of verticals, including financial services, healthcare, utilities, technology, and government. Our customers include large enterprises with thousands of employees, as well as small to medium sized business (“SMB”) organizations. Verint is headquartered in Melville, New York, and has approximately 30 offices worldwide. We have approximately 4,300 passionate employees plus a few hundred contractors around the globe exclusively focused on helping brands provide Boundless Customer Engagement™. Spin-Off of Cognyte Software Ltd. On February 1, 2021, we completed the spin-off (the “Spin-Off”) of Cognyte Software Ltd. (“Cognyte”), a company limited by shares incorporated under the laws of the State of Israel whose business and operations consist of our former Cyber Intelligence Solutions business (the “Cognyte Business”). The Spin-Off of Cognyte was completed by way of a pro rata distribution in which holders of Verint’s common stock, par value $0.001 per share, received one ordinary share of Cognyte, no par value, for every share of common stock of Verint held of record as of the close of business on January 25, 2021. After the distribution, we do not beneficially own any ordinary shares of Cognyte and no longer consolidate Cognyte into our financial results for periods ending after January 31, 2021. The Spin-Off was intended to be generally tax-free to our stockholders for U.S. federal income tax purposes. The financial results of Cognyte for the year ended January 31, 2021 are presented as income from discontinued operations, net of taxes on the consolidated statement of operations. The historical consolidated statement of cash flows has also been revised to reflect the effect of the Spin-Off. The historical statements of comprehensive income (loss) and the balances related to stockholders’ equity have not been revised to reflect the effect of the Spin-Off. For further information on discontinued operations, see Note 2, “Discontinued Operations”. Unless noted otherwise, discussion in the notes to the consolidated financial statements pertain to continuing operations. Apax Convertible Preferred Stock Investment On December 4, 2019, we announced that an affiliate (the “Apax Investor”) of Apax Partners (“Apax”) would make an investment in us in an amount of up to $400.0 million. Under the terms of the Investment Agreement, dated as of December 4, 2019 (the “Investment Agreement”), on May 7, 2020, the Apax Investor purchased $200.0 million of our Series A convertible preferred stock (“Series A Preferred Stock”). In connection with the completion of the Spin-Off, on April 6, 2021, the Apax Investor purchased $200.0 million of our Series B convertible preferred stock (the “Series B Preferred Stock” and together with the Series A Preferred Stock, the “Preferred Stock”). As of January 31, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%. Please refer to Note 10, “Convertible Preferred Stock” for a more detailed discussion of the Apax investment. Principles of Consolidation The accompanying consolidated financial statements include the accounts of Verint Systems Inc., and our wholly owned or otherwise controlled subsidiaries. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders’ equity on our consolidated balance sheet, but separately from our stockholders’ equity. On January 31, 2022, we exercised the option to acquire the noncontrolling interests in two majority owned subsidiaries. Prior to the exercise, we accounted for the option as an in-substance investment in the noncontrolling common stock of each such subsidiary. We included the fair value of the option within accrued expenses and other current liabilities and did not recognize noncontrolling interests in these subsidiaries. Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment. We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents We consider all highly liquid investments with original maturities of 90 days or less at the time of purchase to be cash equivalents. For further information regarding our cash and cash equivalents, see Note 5, “Cash, Cash Equivalents, and Short-Term Investments.” Investments Our investments generally consist of bank time deposits, and marketable debt securities of corporations, the U.S. government, and agencies of the U.S. government, all with remaining maturities in excess of 90 days at the time of purchase. We held no marketable debt securities at January 31, 2023 and 2022. Investments with maturities in excess of one year are included in other assets. Accounts Receivable, Net Trade accounts receivable are comprised of invoiced amounts due from customers for which we have an unconditional right to collect and are not interest-bearing. Credit is extended to customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. Concentrations of Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and cash equivalents, bank time deposits, short-term investments, trade accounts receivable, and contract assets. We invest our cash in bank accounts, certificates of deposit, and money market accounts with major financial institutions, in U.S. government and agency obligations, and in debt securities of corporations. By policy, we seek to limit credit exposure on investments through diversification and by restricting our investments to highly rated securities. We grant credit terms to our customers in the ordinary course of business. Concentrations of credit risk with respect to trade accounts receivable and contract assets are generally limited due to the large number of customers comprising our customer base and their dispersion across different industries and geographic areas. No end-customer represented more than 10% of our revenue during the years ended January 31, 2023, 2022, and 2021. We had two partners, both authorized global resellers of our solutions, that accounted for more than 10% of our aggregated accounts receivable and contract assets in recent years. Partner A accounted for approximately 15% and 14% of our aggregated accounts receivable and contract assets at January 31, 2023 and 2022, respectively, and Partner B accounted for approximately 15% of our aggregated accounts receivable and contract assets at January 31, 2023, but did not account for more than 10% of our aggregated accounts receivable and contract assets at January 31, 2022. Partner A represented approximately 10% of our total revenue for the year end January 31, 2021, but did not represent 10% or greater of our total revenue for the years ended January 31, 2023 or 2022. Partner B did not represent 10% or greater of our total revenue for the years ended January 31, 2023, 2022, and 2021. Credit losses related to these partners have historically been immaterial. Allowance for Credit Losses We adopted Accounting Standard Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments on February 1, 2020 . ASU No. 2016-13 requires us to make judgments as to our ability to collect outstanding receivables and provide allowances for a portion of receivables over the lifetime of the receivables. Our allowance for expected credit losses is estimated based on an analysis of the aging of our accounts receivable and contract assets, historical write-offs, customer payment patterns, individual customer creditworthiness, current economic trends, reasonable and supportable forecasts of future economic conditions, and/or establishment of specific reserves for customers in adverse financial condition. We write-off an account receivable and charge it against its recorded allowance at the point when it is considered uncollectible. We assess the adequacy of the allowance for credit losses on a quarterly basis. The following table summarizes the activity in our allowance for credit losses for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Allowance for credit losses, beginning of year $ 1,260 $ 1,609 $ 1,239 Cumulative effect of adoption of ASU No. 2016-13 — — 577 Provisions charged to expense 565 1,242 1,899 Amounts written off (566) (1,666) (1,931) Other, including fluctuations in foreign exchange rates 31 75 (175) Allowance for credit losses, end of year $ 1,290 $ 1,260 $ 1,609 Our estimated expected credit losses associated with contract assets were $0.1 million for the year ended January 31, 2023, and were not material for the years ended January 31, 2022 and 2021. Historical write-offs of contract assets have been insignificant. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the weighted-average method of inventory accounting. The valuation of our inventories requires us to make estimates regarding excess or obsolete inventories, including making estimates of the future demand for our products. Although we make every effort to ensure the accuracy of our forecasts of future product demand, any significant unanticipated changes in demand, price, or technological developments could have a significant impact on the value of our inventory and reported operating results. Charges for excess and obsolete inventories are included within cost of revenue. Property and Equipment, net Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation is computed using the straight-line method based over the estimated useful lives of the assets. The vast majority of equipment, furniture and other is depreciated over periods ranging from three years to seven years. Software is typically depreciated over periods ranging from three years to four years. Buildings are depreciated over ten years. Leasehold improvements are amortized over the shorter of their estimated useful lives or the related lease term. Finance leased assets are amortized over the related lease term. The cost of maintenance and repairs of property and equipment is charged to operations as incurred. When assets are retired or disposed of, the cost and accumulated depreciation or amortization thereon are removed from the consolidated balance sheet and any resulting gain or loss is recognized in the consolidated statement of operations. Business Segment Information Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the enterprise’s chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. We are a pure-play customer engagement company that operates as a single reporting segment as our Chief Executive Officer, who is our CODM, reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Goodwill and Other Acquired Intangible Assets For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill. We test goodwill for impairment at the reporting unit level, which can be an operating segment or one level below an operating segment, on an annual basis as of November 1, or more frequently if changes in facts and circumstances indicate that impairment in the value of goodwill may exist. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we elect to bypass a qualitative assessment, or if our qualitative assessment indicates that goodwill impairment is more likely than not, we perform quantitative impairment testing. If our quantitative testing determines that the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized in an amount equal to that excess, limited to the total goodwill allocated to the reporting unit. We utilize some or all of three primary approaches to assess the fair value of a reporting unit: (a) an income-based approach, using projected discounted cash flows, (b) a market-based approach, using valuation multiples of comparable companies, and (c) a transaction-based approach, using valuation multiples for recent acquisitions of similar businesses made in the marketplace. Our estimate of fair value of our reporting unit is based on a number of subjective factors, including: (a) appropriate consideration of valuation approaches (income approach, comparable public company approach, and comparable transaction approach), (b) estimates of future growth rates, (c) estimates of our future cost structure, (d) discount rates for our estimated cash flows, (e) selection of peer group companies for the comparable public company and the comparable market transaction approaches, (f) required levels of working capital, (g) assumed terminal value, and (h) time horizon of cash flow forecasts. The valuation methodology to determine the fair value of the reporting units is sensitive to management's forecasts of future revenue, profitability and market conditions. This methodology also considers various macroeconomic, industry-specific, and company-specific factors. Any resulting financial impact cannot be estimated reasonably at this time but may adversely affect our business and financial results. If there were an adverse change in facts and circumstances, then an impairment charge may be necessary in the future. Should the fair value of our reporting unit fall below its carrying amount because of reduced operating performance, market declines, changes in the discount rate, or other conditions, charges for impairment may be necessary. We monitor our reporting unit to determine if there is an indicator of potential impairment. Acquired identifiable intangible assets include identifiable acquired technologies, customer relationships, trade names, distribution networks, non-competition agreements, sales backlog, and in-process research and development. We amortize the cost of finite-lived identifiable intangible assets over their estimated useful lives, which are periods of 10 years or less. Amortization is based on the pattern in which the economic benefits of the intangible asset are expected to be realized, which typically is on a straight-line basis. The fair values assigned to identifiable intangible assets acquired in business combinations are determined primarily by using the income approach, which discounts expected future cash flows attributable to these assets to present value using estimates and assumptions determined by management. The acquired identifiable finite-lived intangible assets are being amortized primarily on a straight-line basis, which we believe approximates the pattern in which the assets are utilized, over their estimated useful lives. Fair Value Measurements Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. This fair value hierarchy consists of three levels of inputs that may be used to measure fair value: • Level 1: quoted prices in active markets for identical assets or liabilities; • Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or • Level 3: unobservable inputs that are supported by little or no market activity. We review the fair value hierarchy classification of our applicable assets and liabilities at each reporting period. Changes in the observability of valuation inputs may result in transfers within the fair value measurement hierarchy. Please refer to Note 14, “Fair Value Measurements”, for further discussion regarding transfers between levels of the fair value measurement hierarchy. Fair Values of Financial Instruments Our recorded amounts of cash and cash equivalents, restricted cash and cash equivalents, and restricted bank time deposits, accounts receivable, contract assets, investments, and accounts payable approximate fair value, due to the short-term nature of these instruments. We measure certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Derivative Financial Instruments As part of our risk management strategy, when considered appropriate, we use derivative financial instruments including foreign currency forward contracts and interest rate swap agreements to hedge against certain foreign currency and interest rate exposures. Our intent is to mitigate gains and losses caused by the underlying exposures with offsetting gains and losses on the derivative contracts. By policy, we do not enter into speculative positions with derivative instruments. We record all derivatives as assets or liabilities on our consolidated balance sheets at their fair values. Gains and losses from the changes in values of these derivatives are accounted for based on the use of the derivative and whether it qualifies for hedge accounting. The counterparties to our derivative financial instruments consist of several major international financial institutions. We regularly monitor the financial strength of these institutions. While the counterparties to these contracts expose us to credit-related losses in the event of a counterparty’s non-performance, the risk would be limited to the unrealized gains on such affected contracts. We do not anticipate any such losses and we do not have a material portfolio of derivative financial instruments. Revenue Recognition We account for revenue in accordance with ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) . Please refer to Note 3, “Revenue Recognition” for a discussion of our accounting policies related to revenue. Cost of Revenue Our cost of revenue includes costs of materials, compensation and benefit costs for operations and service personnel, subcontractor costs, royalties and license fees related to third-party software included in our products, cloud infrastructure costs, depreciation of equipment used in operations and service, amortization of capitalized software development costs and certain purchased intangible assets, and related overhead costs. Costs that relate to satisfied (or partially satisfied) performance obligations in customer contracts (i.e., costs that relate to past performance) are expensed as incurred. Costs to Obtain and Fulfill Contracts We capitalize commissions paid to internal sales personnel and agent commissions that are incremental to obtaining customer contracts. We have determined that these commissions are in fact incremental and would not have occurred absent the customer contract. Deferred commissions also include the associated payroll taxes and fringe benefit costs associated with payments to our sales employees to the extent they are incremental. Sales and agent commissions are primarily deferred and amortized on a straight-line basis over the period the goods or services are transferred to the customer to which the assets relate, which ranges from immediate to as long as six years, if commission amounts paid upon renewal are not commensurate with amounts paid on the initial contract. A portion of the initial commission payable on the majority of our contracts is amortized over the anticipated renewal period, which is generally five We capitalize costs incurred to fulfill our contracts when the costs relate directly to the contract and are expected to generate resources that will be used to satisfy the performance obligation under the contract and are expected to be recovered through revenue generated under the contract. Costs to fulfill contracts are expensed to cost of revenue as we satisfy the related performance obligations. Deferred cost of revenue is classified in its entirety as current or long-term based on whether the related revenue will be recognized within twelve months of the origination date of the arrangement. The amounts capitalized primarily relate to one-time costs incurred in the initial phase of our bundled SaaS arrangements (i.e., setup costs), which consist of costs related to the installation of systems and processes. Capitalized setup costs are amortized on a straight-line basis over the expected period of benefit, which includes anticipated contract renewals or extensions, consistent with the transfer to the customer of the services to which the asset relates. Research and Development, net With the exception of certain software development costs, all research and development costs are expensed as incurred, and consist primarily of personnel and consulting costs, travel, depreciation of research and development equipment, and related overhead and other costs associated with research and development activities. We periodically derive benefits from participation in government-sponsored programs in certain jurisdictions, for the support of research and development activities conducted in those locations. Software Development Costs Costs incurred to acquire or develop software to be sold, leased or otherwise marketed are capitalized after technological feasibility is established, and continue to be capitalized through the general release of the related software product. Amortization of capitalized costs begins in the period in which the related product is available for general release to customers and is recorded on a straight-line basis, which approximates the pattern in which the economic benefits of the capitalized costs are expected to be realized, over the estimated economic lives of the related software products, generally five years. Internal-Use Software Development Costs and Cloud Computing Arrangements We expense costs associated with the assessment stage of software development projects. Capitalization begins when the preliminary project stage has been completed and management with the relevant authority authorizes and commits to the funding of the project. These capitalized costs include external direct costs utilized in developing or obtaining the applications and payroll and payroll-related costs for employees who are directly associated with the development of the applications. We expense the personnel-related costs of training and data conversion. We also expense costs associated with the post-implementation and operation stage, including maintenance and specified upgrades; however, we capitalize internal and external costs associated with significant upgrades to existing systems that result in additional functionality. Cloud computing arrangement costs follow the internal-use software accounting guidance to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized internal-use software development costs are generally amortized over periods ranging from four years to seven years on a straight-line basis, which best represents the pattern of the software’s use. Capitalized implementation costs related to a service contract will be amortized over the term of the hosting arrangement beginning when the component of the hosting arrangement is ready for its intended use. Periodically, we reassess the useful life considering technology, obsolescence, and other factors. Income Taxes We account for income taxes under the asset and liability method which includes the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our consolidated financial statements. Under this approach, deferred taxes are recorded for the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus deferred taxes. Deferred taxes result from differences between the financial statement and tax bases of our assets and liabilities, and are adjusted for changes in tax rates and tax laws when changes are enacted. The effects of future changes in income tax laws or rates are not anticipated. We are subject to income taxes in the United States and numerous foreign jurisdictions. The calculation of our income tax provision involves the application of complex tax laws and requires significant judgment and estimates. We evaluate the realizability of our deferred tax assets for each jurisdiction in which we operate at each reporting date, and establish valuation allowances when it is more likely than not that all or a portion of our deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income of the same character and in the same jurisdiction. We consider all available positive and negative evidence in making this assessment, including, but not limited to, the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. In circumstances where there is sufficient negative evidence indicating that our deferred tax assets are not more-likely-than-not realizable, we establish a valuation allowance. We use a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate tax positions taken or expected to be taken in a tax return by assessing whether they are more-likely-than-not sustainable, based solely on their technical merits, upon examination and including resolution of any related appeals or litigation process. The second step is to measure the associated tax benefit of each position as the largest amount that we believe is more-likely-than-not realizable. Differences between the amount of tax benefits taken or expected to be taken in our income tax returns and the amount of tax benefits recognized in our financial statements represent our unrecognized income tax benefits, which we either record as a liability or as a reduction of deferred tax assets. Our policy is to include interest (expense and/or income) and penalties related to unrecognized income tax benefits as a component of the provision for income taxes. Functional Currencies and Foreign Currency Transaction Gains and Losses The functional currency for most of our foreign subsidiaries is the applicable local currency, although we have some subsidiaries with functional currencies that differ from their local currency, of which the most notable exception is our subsidiary in Israel, whose functional currency is the U.S. dollar. Transactions denominated in currencies other than a functional currency are converted to the functional currency on the transaction date, and any resulting assets or liabilities are further remeasured at each reporting date and at settlement. Gains and losses recognized upon such remeasurements are included within other income (expense), net in the consolidated statements of operations. We recorded net foreign currency gains of $3.5 million for the year ended January 31, 2023, and net foreign currency losses of $1.6 million for each of the years ended January 31, 2022 and 2021. For consolidated reporting purposes, in those instances where a foreign subsidiary has a functional currency other than the U.S. dollar, revenue and expenses are translated into U.S. dollars using average exchange rates for the reporting period, while assets and liabilities are translated into U.S. dollars using period-end rates. The effects of foreign currency translation adjustments are included in stockholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets. Stock-Based Compensation We recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of the award. We recognize the fair value of the award as compensation expense over the period during which an employee is required to provide service in exchange for the award. For performance stock units for which vesting is in part dependent on total shareholder return, the fair value of the award is estimated on the date of grant using a Monte Carlo Simulation. Expected volatility and expected term are input factors for that model and may require significant management judgment. Expected volatility is estimated utilizing daily historical volatility for Verint common stock price and the constituents of the specific comparator index over a period commensurate with the remaining award performance period. The risk-free interest rate used is equal to the implied daily yield of the zero-coupon U.S. Treasury bill that corresponds with the remaining performance period of the award as of the valuation date. Net Income (Loss) Per Common Share Attributable to Verint Systems Inc. Basic net income (loss) per common share is computed by dividing net income (loss) attributable to common shareholders by the weighted-average common stock outstanding during the respective period. Net income (loss) attributable to common shareholders is computed by deducting both the dividends declared in the period on the Preferred Stock and the dividends accumulated for the period on the Preferred Stock from net income (loss). Shares used in the calculation of basic net income (loss) per common share include vested but unissued shares underlying awards of restricted stock units when all necessary conditions for earning those shares have been satisfied at the award’s vesting date, but exclude unvested shares of restricted stock because they are contingent upon future service conditions. Diluted net income (loss) per common share is computed by dividing net income (loss) attributable to common and common equivalent shareholders by the total of the weighted-average common stock outstanding and common e

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Jan. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	DISCONTINUED OPERATIONS On February 1, 2021 (the “Spin-Off Date”), we completed the Spin-Off of Cognyte by way of a pro rata distribution of all of the then-issued and outstanding ordinary shares of Cognyte to holders of record of our common stock as of the close of business on January 25, 2021. To effect the Spin-Off and provide a framework for our relationship with Cognyte post Spin-Off we entered into several agreements with Cognyte, including the following: • a Separation and Distribution Agreement; • a Tax Matters Agreement; • an Employee Matters Agreement; • a Transition Services Agreement; • an Intellectual Property Cross License Agreement; and • a Trademark Cross License Agreement. These agreements provide for the allocation of assets, employees, liabilities, and obligations (including property, employee benefits, litigation, and tax-related assets and liabilities) between us and Cognyte attributable to periods prior to, at and after the Spin-Off. For the year ended January 31, 2022, we invoiced Cognyte $5.9 million, and Cognyte invoiced us $1.1 million, for transition services provided under the Transition Services Agreement and the services were substantially concluded. Under the Tax Matters Agreement with Cognyte, we and Cognyte each agreed to share the obligation to pay any taxes as shown on tax returns filed by Cognyte (or any member of its group), on one hand, and us (or any member of our group), on the other hand, such that we will be primarily responsible for any taxes related to, or arising in connection with our business and Cognyte will be responsible for any taxes related to, or arising in connection with, the Cognyte Business, regardless of which party prepares and files any such tax return and whether such taxes arise prior to or after the Spin-Off. We and Cognyte also agreed to share responsibility for preparing relevant tax returns, which responsibility will depend on the type of tax return and the period for which such tax return is being filed. We and Cognyte agreed to indemnify each other under the Tax Matters Agreement for certain actions or inactions. The Spin-Off met the criteria for classification as “discontinued operations” in accordance with the accounting guidance upon completion of the separation, and as such, the results of our former Cognyte Business have been classified as discontinued operations in our consolidated statements of operations and consolidated statements of cash flows for all applicable periods presented. For the years ended January 31, 2023 and 2022, there were no assets or liabilities from discontinued operations associated with Cognyte. There was no revenue earned or costs and expenses incurred by discontinued operations during the years ended January 31, 2023 and 2022. The following table summarizes the major classes of line items included within discontinued operations in our consolidated statements of operations for the year ended January 31, 2021: Year ended January 31, (in thousands) 2021 Revenue $ 443,458 Cost of revenue 128,043 Operating expenses 264,132 Other income, net 6,604 Income from discontinued operations before benefit from income taxes 57,887 Provision for income taxes 9,393 Net income from discontinued operations 48,494 Net income from discontinued operations attributable to noncontrolling interests 6,107 Net income from discontinued operations attributable to Verint Systems Inc. common shares $ 42,387 The following table summarizes the assets and liabilities that were transferred to Cognyte on February 1, 2021: (in thousands) January 31, 2021 Assets Current Assets: Cash and cash equivalents $ 78,570 Restricted cash and cash equivalents, and restricted bank time deposits 27,042 Short-term investments 4,713 Accounts receivable, net 175,001 Contract assets, net 20,317 Inventories 14,542 Prepaid expenses and other current assets 34,741 Total current assets of discontinued operations 354,926 Property and equipment, net 37,152 Operating lease right-of-use assets 31,040 Goodwill 158,183 Intangible assets, net 5,299 Deferred income taxes 7,202 Other assets 42,076 Total long-term assets of discontinued operations 280,952 Total assets of discontinued operations $ 635,878 Liabilities Current Liabilities: Accounts payable $ 41,512 Accrued expenses and other current liabilities 100,189 Contract liabilities 127,012 Total current liabilities of discontinued operations 268,713 Long-term contract liabilities 22,037 Operating lease liabilities 23,174 Deferred income taxes 3,985 Other liabilities 8,922 Total long-term liabilities of discontinued operations 58,118 Total liabilities of discontinued operations $ 326,831 In connection with the Spin-Off, $17.1 million of accumulated other comprehensive income, net of income taxes, related to foreign currency translation adjustments and foreign exchange contracts designated as cash flow hedges were transferred to Cognyte on the Spin-Off Date. Additionally, Verint transferred its interests in Cognyte Technologies Israel Ltd. (formerly Verint Systems Limited) (“CTIL”) on the Spin-Off Date. Prior to the transfer, CTIL was a wholly owned subsidiary of Verint and the CTIL board of directors declared a cash dividend in the aggregate amount of $35.0 million payable to Verint, as its sole holder of record of ordinary shares, on January 29, 2021. In April 2021, we received the dividend from Cognyte less applicable

REVENUE RECOGNITION

REVENUE RECOGNITION	12 Months Ended
	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
REVENUE RECOGNITION	REVENUE RECOGNITION Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. When an arrangement contains multiple performance obligations, we account for individual performance obligations separately if they are distinct. We recognize revenue through the application of the following five steps: 1) Identify the contract(s) with a customer A contract with a customer exists when (i) we enter into an enforceable contract with the customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance, and (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or in the case of a new customer, published credit and financial information pertaining to the customer. Our customary business practice is to enter into legally enforceable written contracts with our customers. The majority of our contracts are governed by a master agreement between us and the customer, which sets forth the general terms and conditions of any individual contract between the parties, which is then supplemented by a customer purchase order to specify the different goods and services, the associated prices, and any additional terms for an individual contract. Multiple contracts with a single counterparty entered into within a close timeframe are evaluated to determine if the contracts should be combined and accounted for as a single contract. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or services either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods or services, we must apply judgment to determine whether promised goods or services are capable of being distinct and are distinct in the context of the contract. If these criteria are not met the promised goods or services are accounted for as a combined performance obligation. Generally, our contracts do not include non-distinct goods or services. 3) Determine the transaction price The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer. We assess the timing of the transfer of goods and services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, we do not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less, which is the case in the majority of our customer contracts. The primary purpose of our invoicing terms is not to receive or provide financing from or to customers. To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price, if we assessed that it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Typically, our contracts do not provide our customers with any right of return or refund, and we do not constrain the contract price as it is probable that there will not be a significant revenue reversal due to a return or refund. 4) Allocate the transaction price to the performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct goods or services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, we must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. We allocate the variable amount to one or more distinct performance obligations but not all or to one or more distinct services that form a part of a single performance obligation, when the payment terms of the variable amount relate solely to our efforts to satisfy that distinct performance obligation and it results in an allocation that is consistent with the overall allocation objective of the revenue standard. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct good or service that forms part of a single performance obligation. We determine standalone selling price (“SSP”) based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we estimate the SSP taking into account available information such as market conditions, including geographic or regional specific factors, competitive positioning, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation. 5) Recognize revenue when (or as) the entity satisfies a performance obligation We satisfy performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. In the case of contracts that include customer acceptance criteria, revenue is not recognized until we can objectively conclude that the product or service meets the agreed-upon specifications in the contract. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to our customers. Revenue is measured based on consideration specified in a contract with a customer, and excludes taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer. Shipping and handling activities that are billed to the customer and occur after control over a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of revenue. Historically, these expenses have not been material. Nature of Goods and Services We derive and report our revenue in two categories: (a) recurring revenue, which includes bundled SaaS, unbundled SaaS, hosting services, optional managed services, initial and renewal support revenue, and product warranties, and (b) nonrecurring revenue, which primarily consists of perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties. Our bundled SaaS contracts are typically comprised of a right to access our software, maintenance, hosting fees and standard managed services. We do not provide the customer with the contractual right to take possession of the software at any time during the hosting period under these contracts. The customer can only benefit from the SaaS license, maintenance and standard managed services when combined with the hosting service as the hosting service is the only way for the customer to access the software and benefit from the maintenance and managed services. Accordingly, each of the license, maintenance, hosting and standard managed services is not considered a distinct performance obligation in the context of the contract, and are combined into a single performance obligation (“bundled SaaS services”) and recognized ratably over the contract period. Our bundled SaaS customer contracts can consist of fixed, variable, and usage-based fees. Typically, we invoice fees at the outset of the contract, though quarterly or monthly billing terms are included in certain contracts. Certain bundled SaaS contracts include a nonrefundable upfront fee for setup services, which are not distinct from the bundled SaaS services. Non-distinct setup services represent an advanced payment for future bundled SaaS services, and are recognized as revenue when those bundled SaaS services are satisfied, unless the nonrefundable fee is considered to be a material right, in which case the nonrefundable fee is recognized over the expected benefit period, which includes anticipated renewals. We determine SSP for our bundled SaaS services based on the price at which the performance obligation is sold separately, which is observable through past renewal transactions. We satisfy our bundled SaaS services by providing access to our software over time and processing transactions for usage-based contracts. For non-usage based fees, the period of time over which we perform is commensurate with the contract term because that is the period during which we have an obligation to provide the service. The performance obligation is recognized on a time elapsed basis, by day for which the services are provided. Our software licenses either provide our customers a perpetual right to use our software or, in the case of unbundled SaaS, the right to use our software for only a fixed term, in most cases between a one order to maximize the use of observable inputs. Software SSP is established based on an appropriate discount from our established list price, taking into consideration whether there are certain stratifications of the population with different pricing practices. Revenue for hardware is recognized at a point in time, generally upon shipment or delivery. Professional services revenues primarily consist of fees for deployment and optimization services, as well as training, and are generally recognized over time as the customer simultaneously receives and consumes the benefits of the professional services as the services are performed. Professional services that are billed on a time and materials basis are recognized over time as the services are performed. For contracts billed on a fixed price basis, revenue is recognized over time using an input method based on labor hours expended to date relative to the total labor hours expected to be required to satisfy the related performance obligation. We determine SSP for our professional services based on the price at which the performance obligation is sold separately, which is observable through past transactions. Customer support revenue is derived from providing remote technical support services, bug fixes and unspecified software updates and upgrades to customers on a when-and-if-available basis. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract. Each of these distinct performance obligations represent a stand ready obligation to provide service to a customer, which is concurrently delivered and has the same pattern of transfer to the customer, which is why we account for these support services as a single performance obligation. We recognize support services ratably over the contractual term, which typically is one year for perpetual licenses and one Our solutions are generally sold with a warranty of one year to three years for hardware and 90 days for software. These warranties do not represent an additional performance obligation as services beyond assuring that the software license and hardware complies with agreed-upon specifications are not provided. Disaggregation of Revenue The following table provides a disaggregation of our recurring and nonrecurring revenue. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions. • Recurring revenue primarily consists of: ◦ Cloud revenue, which consists primarily of software as a service (“SaaS”) revenue and optional managed services revenue. ▪ SaaS revenue consists predominately of bundled SaaS (software access rights with standard managed services) and unbundled SaaS (software licensing rights accounted for as term-based licenses whereby customers have a license to our software with related support for a specific period). ▪ Bundled SaaS revenue is recognized over time. ▪ Unbundled SaaS revenue is recognized at a point in time, except for the related support which is recognized over time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a one ◦ Support revenue, which consists of initial and renewal support. • Nonrecurring revenue primarily consists of our perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties. Year Ended January 31, (in thousands) 2023 2022 2021 Recurring revenue Bundled SaaS revenue $ 222,560 $ 183,035 $ 145,962 Unbundled SaaS revenue 221,645 139,729 71,990 Optional managed services revenue 61,388 65,648 59,459 Total cloud revenue 505,593 388,412 277,411 Support revenue 179,944 244,717 298,213 Total recurring revenue 685,537 633,129 575,624 Nonrecurring revenue Perpetual revenue 116,611 138,078 141,840 Professional services revenue 100,097 103,302 112,783 Total nonrecurring revenue 216,708 241,380 254,623 Total revenue $ 902,245 $ 874,509 $ 830,247 Contract Balances The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers: January 31, (in thousands) 2023 2022 Accounts receivable, net $ 188,414 $ 193,831 Contract assets, net $ 60,444 $ 42,688 Long-term contract assets, net (included in other assets) $ 37,950 $ 30,510 Contract liabilities $ 271,476 $ 271,271 Long-term contract liabilities $ 18,047 $ 15,872 We receive payments from customers based upon contractual billing schedules, and accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to multi-year unbundled SaaS contracts and arrangements where our right to consideration is subject to the contractually agreed upon billing schedule. We expect billing and collection of a majority of our contract assets to occur within the next twelve months and asset impairment charges related to contract assets were immaterial for each of the years ended January 31, 2023, 2022, and 2021. We had two partners, both authorized global resellers of our solutions, that accounted for more than 10% of our aggregated accounts receivable and contract assets in recent years. Partner A accounted for approximately 15% and 14% of our aggregated accounts receivable and contract assets at January 31, 2023 and 2022, respectively, and Partner B accounted for approximately 15% of our aggregated accounts receivable and contract assets at January 31, 2023, but did not account for more than 10% of our aggregated accounts receivable and contract assets at January 31, 2022. Credit losses related to these partners have historically been immaterial. During the years ended January 31, 2023 and 2022, we transferred $43.2 million and $37.7 million, respectively, to accounts receivable from contract assets recognized at the beginning of each period, as a result of the right to the transaction consideration becoming unconditional. We recognized $69.9 million and $57.4 million of contract assets during the years ended January 31, 2023 and 2022, respectively. Contract assets recognized during each year primarily related to multi-year unbundled SaaS contracts that are invoiced annually with license revenue recognized upfront. Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract. Revenue recognized during the years ended January 31, 2023 and 2022 from amounts included in contract liabilities at the beginning of each period was $242.4 million and $247.9 million, respectively. Remaining Performance Obligations Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. The majority of our arrangements are for periods of up to three years, with a significant portion being one year or less. We elected to exclude amounts of variable consideration attributable to sales- or usage-based royalties in exchange for a license of our IP from the remaining performance obligations. The timing and amount of revenue recognition for our remaining performance obligations is influenced by several factors, including seasonality, the timing of renewals, the timing of delivery of software licenses, the average length of the contract terms, and foreign currency exchange rates. The following table provides information about when we expect to recognize our remaining performance obligations: January 31, (in thousands) 2023 2022 RPO: Expected to be recognized within 1 year $ 464,346 $ 447,428 Expected to be recognized in more than 1 year 262,695 274,404 Total RPO $ 727,041 $ 721,832 Costs to Obtain and Fulfill Contracts Total capitalized costs to obtain contracts were $58.6 million as of January 31, 2023, of which $3.7 million is included in prepaid expenses and other current assets and $54.9 million is included in other assets on our consolidated balance sheet. Total capitalized costs to obtain contracts were $55.8 million as of January 31, 2022, of which $3.9 million is included in prepaid expenses and other current assets and $51.9 million is included in other assets on our consolidated balance sheet. During the years ended January 31, 2023, 2022, and 2021, we expensed $33.1 million, $33.1 million and $26.1 million, respectively, of sales and agent commissions, which are included in selling, general and administrative expenses and there were no impairment losses recognized for these capitalized costs. Total capitalized costs to fulfill contracts were $5.1 million as of January 31, 2023, of which $0.2 million is included in prepaid expenses and other current assets and $4.9 million is included in other assets on our consolidated balance sheet. Total capitalized costs to fulfill contracts were $6.1 million as of January 31, 2022, of which $0.2 million is included in prepaid expenses and other current assets and $5.9 million is included in other assets on our consolidated balance sheet. During the years ended January 31, 2023, 2022, and 2021, we amortized $3.0 million, $3.2 million, and $2.7 million, respectively, of contract fulfillment costs.

NET LOSS PER COMMON SHARE ATTRI

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.	12 Months Ended
	Jan. 31, 2023
Earnings Per Share [Abstract]
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.	NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. The following table summarizes the calculation of basic and diluted net loss per common share attributable to Verint Systems Inc. for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands, except per share amounts) 2023 2022 2021 Net income (loss) from continuing operations $ 15,659 $ 15,651 $ (48,601) Net income from discontinued operations — — 48,494 Net income (loss) 15,659 15,651 (107) Net income attributable to noncontrolling interests from continuing operations 761 1,238 1,053 Net income attributable to noncontrolling interests from discontinued operations — — 6,107 Net income (loss) attributable to Verint Systems Inc. 14,898 14,413 (7,267) Dividends on preferred stock (20,800) (18,922) (7,656) Net loss attributable to Verint Systems Inc. for basic net loss per common share (5,902) (4,509) (14,923) Dilutive effect of dividends on preferred stock — — — Net loss attributable to Verint Systems Inc. for diluted net loss per common share $ (5,902) $ (4,509) $ (14,923) Net (loss) income attributable to Verint Systems Inc. common shares Year Ended January 31, (in thousands, except per share amounts) 2023 2022 2021 Net loss from continuing operations attributable to Verint Systems Inc. common shares (5,902) (4,509) (57,310) Net income from discontinued operations attributable to Verint Systems Inc. common shares — — 42,387 Weighted-average shares outstanding: Basic 65,332 65,591 65,173 Dilutive effect of employee equity award plans — — — Dilutive effect of 2021 Notes — — — Dilutive effect of 2014 Notes — — — Dilutive effect of warrants — — — Dilutive effect of assumed conversion of preferred stock — — — Diluted 65,332 65,591 65,173 Basic net (loss) income per common share attributable to Verint Systems Inc.: Continuing Operations $ (0.09) $ (0.07) $ (0.88) Discontinued Operations — — 0.65 Total basic net loss per common share attributable to Verint Systems Inc. $ (0.09) $ (0.07) $ (0.23) Diluted net (loss) income per common share attributable to Verint Systems Inc.: Continuing operations $ (0.09) $ (0.07) $ (0.88) Discontinued operations — — 0.65 Total diluted net loss per common share attributable to Verint Systems Inc. $ (0.09) $ (0.07) $ (0.23) We excluded the following weighted-average potential common shares from the calculations of diluted net loss per common share during the applicable periods because their inclusion would have been anti-dilutive: Year Ended January 31, (in thousands) 2023 2022 2021 Common shares excluded from calculation: Stock options and restricted stock-based awards 2,120 1,580 1,337 2014 Notes — 481 6,002 Warrants — 117 6,205 Series A Preferred Stock 5,498 5,498 2,743 Series B Preferred Stock 3,980 3,282 — In periods for which we report a net loss attributable to Verint Systems Inc. common shares, basic net loss per common share and diluted net loss per common share are identical since the effect of all potential common shares is anti-dilutive and therefore excluded. For the year ended January 31, 2023, the average price of our common stock did not exceed the $62.08 per share conversion price of our 2021 Notes, and other requirements for the 2021 Notes to be convertible were not met. The 2021 Notes will have a dilutive impact on net income per common share at any time when the average market price of our common stock for a quarterly reporting period exceeds the conversion price. The Capped Calls (as defined in Note 8, “Long-Term Debt”) do not impact our diluted earnings per common share calculations as their effect would be anti-dilutive. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the $62.08 conversion price, with such reduction and/or offset subject to a cap of $100.00. Following the completion of the Spin-Off on February 1, 2021, the strike prices of the conversion features of our 2014 Notes and Warrants (each as defined in Note 8, “Long-Term Debt”) were reduced to $40.55 per share and $47.18 per share, respectively, which increased the equivalent number of underlying common shares to 9,541,000 and 9,865,000, respectively. Our Note Hedges (as defined in Note 8, “Long-Term Debt”) did not impact our diluted earnings per common share calculation because their effect would be anti-dilutive. However, in connection with the maturity of the 2014 Notes, the common shares delivered to us under the Note Hedges neutralized the dilutive effect of the common shares that we issued under the 2014 Notes to settle the conversion premium. As a result, the settlement of the outstanding 2014 Notes did not increase our outstanding common stock. Our Warrants had a dilutive impact on net income per common share to the extent that we reported net income for the applicable period and the average market value of our common stock exceeded the strike price of the Warrants. The Warrants expired incrementally on a series of expiration dates between August 30, 2021 and January 21, 2022. At each expiration date the Warrants were exercised when the market price per share of our common stock exceeded the strike price of the Warrants, and we issued an aggregate of 293,143 shares of our common stock as part of the cashless exercise of approximately 5,031,000 Warrants. All outstanding Warrants were exercised or expired as of January 31, 2022. Further details regarding the 2021 Notes, Capped Calls, 2014 Notes, Note Hedges, and the Warrants appear in Note 8, “Long-Term Debt”. The weighted-average common shares underlying the assumed conversion of the Preferred Stock, on an as-converted basis, were excluded from the calculations of diluted net loss per common share for the years ended January 31, 2023, 2022, and 2021, as their effect would have been anti-dilutive. Further details regarding the Preferred Stock investment appear in Note 10, “Convertible Preferred Stock”.

CASH, CASH EQUIVALENTS, AND SHO

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS	12 Months Ended
	Jan. 31, 2023
Cash, Cash Equivalents, and Short-Term Investments [Abstract]
CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS	CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS The following tables summarize our cash, cash equivalents, and short-term investments as of January 31, 2023 and 2022: January 31, 2023 (in thousands) Cost Basis Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash and cash equivalents: Cash and bank time deposits $ 134,289 $ — $ — $ 134,289 Money market funds 96,941 — — 96,941 Commercial paper 50,869 — — 50,869 Total cash and cash equivalents $ 282,099 $ — $ — $ 282,099 Short-term investments: Bank time deposits $ 697 $ — $ — $ 697 Total short-term investments $ 697 $ — $ — $ 697 January 31, 2022 (in thousands) Cost Basis Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash and cash equivalents: Cash and bank time deposits $ 201,769 $ — $ — $ 201,769 Money market funds 127,041 — — 127,041 Commercial paper $ 29,995 $ — $ — 29,995 Total cash and cash equivalents $ 358,805 $ — $ — $ 358,805 Short-term investments: Bank time deposits $ 765 $ — $ — $ 765 Total short-term investments $ 765 $ — $ — $ 765 Bank time deposits which are reported within short-term investments consist of deposits held outside of the United States with maturities of greater than 90 days, or without specified maturity dates which we intend to hold for periods in excess of 90 days. All other bank deposits are included within cash and cash equivalents. During the years ended January 31, 2023, 2022, and 2021, proceeds from maturities and sales of short-term investments were $10.7 million, $46.3 million, and $69.8 million, respectively.

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	12 Months Ended
	Jan. 31, 2023
Business Combination and Asset Acquisition [Abstract]
BUSINESS COMBINATIONS	BUSINESS COMBINATIONS Year Ended January 31, 2023 During the year ended January 31, 2023, we completed two business combinations: • In August 2022, we completed the acquisition of a company with conversational AI technology including six employees. • In January 2023, we completed the acquisition of a provider of appointment scheduling solutions including approximately 20 employees. These business combinations were not material to our consolidated financial statements. The combined consideration for these business combinations was approximately $38.3 million, including $26.1 million of combined cash paid at the closings, partially offset by $4.2 million of combined cash received in the acquisitions. In connection with these acquisitions, we also agreed to make potential additional cash payments to the respective former shareholders aggregating up to approximately $21.4 million, contingent upon the achievement of certain performance targets over periods extending through January 2026. The fair value of these contingent consideration obligations was estimated to be approximately $12.2 million at the respective acquisition dates. Cash paid for these business combinations was funded by cash on hand. The combined purchase prices were allocated to intangible assets, including the recognition of $6.0 million of developed technology, $4.2 million of customer relationships, and $0.1 million of trade names. The acquisition resulted in the recognition of $25.5 million of goodwill, of which $5.1 million is deductible for income tax purposes and $20.4 million is not deductible. Included among the factors contributing to the recognition of goodwill in these transactions were synergies in products and technologies, and the addition of skilled, assembled workforces. We incurred approximately $1.1 million of acquisition related costs, which were recorded as selling, general, and administrative expenses for the year ended January 31, 2023. Revenue and net income (loss) attributable to these acquisitions for the year ended January 31, 2023 were not material. Year Ended January 31, 2022 Conversocial Limited On August 23, 2021, we completed the acquisition of all of the outstanding shares of Conversocial Limited (together with its subsidiaries, “Conversocial”), a leading messaging platform that enables brands to deliver superior customer experiences. Conversocial has offices in London, United Kingdom and New York, New York. The purchase price consisted of (i) $53.4 million of cash paid at closing, funded from cash on hand, partially offset by $3.2 million of Conversocial’s cash received in the acquisition, resulting in net cash consideration at closing of $50.2 million; and (ii) $0.2 million of other purchase price adjustments. The purchase price for Conversocial was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date, with the remaining unallocated purchase price recorded as goodwill. The fair values assigned to identifiable intangible assets acquired were determined primarily by using the income approach, which discounts the expected future cash flows to present value using estimates and assumptions determined by management. Among the factors contributing to the recognition of goodwill as a component of the Conversocial purchase price allocation were synergies in products and technologies, and the addition of a skilled, assembled workforce. The acquisition resulted in the recognition of $31.3 million of goodwill, of which $0.5 million is deductible for income tax purposes and $30.8 million is not deductible. In connection with the purchase price allocation for Conversocial, the estimated fair value of undelivered performance obligations under customer contracts assumed in the acquisition was determined utilizing a cost build-up approach. The cost build-up approach calculated fair value by estimating the costs required to fulfill the obligations plus a reasonable profit margin, which approximates the amount that we believe would be required to pay a third party to assume the performance obligations. The estimated costs to fulfill the performance obligations were based on the historical direct costs for delivering similar services. As a result, in allocating the purchase price, we recorded $3.4 million of current and long-term contract liabilities, representing the estimated fair value of undelivered performance obligations for which payment had been received, which will be recognized as revenue as the underlying performance obligations are delivered. For undelivered performance obligations for which payment had not been received, we recorded a $1.2 million asset as a component of the purchase price allocation, representing the estimated fair value of these obligations, $0.7 million of which is included within prepaid expenses and other current assets and $0.5 million of which is included in other assets. We are amortizing this asset over the underlying delivery periods, which adjusts the revenue we recognize for providing these services to its estimated fair value. Transaction and related costs directly related to the acquisition of Conversocial, consisting primarily of professional fees and integration expenses, were $1.2 million and $3.4 million for the year ended January 31, 2023 and 2022, respectively, and were expensed as incurred and are included in selling, general and administrative expenses. Revenue and net income (loss) attributable to Conversocial included in our consolidated statement of operations for the years ended January 31, 2023 and 2022 were not material. The purchase price allocation for Conversocial is final. The following table sets forth the components and the allocation of the purchase price for our acquisition of Conversocial, including adjustments identified subsequent to the valuation date none of which were material: (in thousands) Amount Components of Purchase Price: Cash $ 53,409 Other purchase price adjustments (190) Total purchase price $ 53,219 Allocation of Purchase Price: Net tangible assets (liabilities): Accounts receivable $ 1,694 Other current assets, including cash acquired 5,462 Other assets 511 Current and other liabilities (1,945) Contract liabilities - current and long-term (3,410) Deferred income taxes (301) Net tangible assets 2,011 Identifiable intangible assets: Customer relationships 9,800 Developed technology 9,900 Trademarks and trade names 200 Total identifiable intangible assets 19,900 Goodwill 31,308 Total purchase price allocation $ 53,219 The acquired customer relationships, developed technology, and trademarks and trade names were assigned estimated useful lives of seven years, five years, and one year, respectively, the weighted average of which is approximately 5.9 years. The acquired identifiable intangible assets are being amortized on a straight-line basis, which we believe approximates the pattern in which the assets are utilized, over their estimated useful lives. Other Business Combinations During the three months ended July 31, 2021, we completed the acquisition of certain assets from a leader in contact center hiring automation that qualified as a business combination. This transaction resulted in increases to goodwill, customer relationships, and acquired technology intangible assets, but was not material to our consolidated financial statements, and as a result, additional business combination disclosures for this acquisition have been omitted. Year Ended January 31, 2021 We did not complete any business combinations during the year ended January 31, 2021. Other Business Combination Information The pro forma impact of all business combinations completed during the three years ended January 31, 2023 was not material to our historical consolidated operating results and is therefore not presented. The acquisition date fair values of contingent consideration obligations associated with business combinations are estimated based on probability adjusted present values of the consideration expected to be transferred using significant inputs that are not observable in the market. Key assumptions used in these estimates include probability assessments with respect to the likelihood of achieving the performance targets and discount rates consistent with the level of risk of achievement. At each reporting date, we revalue the contingent consideration obligations to their fair values and record increases and decreases in fair value within selling, general and administrative expenses in our consolidated statements of operations. Changes in the fair value of the contingent consideration obligations result from changes in discount periods and rates, and changes in probability assumptions with respect to the likelihood of achieving the performance targets. For the years ended January 31, 2023 and 2022, we recorded charges of $0.2 million and $0.9 million, respectively, and we recorded a benefit of $0.8 million in the year ended January 31, 2021, within selling, general and administrative expenses 31, 2023, of which $4.5 million was recorded within accrued expenses and other current liabilities, and $8.2 million was recorded within other liabilities. Payments of contingent consideration earned under these agreements were $7.5 million, $9.6 million, and $15.2 million for the years ended January 31, 2023, 2022, and 2021, respectively.

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL	12 Months Ended
	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND GOODWILL	INTANGIBLE ASSETS AND GOODWILL Acquisition-related intangible assets, excluding certain intangible assets previously acquired that were fully amortized and removed from our consolidated balance sheets, consisted of the following as of January 31, 2023 and 2022: January 31, 2023 (in thousands) Cost Accumulated Net Intangible assets with finite lives: Customer relationships $ 458,013 $ (390,113) $ 67,900 Acquired technology 229,317 (212,065) 17,252 Trade names 4,479 (4,359) 120 Distribution network 2,440 (2,440) — Total intangible assets $ 694,249 $ (608,977) $ 85,272 January 31, 2022 (in thousands) Cost Accumulated Net Intangible assets with finite lives: Customer relationships $ 467,408 $ (375,827) $ 91,581 Acquired technology 229,501 (203,895) 25,606 Trade names 5,677 (4,610) 1,067 Distribution network 2,440 (2,440) — Total intangible assets $ 705,026 $ (586,772) $ 118,254 Total amortization expense recorded for acquisition-related intangible assets was $39.4 million, $46.8 million, and $47.7 million for the years ended January 31, 2023, 2022, and 2021, respectively. The reported amount of net acquisition-related intangible assets can fluctuate from the impact of changes in foreign currency exchange rates on intangible assets not denominated in U.S. dollars. Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows: (in thousands) Years Ending January 31, Amount 2024 $ 32,380 2025 16,581 2026 15,219 2027 11,462 2028 6,839 Thereafter 2,791 Total $ 85,272 There were no material impairments for the years ended January 31, 2023 and 2021. We recorded $0.4 million of impairments for certain acquired trade names, which was included within selling, general and administrative expenses Goodwill activity for the years ended January 31, 2023, and 2022 was as follows: (in thousands) Total Year Ended January 31, 2022: Goodwill, gross, at January 31, 2021 $ 1,383,450 Accumulated impairment losses through January 31, 2021 (56,043) Goodwill, net, at January 31, 2021 1,327,407 Business combinations 36,006 Foreign currency translation and other (9,992) Goodwill, net, at January 31, 2022 $ 1,353,421 Year Ended January 31, 2023: Goodwill, gross, at January 31, 2022 $ 1,409,464 Accumulated impairment losses through January 31, 2022 (56,043) Goodwill, net, at January 31, 2022 1,353,421 Business combinations, including adjustments to prior period acquisitions 25,239 Foreign currency translation and other (31,447) Goodwill, net, at January 31, 2023 $ 1,347,213 Balance at January 31, 2023 Goodwill, gross, at January 31, 2023 $ 1,403,256 Accumulated impairment losses through January 31, 2023 (56,043) Goodwill, net, at January 31, 2023 $ 1,347,213 For purposes of reviewing for potential goodwill impairment, as of January 31, 2023, we had one reporting unit. Based on our November 1, 2022 and 2021 quantitative goodwill impairment reviews, we concluded that the estimated fair value of our reporting unit significantly exceeded its carrying value. No changes in circumstances or indicators of potential impairment were identified between November 1 and January 31 in each of the years ended January 31, 2023 and 2022. No goodwill impairment was identified for the years ended January 31, 2023, 2022, and 2021.

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
	Jan. 31, 2023
Debt Disclosure [Abstract]
LONG-TERM DEBT	LONG-TERM DEBT The following table summarizes our long-term debt at January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 2021 Notes $ 315,000 $ 315,000 Term Loan 100,000 100,000 Less: Unamortized debt discounts and issuance costs (6,092) (8,046) Total debt 408,908 406,954 Less: current maturities — — Long-term debt $ 408,908 $ 406,954 2021 Notes On April 9, 2021, we issued $315.0 million in aggregate principal amount of 0.25% convertible senior notes due April 15, 2026, unless earlier converted by the holders pursuant to their terms. The 2021 Notes are unsecured and pay interest in cash semiannually in arrears at a rate of 0.25% per annum. We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the capped call transactions described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the April 6, 2021 issuance of $200.0 million of Series B Preferred Stock, to repay a portion of the outstanding indebtedness under our Credit Agreement described below, to terminate the 2018 Swap (as defined in Note 15, “Derivative Financial Instruments”), and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes. The 2021 Notes are convertible into shares of our common stock at an initial conversion rate of 16.1092 shares per $1,000 principal amount of 2021 Notes, which represents an initial conversion price of approximately $62.08 per share, subject to adjustment upon the occurrence of certain events, and subject to customary anti-dilution adjustments. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. As of January 31, 2023, the 2021 Notes were not convertible. We incurred approximately $8.9 million of issuance costs in connection with the 2021 Notes, which were deferred and are presented as a reduction of long-term debt, and which are being amortized as interest expense over the term of the 2021 Notes. Including the impact of the deferred debt issuance costs, the effective interest rate on the 2021 Notes was approximately 0.83% at January 31, 2023. Based on the closing market price of our common stock on January 31, 2023, the if-converted value of the 2021 Notes was less than their aggregate principal amount. 2014 Notes On June 18, 2014, we issued $400.0 million in aggregate principal amount of 1.50% convertible senior notes, with a maturity date of June 1, 2021 (the “2014 Notes”). Net proceeds from the 2014 Notes after underwriting discounts were $391.9 million. The 2014 Notes were unsecured and paid interest in cash semiannually in arrears at a rate of 1.50% per annum. During the three months ended July 31, 2020, we repurchased $13.1 million principal amount of the 2014 Notes (the “Repurchased 2014 Notes”) in open market transactions for an aggregate of $13.0 million in cash, resulting in a debt extinguishment loss of $0.1 million and a $0.2 million charge to additional paid-in-capital. On February 1, 2021, we early adopted ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which eliminated the liability and equity separation model for convertible instruments with a cash conversion feature, such as the 2014 Notes. As a result, effective February 1, 2021, we no longer presented separate liability and equity components for the 2014 Notes on our consolidated balance sheet. The adoption of ASU No. 2020-06 resulted in the $78.0 million carrying value of the 2014 Notes’ equity component at January 31, 2021, which included applicable issuance costs and the portion classified within temporary equity, being reclassified and combined with the liability component of the 2014 Notes. Upon adoption we recorded $43.4 million decrease to additional paid-in capital, a $4.8 million decrease to temporary equity, a $4.4 million increase to current maturities of long-term debt, a $0.9 million decrease to deferred tax liabilities, a $0.1 million increase in unamortized debt issuance costs (a component of long-term debt), and a $44.9 million decrease to our accumulated deficit. In connection with the maturity of the 2014 Notes on June 1, 2021, we paid an aggregate of $389.8 million in cash for the settlement of the 2014 Notes, which included $386.9 million in satisfaction of the outstanding principal of the 2014 Notes and $2.9 million related to the final interest payment on the 2014 Notes. Additionally, the 2014 Notes had an incremental conversion value of $57.7 million as the market value per share of our common stock, as measured under the terms of the 2014 Notes, was greater than the conversion price of the 2014 Notes. We issued approximately 1,250,000 shares of common stock to the holders of the 2014 Notes as payment of the conversion premium, which we issued from treasury stock. See the discussion of the Note Hedges and Warrants below for more information. Capped Calls, Note Hedges and Warrants Capped Calls In connection with the issuance of the 2021 Notes, on April 6, 2021 and April 8, 2021, we entered into capped call transactions (the “Capped Calls”) with certain counterparties. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the conversion price, with such reduction and/or offset subject to a cap. The Capped Calls exercise price is equal to the $62.08 initial conversion price of each of the 2021 Notes, and the cap price is $100.00, each subject to certain adjustments under the terms of the Capped Calls. Our exercise rights under the Capped Calls generally trigger upon conversion of the 2021 Notes, and the Capped Calls terminate upon maturity of the 2021 Notes, or the first day the 2021 Notes are no longer outstanding. As of January 31, 2023, no Capped Calls have been exercised. Pursuant to their terms, the Capped Calls qualify for classification within stockholders’ equity, and their fair value is not remeasured and adjusted as long as they continue to qualify for stockholders’ equity classification. We paid approximately $41.1 million for the Capped Calls, including applicable transaction costs, which was recorded as a reduction to additional paid-in capital. Note Hedges and Warrants Concurrently with the issuance of the 2014 Notes, we entered into convertible note hedge transactions (the “Note Hedges”) and sold warrants (the “Warrants”). The combination of the Note Hedges and the Warrants served to increase the effective initial conversion price for the 2014 Notes to $75.00 per share. Subsequent to the Spin-Off, as a result of conversion rate adjustments, the Note Hedges and the Warrants served to increase the effective conversion price for the 2014 Notes to $47.18 per share. The Note Hedges and Warrants were each separate instruments from the 2014 Notes. Note Hedges Pursuant to the Note Hedges, we purchased call options on our common stock, under which we had the right to acquire from the counterparties up to approximately 6,205,000 shares of our common stock, subject to customary anti-dilution adjustments, at a price of $64.46, which equaled the initial conversion price of the 2014 Notes. As a result of the Spin-Off, on February 1, 2021, the call options on our stock were adjusted to allow us to purchase up to 9,865,000 shares of our common stock at a price of $40.55, which was equal to the adjusted conversion price of the 2014 Notes. We were permitted to settle the Note Hedges in cash, shares of our common stock, or a combination thereof, at our option, and the Note Hedges were intended to reduce our exposure to potential dilution upon conversion of the 2014 Notes. We paid $60.8 million for the Note Hedges, which was recorded as a charge to additional paid-in capital. Our exercise rights under the Note Hedges were automatically triggered upon conversion of any 2014 Notes and the Note Hedges otherwise terminated upon maturity of the 2014 Notes on June 1, 2021. In connection with the maturity of the 2014 Notes on June 1, 2021, we received approximately 1,250,000 shares of our common stock from the counterparties under the Note Hedges, which offset the dilution resulting from the stock settlement of the conversion premium on the 2014 Notes as the market value per share of our common stock, as measured under the terms of the Note Hedges, was greater than the strike price of the Note Hedges. The Repurchased 2014 Notes acquired during the three months ended July 31, 2020 as described above did not change the number of common shares subject to the Note Hedges as the counterparties agreed that the options under the Note Hedges remained outstanding notwithstanding such repurchase. Upon maturity of the 2014 Notes, we received approximately 42,000 shares of our common stock from the counterparties to the Note Hedges as reimbursement for the in-the-money portion of the Repurchased 2014 Notes. Warrants We sold the Warrants to several counterparties. The Warrants initially provided the counterparties rights to acquire from us up to approximately 6,205,000 shares of our common stock at a price of $75.00 per share. As a result of the Spin-Off, the terms of the Warrants were adjusted to provide the counterparties the rights to acquire from us up to approximately 9,865,000 shares of our common stock at a price of $47.18 per share. Proceeds from the sale of the Warrants were $45.2 million and were recorded as additional paid-in capital. The Warrants expired incrementally on a series of expiration dates between August 30, 2021 and January 21, 2022. At each expiration date, the Warrants were exercised when the market price per share of our common stock exceeded the strike price of the Warrants, and we issued an aggregate of 293,143 shares of our common stock as part of the cashless exercise of approximately 5,031,000 Warrants. The Warrants had a dilutive effect on net income per share to the extent that the average market value of our common stock, as measured under the terms of the Warrants, exceeded the strike price of the Warrants. All outstanding Warrants were exercised or expired as of January 31, 2022. The Note Hedges and Warrants both qualified for classification within stockholders’ equity, and therefore no changes to their respective fair values were recorded in our consolidated statements of operations for any period. Credit Agreement Credit Agreement On June 29, 2017, we entered into a credit agreement with certain lenders and terminated a prior credit agreement. The credit agreement was amended in 2018, 2020, and 2021, as further described below (as amended, the “Credit Agreement”). The Credit Agreement provides for $725.0 million of senior secured credit facilities, comprised of a $425.0 million term loan maturing on June 29, 2024 (the “Term Loan”), of which $100.0 million was outstanding at January 31, 2023 and 2022, and a $300.0 million revolving credit facility maturing on April 9, 2026 (the “Revolving Credit Facility”), none of which was drawn on as of January 31, 2023 and 2022. The Revolving Credit Facility replaced our prior $300.0 million revolving credit facility (the “Prior Revolving Credit Facility”) and is subject to increase and reduction from time to time according to the terms of the Credit Agreement. The majority of the proceeds from the Term Loan were used to repay all outstanding terms loans under our prior credit agreement. The Term Loan was subject to an original issuance discount of approximately $0.5 million, which is being amortized as interest expense over the term of the Term Loan using the effective interest method. Interest rates on loans under the Credit Agreement are periodically reset, at our option, at either a Eurodollar Rate or an ABR Rate (each as defined in the Credit Agreement), plus in each case a margin. On January 31, 2018, we entered into an amendment to the Credit Agreement providing for, among other things, a reduction of the interest rate margins on the Term Loan from 2.25% to 2.00% for Eurodollar loans, and from 1.25% to 1.00% for ABR loans. During the three months ended April 30, 2021, in addition to our regular quarterly $1.1 million principal payment, we repaid $309.0 million of our Term Loan, reducing the outstanding balance to $100.0 million. As a result, $1.8 million of deferred debt issuance costs and $0.2 million of unamortized discount associated with the Term Loan were written off, and are included within losses on early retirements of debt on our consolidated statement of operations for the year ended January 31, 2022. Optional prepayments of loans under the Credit Agreement are generally permitted without premium or penalty. On April 9, 2021, we amended the Credit Agreement (the “2021 Amendment”), pursuant to which we replaced the Prior Revolving Credit Facility, which would otherwise have matured on June 29, 2022, with the current $300.0 million Revolving Credit Facility maturing on April 9, 2026. As of January 31, 2023, the interest rate on the Term Loan was 6.37%. Taking into account the impact of the original issuance discount and related deferred debt issuance costs, the effective interest rate on the Term Loan was approximately 6.58% at January 31, 2023. As of January 31, 2022, the interest rate on the Term Loan was 2.10%. For borrowings under the Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement) leverage ratio (the "Leverage Ratio"). In addition, under the Revolving Credit Facility, we are required to pay a commitment fee with respect to unused availability at rates per annum determined by reference to our Leverage Ratio. Our obligations under the Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries, and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions. The Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The Credit Agreement also contains a financial covenant that, solely with respect to the Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.50 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the Credit Agreement. We were in compliance with all of the financial covenants of the Credit Agreement as of January 31, 2023. The Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the Credit Agreement may be declared immediately due and payable, and the lenders’ commitments to make loans under the Credit Agreement may be terminated. Credit Agreement Issuance and Amendment Costs During the year ended January 31, 2021, we incurred $2.1 million of debt modification costs related to the second amendment to the Credit Agreement (the “ 2020 Amendment”), $1.2 million of which were expensed, and $0.9 million of which were deferred (comprised of $0.5 million associated with the Term Loan, and $0.4 million associated with the Prior Revolving Credit Facility), and which are being amortized along with the previously deferred debt issuance costs. At the time of the 2021 Amendment, there were $1.3 million of unamortized deferred debt issuance costs associated with the Prior Revolving Credit Facility, of which $0.8 million were associated with commitments under the Prior Revolving Credit Facility provided by lenders that are continuing to provide commitments under the current Revolving Credit Facility and therefore continued to be deferred, and which are now being amortized over the term of the Revolving Credit Facility. The remaining $0.5 million of unamortized deferred debt issuance costs associated with the Prior Revolving Credit Facility were written off and are included within losses on early retirements of debt on our consolidated statement of operations for the year ended January 31, 2022. We incurred $1.5 million of debt modification costs related to the 2021 Amendment, all of which are associated with the Revolving Credit Facility, which have been deferred and are being amortized along with the previously deferred debt issuance costs over the term of the Revolving Credit Facility. Deferred debt issuance costs associated with the Term Loan are being amortized using the effective interest rate method, and deferred debt issuance costs associated with the Revolving Credit Facility are being amortized on a straight-line basis. Future Principal Payments on the Term Loan As a result of the significant Term Loan principal payments made during the three months ended April 30, 2021, no further principal payments are required prior to the maturity of the Term Loan on June 29, 2024. Interest Expense The following table presents the components of interest expense incurred on the 2021 Notes, the 2014 Notes, and on borrowings under our Credit Agreement for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 2021 Notes: Interest expense at 0.25% coupon rate $ 787 $ 639 $ — Amortization of deferred debt issuance costs 1,762 1,416 — Total Interest Expense - 2021 Notes $ 2,549 $ 2,055 $ — 2014 Notes: Interest expense at 1.50% coupon rate $ — $ 1,933 $ 5,887 Amortization of debt discount — — 12,884 Amortization of deferred debt issuance costs — 522 1,215 Total Interest Expense - 2014 Notes $ — $ 2,455 $ 19,986 Borrowings under Credit Agreement: Interest expense at contractual rates $ 4,114 $ 3,366 $ 13,018 Impact of interest rate swap agreement — 1,014 4,368 Amortization of debt discounts 19 18 74 Amortization of deferred debt issuance costs 863 930 1,811 Total Interest Expense - Borrowings under Credit Agreement $ 4,996 $ 5,328 $ 19,271 Please refer to Note 15, “Derivative Financial Instruments” for information regarding our interest rate swap.

SUPPLEMENTAL CONSOLIDATED FINAN

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION	12 Months Ended
	Jan. 31, 2023
Condensed Financial Information Disclosure [Abstract]
SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION	SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION Consolidated Balance Sheets Inventories consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Raw materials $ 3,325 $ 3,001 Work-in-process 40 150 Finished goods 9,263 2,186 Total inventories $ 12,628 $ 5,337 Property and equipment, net consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Land and buildings $ 820 $ 7,994 Leasehold improvements 15,026 18,155 Software 73,569 76,152 Equipment, furniture, and other 41,966 64,363 Total cost 131,381 166,664 Less: accumulated depreciation and amortization (66,571) (102,574) Total property and equipment, net $ 64,810 $ 64,090 Depreciation expense on property and equipment was $18.6 million, $20.7 million, and $30.6 million in the years ended January 31, 2023, 2022, and 2021, respectively. Prepaid and other current assets consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Prepaid expenses $ 24,364 $ 22,639 Other current assets 27,257 31,113 Insurance recovery receivable 12,503 — CTI litigation settlement indemnification asset - current portion 11,250 — Total prepaid expenses and other current assets $ 75,374 $ 53,752 Other assets consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Deferred commissions $ 54,512 $ 51,714 Long-term contract assets, net 37,950 30,510 Capitalized software development costs, net 23,527 22,483 Noncontrolling equity investments 5,146 5,146 Long-term deferred cost of revenue 4,951 5,907 CTI litigation settlement indemnification asset - long-term portion 4,750 — Deferred debt issuance costs, net 1,485 1,950 Long-term restricted cash and time deposits 287 409 Other 15,674 8,519 Total other assets $ 148,282 $ 126,638 Accrued expenses and other current liabilities consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Compensation and benefits $ 73,766 $ 86,777 Taxes other than income taxes 16,346 16,313 Preferred Stock dividends payable 10,400 10,400 CTI litigation settlement liability - current portion 11,250 — Operating lease obligations - current portion 7,965 24,551 DOJ legal settlement liability 7,000 — Contingent consideration - current portion 4,496 7,776 Professional and consulting fees 2,635 3,771 Income taxes 443 602 Other 21,643 18,504 Total accrued expenses and other current liabilities $ 155,944 $ 168,694 Other liabilities consisted of the following as of January 31, 2023 and 2022: January 31 (in thousands) 2023 2022 Unrecognized tax benefits, including interest and penalties $ 52,887 $ 16,345 Contingent consideration - long-term portion 8,221 — CTI litigation settlement liability - long-term portion 4,750 — Finance lease obligations - long-term portion 2,308 3,831 Other 466 1,820 Total other liabilities $ 68,632 $ 21,996 Consolidated Statements of Operations Other income (expense), net consisted of the following for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Foreign currency gains (losses), net $ 3,453 $ (1,644) $ (1,584) Losses on derivative financial instruments, net — (14,374) (1,267) Change in fair value of future tranche right — 15,810 (56,146) Other, net (1,471) 5,435 (1,604) Total other income (expense), net $ 1,982 $ 5,227 $ (60,601) Please refer to Note 10, “Convertible Preferred Stock” for additional information regarding the future tranche right. Consolidated Statements of Cash Flows The following table provides supplemental information regarding our consolidated cash flows for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Cash paid for interest $ 4,661 $ 9,716 $ 24,612 Cash payments of income taxes, net $ 15,886 $ 42,917 $ 21,476 Non-cash investing and financing transactions: Liabilities for contingent consideration in business combinations $ 12,184 $ 900 $ — Preferred Stock dividends declared $ 10,400 $ 10,400 $ 5,200 Finance leases of property and equipment $ 647 $ 4,041 $ 903 Settlement of Future Tranche Right upon issuance of Series B Preferred Stock $ — $ 36,962 $ — Retirement of treasury stock $ 106,146 $ 234,999 $ — Settlement of convertible note premium with common stock $ — $ 59,131 $ — Receipt of common stock from the counterparties under the Note Hedges $ — $ 59,651 $ — Accrued but unpaid purchases of property and equipment $ 2,353 $ 750 $ 2,731 Accrued but unpaid purchases of treasury stock $ 616 $ — $ —

CONVERTIBLE PREFERRED STOCK

CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Jan. 31, 2023
Equity [Abstract]
CONVERTIBLE PREFERRED STOCK	CONVERTIBLE PREFERRED STOCK On December 4, 2019, we entered into the Investment Agreement with the Apax Investor whereby, subject to certain closing conditions, the Apax Investor agreed to make an investment in us in an amount up to $400.0 million as follows: • On May 7, 2020, we issued a total of 200,000 shares of our Series A Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $2.7 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series A Preferred Stock. • In connection with the completion of the Spin-Off, on April 6, 2021, we issued a total of 200,000 shares of our Series B Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $1.3 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series B Preferred Stock. Each of the rights, preferences, and privileges of the Series A Preferred Stock and Series B Preferred Stock are set forth in separate certificates of designation filed with the Secretary of State of the State of Delaware on the applicable issuance date. Voting Rights Holders of the Preferred Stock have the right to vote on matters submitted to a vote of the holders of our common stock, on an as-converted basis; however, in no event will the holders of Preferred Stock have the right to vote shares of the Preferred Stock on an as-converted basis in excess of 19.9% of the voting power of the common stock outstanding immediately prior to December 4, 2019. Dividends and Liquidation Rights The Preferred Stock ranks senior to the shares of our common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of our affairs. Shares of Preferred Stock have a liquidation preference of the greater of $1,000 per share or the amount that would be received if the shares are converted at the then applicable conversion price at the time of such liquidation. Each series of Preferred Stock pays dividends at an annual rate of 5.2% until May 7, 2024, and thereafter at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends on the Preferred Stock are cumulative and payable semi-annually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Preferred Stock. The dividend rate is subject to increase (i) to 6.0% per annum in the event the number of shares of common stock into which the Preferred Stock could be converted exceeds 19.9% of the voting power of outstanding common stock on December 4, 2019 (unless we obtain shareholder approval of the issuance of common stock upon conversion of the Preferred Stock) and (ii) by 1.0% each year, up to a maximum dividend rate of 10.0% per annum, in the event we fail to satisfy our obligations to redeem the Preferred Stock in specified circumstances. For the year ended January 31, 2023, we paid $20.8 million of preferred stock dividends, $10.4 million of which was accrued as of January 31, 2022, and there were $12.1 million of cumulative unpaid preferred stock dividends at January 31, 2023, of which $10.4 million was declared and recorded within accrued expenses and other liabilities on our consolidated balance sheet as of January 31, 2023. We reflected $20.8 million and $18.9 million of preferred stock dividends in our consolidated results of operations, for purposes of computing net loss attributable to Verint Systems Inc. common shares, for the years ended January 31, 2023 and 2022. Conversion The Series A Preferred Stock was initially convertible into common stock at the election of the holder, subject to certain conditions, at an initial conversion price of $53.50 per share. The initial conversion price represented a conversion premium of 17.1% over the volume-weighted average price per share of our common stock over the 45 consecutive trading days immediately prior to December 4, 2019. In accordance with the Investment Agreement, the Series A Preferred Stock did not participate in the Spin-Off distribution of the Cognyte shares, which occurred on February 1, 2021, and the Series A Preferred Stock conversion price was instead adjusted to $36.38 per share based on the ratio of the relative trading prices of Verint and Cognyte following the Spin-Off. The Series B Preferred Stock is convertible at a conversion price of $50.25, based in part on our trading price over the 20-day trading period following the Spin-Off. As of January 31, 2023, the maximum number of shares of common stock that could be required to be issued upon conversion of the outstanding shares of Preferred Stock was approximately 9.8 million shares and Apax’s ownership in us on an as-converted basis was approximately 13.0%. At any time after May 7, 2023, in the case of the Series A Preferred Stock, and April 6, 2024, in the case of the Series B Preferred Stock, we will have the option to require that all (but not less than all) of the then-outstanding shares of Preferred Stock of the series convert into common stock if the volume-weighted average price per share of the common stock for at least 30 trading days in any 45 consecutive trading day period exceeds 175% of the then-applicable conversion price of such series (a “Mandatory Conversion”). We may redeem any or all of the Preferred Stock of a series for cash at any time after May 7, 2026, in the case of the Series A Preferred Stock, and April 6, 2027, in the case of the Series B Preferred Stock, at a redemption price equal to 100% of the liquidation preference of the shares of the Preferred Stock, plus any accrued and unpaid dividends to, but excluding, the redemption date, plus a make-whole amount designed to allow the Apax Investor to earn a total 8.0% internal rate of return on such shares. The Preferred Stock may not be sold or transferred without our prior written consent. The common stock issuable upon conversion of the Preferred Stock is not subject to this restriction. The restriction on the sale or transfer of the Preferred Stock does not apply to certain transfers to one or more permitted co-investors or transfers or pledges of the Preferred Stock pursuant to the terms of specified margin loans entered into by the Apax Investor as well as transfers effected pursuant to a merger, consolidation, or similar transaction consummated by us and transfers that are approved by our board of directors. At any time after November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, or upon the occurrence of a change of control triggering event (as defined in the certificates of designation), the holders of the applicable series of Preferred Stock will have the right to cause us to redeem all of the outstanding shares of Preferred Stock for cash at a redemption price equal to 100% of the liquidation preference of the shares of such series, plus any accrued and unpaid dividends to, but excluding, the redemption date. Therefore, the Preferred Stock has been classified as temporary equity on our consolidated balance sheets as of January 31, 2023 and 2022, separate from permanent equity, as the potential required repurchase of the Preferred Stock, however remote in likelihood, is not solely under our control. As of January 31, 2023, the Preferred Stock was not redeemable, and we have concluded that it is currently not probable of becoming redeemable, including from the occurrence of a change in control triggering event. The holders’ redemption rights which occur at November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, are not considered probable because there is a more than remote likelihood that the Mandatory Conversion may occur prior to such redemption rights. We therefore did not adjust the carrying amount of the Preferred Stock to its current redemption amount, which was its liquidation preference at January 31, 2023 plus accrued and unpaid dividends. As of January 31, 2023, the stated value of the liquidation preference for each series of Preferred Stock was $200.0 million and cumulative, unpaid dividends on the Series A Preferred Stock and the Series B Preferred Stock were $6.1 million and $6.1 million, respectively. Future Tranche Right We determined that our obligation to issue and the Apax Investor’s obligation to purchase 200,000 shares of the Series B Preferred Stock in connection with the completion of the Spin-Off and the satisfaction of other customary closing conditions (the “Future Tranche Right”) met the definition of a freestanding financial instrument as the Future Tranche Right is legally detachable and separately exercisable from the Series A Preferred Stock. At issuance, we allocated a portion of the proceeds from the issuance of the Series A Preferred Stock to the Future Tranche Right based upon its fair value at such time, with the remaining proceeds being allocated to the Series A Preferred Stock. The Future Tranche Right was remeasured at fair value each reporting period until the settlement of the right (at the time of the issuance of the Series B Preferred Stock), and changes in its fair value were recognized as a non-cash charge or benefit within other income (expense), net on the consolidated statement of operations. Upon issuance of the Series A Preferred Stock on May 7, 2020, the Future Tranche Right was recorded as an asset of $3.4 million, as the purchase price of the Series B Preferred Stock was greater than its estimated fair value at the expected settlement date. This resulted in a $203.4 million carrying value, before direct and incremental issuance costs, for the Series A Preferred Stock. Immediately prior to the issuance of the Series B Preferred Stock, the Future Tranche Right was remeasured to fair value and as a result we recorded a non-cash benefit of $15.8 million related to the change in fair value of the Future Tranche Right for the three months ended April 30, 2021, within other income (expense), net. Upon the issuance of the Series B Preferred Stock in April 2021, the Future Tranche Right was settled, resulting in a reclassification of the $37.0 million fair value of the Future Tranche Right liability at that time to the carrying value of the Series B Preferred Stock. This resulted in a $237.0 million carrying value, before direct and incremental issuance costs, for the Series B Preferred Stock. As a result of the issuance of the Series B Preferred Stock, we no longer recognize changes in the fair value of the Future Tranche Right in our consolidated statement of operations. For the year ended January 31, 2021, we recognized non-cash charges of $56.1 million within other income (expense), net in the consolidated statement of operations for the change in the fair value of the Future Tranche Right. Please refer to Note 14, “Fair Value Measurements” for additional information regarding valuations of the Future Tranche Right.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Jan. 31, 2023
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Common Stock Dividends We did not declare or pay any cash dividends on our common stock during the years ended January 31, 2023, 2022, and 2021. Under the terms of our Credit Agreement, we are subject to certain restrictions on declaring and paying cash dividends on our common stock. In connection with the Spin-Off, each holder of Verint’s common stock received one ordinary share of Cognyte for every share of common stock of Verint held of record as of the close of business on January 25, 2021. Treasury Stock From time to time, our board of directors has approved limited programs to repurchase shares of our common stock from our directors or officers in connection with the vesting of restricted stock or restricted stock units to facilitate required income tax withholding by us or the payment of required income taxes by such holders. In addition, the terms of some of our equity award agreements with all grantees provide for automatic repurchases by us for the same purpose if a vesting-related or delivery-related tax event occurs at a time when the holder is not permitted to sell shares in the market. Our stock bonus program contains similar terms. Any such repurchases of common stock occur at prevailing market prices and are recorded as treasury stock. Repurchased shares of common stock are typically recorded as treasury stock, at cost, but may from time to time be retired at management’s discretion, as approved by the board of directors in March 2021. We periodically purchase common stock from our directors, officers, and other employees to facilitate income tax withholding by us or the payment of required income taxes by such holders in connection with the vesting of equity awards occurring during a Company-imposed trading blackout lockup period. When treasury shares are reissued, they are recorded at the average cost of the treasury shares acquired. No treasury stock remained outstanding at January 31, 2023 and 2022, respectively. Stock Repurchase Programs On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock in an amount not to exceed, in the aggregate, $200.0 million during the repurchase period. During the year ended January 31, 2023, we repurchased approximately 2,659,000 shares of our common stock for a cost of $129.6 million, which included $105.7 million of share repurchases under a prior authorized stock repurchase program, $23.5 million of share repurchases under the current stock repurchase program, as well as other repurchases to facilitate income tax withholding or payments as described above. During the year ended January 31, 2023, we retired all 2,659,000 shares of our common stock with a cost of $129.6 million, which was recorded as a reduction of common stock and additional paid-in capital. These shares were returned to the status of authorized and unissued shares. Subsequent to January 31, 2023, through March 27, 2023, we repurchased approximately 472,000 shares of our common stock for $17.4 million under this program. Repurchases were financed with available cash in the United States. During the year ended January 31, 2022 we repurchased approximately 1,613,000 shares of our common stock for a cost of $76.0 million, which included $75.4 million of share repurchases under a prior authorized stock repurchase program and other repurchases to facilitate income tax withholding or payments as described above. During the year ended January 31, 2022, we retired 1,058,300 shares of our common stock with a cost of $49.6 million that had been repurchased under a prior authorized share repurchase program, as well as all of our common stock held as treasury stock, which totaled 5,000,786 shares, and restored them to the status of authorized and unissued shares. The aggregate cost of the treasury stock retired was $235.0 million, which was recorded as a reduction of common stock and additional paid-in capital. During the three months ended July 31, 2021, in connection with the maturity of our 2014 Notes, we issued approximately 1,250,000 treasury shares with an average cost of $47.30 per share to the holders of the 2014 Notes in satisfaction of the conversion premium, which was recorded as a $59.1 million reduction of treasury stock and additional paid-in capital. Additionally, we received approximately 1,250,000 shares of our common stock having a value of $57.7 million from the counterparties under the Note Hedges, as well as approximately 42,000 shares of our common stock having a value of $2.0 million from the counterparties related to the reimbursement for the in-the-money portion of the Repurchased 2014 Notes under the Note Hedge agreements, which was recorded as an increase to treasury stock and additional paid-in capital. Issuance of Convertible Preferred Stock On December 4, 2019, in conjunction with the planned Spin-Off , we announced that an affiliate of Apax Partners would invest up to $400.0 million in us, in the form of convertible preferred stock. Under the terms of the Investment Agreement, the Apax Investor purchased $200.0 million of our Series A Preferred Stock, which closed on May 7, 2020. In connection with the completion of the Spin-Off, the Apax Investor purchased $200.0 million of our Series B Preferred Stock, which closed on April 6, 2021. As of January 31, 2023, Apax’s ownership in us on an as-converted basis was approximately 13.0%. Please refer to Note 10, “Convertible Preferred Stock” for a more detailed discussion of the Apax investment. Accumulated Other Comprehensive Income (Loss) Accumulated other comprehensive income (loss) includes items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities and derivative financial instruments designated as hedges. Accumulated other comprehensive income (loss) is presented as a separate line item in the stockholders’ equity section of our consolidated balance sheets. Accumulated other comprehensive income (loss) items have no impact on our net income (loss) as presented in our consolidated statements of operations. The following table summarizes changes in the components of our accumulated other comprehensive income (loss) by component for the years ended January 31, 2023 and 2022: (in thousands) Unrealized Gains (Losses) on Foreign Exchange Contracts Designated as Hedges Unrealized Losses on Interest Rate Swap Designated as Hedge Foreign Currency Translation Adjustments Total Accumulated other comprehensive income (loss) at January 31, 2021 $ 634 $ (13,031) $ (124,481) $ (136,878) Distribution of Cognyte Software Ltd. (559) — 17,682 17,123 Other comprehensive income (loss) before reclassifications 70 — (11,668) (11,598) Amounts reclassified out of accumulated other comprehensive income (loss) 193 (1,014) — (821) Amounts reclassified upon partial early retirement of the Term Loan — (12,017) — (12,017) Net other comprehensive (loss) income (682) 13,031 6,014 18,363 Accumulated other comprehensive loss at January 31, 2022 (48) — (118,467) (118,515) Other comprehensive loss before reclassifications (588) — (35,545) (36,133) Amounts reclassified out of accumulated other comprehensive loss (549) — — (549) Net other comprehensive loss (39) — (35,545) (35,584) Accumulated other comprehensive loss at January 31, 2023 $ (87) $ — $ (154,012) $ (154,099) All amounts presented in the table above are net of income taxes, if applicable. The accumulated net losses in foreign currency translation adjustments primarily reflect the strengthening of the U.S. dollar against the British pound sterling, which has resulted in lower U.S. dollar-translated balances of British pound sterling-denominated goodwill and intangible assets. Please refer to Note 15, “Derivative Financial Instruments” for further information regarding our interest rate swap agreement. The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of operations, with presentation location, for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, Financial Statement Location (in thousands) 2023 2022 2021 Unrealized (losses) gains on derivative financial instruments: Foreign currency forward contracts $ (1) $ 1 $ 1 Cost of recurring revenue (60) 24 28 Cost of nonrecurring revenue (392) 142 182 Research and development, net (207) 65 56 Selling, general and administrative (660) 232 267 Total, before income taxes 111 (39) (42) Provision for income taxes $ (549) $ 193 $ 225 Total, net of income taxes Interest rate swap agreement $ — $ (1,014) $ (4,367) Interest expense — (15,655) — Other income (expense), net — (16,669) (4,367) Total, before income taxes — 3,638 954 Benefit from income taxes $ — $ (13,031) $ (3,413) Total, net of income taxes

RESEARCH AND DEVELOPMENT, NET

RESEARCH AND DEVELOPMENT, NET	12 Months Ended
	Jan. 31, 2023
Research and Development [Abstract]
RESEARCH AND DEVELOPMENT, NET	RESEARCH AND DEVELOPMENT, NETOur gross research and development expenses for the years ended January 31, 2023, 2022, and 2021, were $130.6 million, $123.3 million, and $128.2 million, respectively. We capitalize certain costs incurred to develop our commercial software products, and we then recognize those costs within cost of revenue as the products are sold. Activity for our capitalized software development costs for the years ended January 31, 2023, 2022, and 2021 was as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Capitalized software development costs, net, beginning of year $ 22,483 $ 19,250 $ 15,351 Software development costs capitalized during the year 7,595 7,560 7,312 Amortization of capitalized software development costs (6,407) (4,247) (3,304) Write-offs of capitalized software development costs (6) — (129) Foreign currency translation and other (138) (80) 20 Capitalized software development costs, net, end of year $ 23,527 $ 22,483 $ 19,250 There were no material impairments of previously capitalized software development costs during the years ended January 31, 2023 and 2022. During the year ended January 31, 2021, we recorded an impairment charge of $0.1 million in nonrecurring cost of revenue, reflecting the write-off of capitalized costs that were deemed non-recoverable based on our expectations of future market conditions.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jan. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The components of income (loss) before provision for income taxes for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Domestic $ (6,676) $ (12,492) $ 127,909 Foreign 61,438 51,996 (169,573) Total income (loss) before provision for income taxes $ 54,762 $ 39,504 $ (41,664) The provision for income taxes from continuing operations for the years ended January 31, 2023, 2022, and 2021 consisted of the following: Year Ended January 31, (in thousands) 2023 2022 2021 Current provision for income taxes: Federal $ 30,637 $ 3,215 $ 373 State 2,733 1,121 1,663 Foreign 15,277 30,840 6,299 Total current provision for income taxes 48,647 35,176 8,335 Deferred (benefit from) provision for income taxes: Federal (8,010) 6,714 1,366 State (699) 255 (188) Foreign (835) (18,292) (2,576) Total deferred benefit from income taxes (9,544) (11,323) (1,398) Total provision for income taxes from continuing operations $ 39,103 $ 23,853 $ 6,937 The reconciliation of the U.S. federal statutory rate to our effective tax rate on income (loss) before provision for income taxes from continuing operations for the years ended January 31, 2023, 2022, and 2021 was as follows: Year Ended January 31, (in thousands) 2023 2022 2021 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % Income tax provision (benefit) at the U.S. federal statutory rate $ 11,499 $ 8,296 $ (8,733) State income tax provision (benefit) 2,617 (1,238) 2,017 Foreign tax rate differential 3,244 6,262 5,992 Tax incentives (3,779) (6,378) (2,681) Valuation allowances (292) 2,616 (3,269) Stock-based and other compensation 3,347 897 2,958 Litigation and other non-deductible expenses 1,770 (238) (1,007) Tax credits 321 117 875 Tax contingencies 2,333 2,108 (5,652) Change in fair value of future tranche right — (3,320) 11,791 Changes in tax laws 9 1,552 — U.S. tax effects of foreign operations 18,642 13,480 3,828 Other, net (608) (301) 818 Total provision for income taxes $ 39,103 $ 23,853 $ 6,937 Effective income tax rate 71.4 % 60.4 % (16.6) % Our operations in Israel have been granted “Approved Enterprise” (“AE”) status by the Investment Center of the Israeli Ministry of Industry, Trade and Labor, which makes us eligible for tax benefits under the Israeli Law for Encouragement of Capital Investments, 1959. Under the terms of the program, income attributable to an approved enterprise is exempt from income tax for a period of two years and is subject to a reduced income tax rate for the subsequent five years to eight years (generally 10% - 23%, depending on the percentage of foreign investment in the company). Our AE status remained in effect through January 31, 2020. Beginning January 31, 2021, based on the current law, the company qualifies for an alternative tax incentive program as a Preferred Technological Enterprise (“PTE”). Pursuant to Amendment 73 to the Investment Law adopted in 2017, a company located in the Center of Israel that meets the conditions for PTE is subject to a 12% tax rate on eligible income. Income not eligible for PTE benefits is taxed at the regular corporate rate of 23%, excluding income derived from manufacturing activity which is entitled to tax benefits according to the “Preferred Enterprise” regime. Income eligible for tax benefits under the Preferred Enterprise regime is taxed at 16%. In total, tax incentives decreased our effective tax rate by 6.9% and 16.1% for the years ended January 31, 2023 and 2022, and increased our effective tax rate by 6.4% for the year ended January 31, 2021, respectively. The negative benefit is a result of taxable losses in Israel. Deferred tax assets and liabilities consisted of the following at January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Deferred tax assets: Accrued expenses $ 4,506 $ 4,464 Operating lease liabilities 7,974 9,275 Loss carryforwards 20,483 21,764 Tax credits 5,408 5,780 Stock-based and other compensation 3,963 6,802 Capitalized research and development expenses 18,669 2,253 Other, net 995 1,082 Total deferred tax assets 61,998 51,420 Deferred tax liabilities: Prepaid expenses (2,600) (1,885) Depreciation of property and equipment (2,732) (670) Deferred cost of revenue (9,707) (8,531) Goodwill and other intangible assets (20,607) (23,063) Unremitted earnings of foreign subsidiaries (1,784) (970) Operating lease right-of-use assets (5,241) (4,959) Total deferred tax liabilities (42,671) (40,078) Valuation allowance (20,357) (20,711) Net deferred tax liabilities $ (1,030) $ (9,369) Recorded as: Deferred tax assets $ 10,719 $ 8,091 Deferred tax liabilities (11,749) (17,460) Net deferred tax liabilities $ (1,030) $ (9,369) As required by the 2017 Tax Cuts and Jobs Act, effective February 1, 2022 certain research and development expenditures were capitalized and amortized for U.S. income tax purposes. These expenditures are the primary component of the capitalized research and development deferred tax asset. In addition, the presentation of several January 31, 2022 deferred tax components has been updated to correspond to the presentation as of January 31, 2023. At January 31, 2023, we had U.S. federal NOL carryforwards of approximately $162.3 million. Except for $13.6 million of NOLs that can be carried forward indefinitely, these loss carryforwards expire in various years ending from January 31, 2024 to January 31, 2037. We had state NOL carryforwards of approximately $172.0 million. Except for $4.5 million of NOLs that can be carried forward indefinitely, those loss carryforwards expire in various years ending from January 31, 2024 to January 31, 2041. We had foreign NOL carryforwards of approximately $38.6 million. At January 31, 2023, all but $2.4 million of these foreign loss carryforwards had indefinite carryforward periods. Certain of these federal, state, and foreign loss carryforwards and credits are subject to Internal Revenue Code Section 382 or similar provisions, which impose limitations on their utilization following certain changes in ownership of the entity generating the loss carryforward. We had U.S. federal, state, and foreign tax credit carryforwards of approximately $8.4 million at January 31, 2023, the utilization of which is subject to limitation. At January 31, 2023, approximately $2.7 million of these tax credit carryforwards may be carried forward indefinitely. The balance of $5.7 million expires in various years ending from January 31, 2024 to January 31, 2037. We currently intend to continue to indefinitely reinvest a portion of the earnings of our foreign subsidiaries to finance foreign activities. Except to the extent that earnings of our foreign subsidiaries have been subject to U.S. taxation as of January 31, 2023, and withholding taxes of $2.0 million accrued as of January 31, 2023 with respect to certain identified cash that may be repatriated to the United States, we have not provided tax on the outside basis difference of foreign subsidiaries nor have we provided for any additional withholding or other tax that may be applicable should a future distribution be made from any unremitted earnings of foreign subsidiaries. Due to complexities in the laws of the foreign jurisdictions and the assumptions that would have to be made, it is not practicable to estimate the total amount of income and withholding taxes that would have to be provided on such earnings. As required by the authoritative guidance on accounting for income taxes, we evaluate the realizability of deferred income tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes guidance requires that a valuation allowance be established when it is more-likely-than-not that all or a portion of the deferred income tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred income tax assets are not more-likely- than- not realizable, we establish a valuation allowance. We determined that there is sufficient negative evidence to maintain the valuation allowances against certain state and foreign deferred income tax assets as a result of historical losses in the most recent three-year period in certain state and foreign jurisdictions. We intend to maintain valuation allowances until sufficient positive evidence exists to support a reversal. We have recorded valuation allowances in the amounts of $20.4 million and $20.7 million at January 31, 2023 and 2022, respectively. Activity in the recorded valuation allowance consisted of the following for the years ended January 31, 2023 and 2022: Year Ended January 31, (in thousands) 2023 2022 Valuation allowance, beginning of year $ (20,711) $ (16,761) Income tax benefit (provision) 292 (2,616) Fair value of derivatives and convertible debt instruments — (1,139) Currency translation adjustment and other 62 (195) Valuation allowance, end of year $ (20,357) $ (20,711) In accordance with the authoritative guidance on accounting for uncertainty in income taxes, differences between the amount of tax benefits taken or expected to be taken in our income tax returns and the amount of tax benefits recognized in our financial statements, determined by applying the prescribed methodologies of accounting for uncertainty in income taxes, represent our unrecognized income tax benefits, which we either record as a liability or as a reduction of deferred tax assets. For the years ended January 31, 2023, 2022, and 2021, the aggregate changes in the balance of gross unrecognized tax benefits were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Gross unrecognized tax benefits, beginning of year $ 84,229 $ 84,847 $ 85,327 Increases related to tax positions taken during the current year 645 672 706 Increases related to tax positions taken during prior years 4,260 430 — (Decreases) increases related to foreign currency exchange rates (404) 45 136 Reductions for tax positions of prior years (84) (152) (193) Lapses of statutes of limitations (718) (1,613) (1,129) Gross unrecognized tax benefits, end of year $ 87,928 $ 84,229 $ 84,847 During the fourth quarter of the year ended January 31, 2023, we identified and recorded a $4.7 million out-of-period adjustment related to uncertain tax positions associated with Cognyte in fiscal years prior to the Spin-Off. We recorded a corresponding indemnification asset, within other assets in our consolidated balance sheet, as we are indemnified by Cognyte under the Tax Matters Agreement for this uncertain tax position. We also recorded a $5.7 million adjustment to increase additional paid-in capital and accumulated deficit in stockholders’ equity during the fourth quarter of the year ended January 31, 2023 in connection with this adjustment. The impact of these adjustments was not material, individually or in the aggregate, to any of our previously issued consolidated financial statements. We had unrecognized income tax benefits of $87.9 million (excluding interest and penalties) as of January 31, 2023, that, if recognized, would impact the effective income tax rate. We recorded $1.4 million, $0.5 million, and $0.4 million of tax expense for interest and penalties related to uncertain tax positions in our provision for income taxes for the years ended January 31, 2023, 2022, and 2021, respectively. The accrued liability for interest and penalties was $5.2 million and $3.4 million at January 31, 2023 and 2022, respectively. Interest and penalties are recorded as a component of the provision for income taxes in the consolidated statements of operations. Our income tax returns are subject to ongoing tax examinations in several jurisdictions in which we operate. In the United Kingdom, with the exception of years which are currently under examination, we are no longer subject to income tax examination for years prior to January 31, 2020. In the United States, with the exception of the 2017 year currently under examination, our federal returns are no longer subject to income tax examination for years prior to January 31, 2020. However, to the extent we generated NOLs or tax credits in closed tax years, future use of the NOL or tax credit carry forward balance would be subject to examination within the relevant statute of limitations for the year in which utilized. As of January 31, 2023, income tax returns are under examination in the following significant tax jurisdictions: Jurisdiction Tax Years United Kingdom December 31, 2006, January 31, 2008 India March 31, 2008, March 31, 2010 - March 31, 2013, March 31, 2017, March 31, 2020 Israel January 31, 2019 - January 31, 2021 Brazil December 31, 2018 United States January 31, 2018 We regularly assess the adequacy of our provisions for income tax contingencies in accordance with the applicable authoritative guidance on accounting for income taxes. As a result, we may adjust the reserves for unrecognized income tax benefits for the impact of new facts and developments, such as changes to interpretations of relevant tax law, assessments from taxing authorities, settlements with taxing authorities, and lapses of statutes of limitation. Further, we believe that it is reasonably possible that the total amount of unrecognized income tax benefits at January 31, 2023 could decrease by approximately $7.2 million in the next twelve months as a result of settlement of certain tax audits or lapses of statutes of limitation. Such decreases may involve the payment of additional income taxes, the adjustment of deferred income taxes including the need for additional valuation allowances, and the recognition of income tax benefits. Our income tax returns are subject to ongoing tax examinations in several jurisdictions in which we operate. We also believe that it is reasonably possible that new issues may be raised by tax authorities or developments in tax audits may occur, which would require increases or decreases to the balance of reserves for unrecognized income tax benefits; however, an estimate of such changes cannot reasonably be made. See Note 2, “Discontinued Operations” for discussion related to the Tax Matters Agreement entered into between us and Cognyte as a result of the Spin-Off. On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted and signed into U.S. law to provide economic relief to individuals and businesses facing economic hardship as a result of the COVID-19 pandemic. The income tax provisions of the CARES Act do not have a significant impact on our current taxes, deferred taxes, or uncertain tax positions. However, we previously deferred the payment of employer payroll taxes. The balance of the deferred employer payroll taxes was paid during the year ended January 31, 2023.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Jan. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Assets and Liabilities Measured at Fair Value on a Recurring Basis Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of January 31, 2023 and 2022: January 31, 2023 Fair Value Hierarchy Category (in thousands) Level 1 Level 2 Level 3 Assets: Money market funds $ 96,941 $ — $ — Commercial paper, classified as cash and cash equivalents — 50,869 — Foreign currency forward contracts — 19 — Contingent consideration receivable — 8 — Total assets $ 96,941 $ 50,896 $ — Liabilities: Foreign currency forward contracts $ — $ 124 $ — Contingent consideration — business combinations — — 12,717 Total liabilities $ — $ 124 $ 12,717 January 31, 2022 Fair Value Hierarchy Category (in thousands) Level 1 Level 2 Level 3 Assets: Money market funds $ 127,041 $ — $ — Commercial paper, classified as cash and cash equivalents — 29,995 $ — Foreign currency forward contracts — 33 — Contingent consideration receivable — — 271 Total assets $ 127,041 $ 30,028 $ 271 Liabilities: Foreign currency forward contracts $ — $ 91 $ — Contingent consideration — business combinations — 7,776 — Total liabilities $ — $ 7,867 $ — In January 2020, we completed the sale of an insignificant subsidiary. In accordance with the terms of the sale agreement, 100% of the aggregate purchase price is contingent in nature based on a percentage of net sales of the former subsidiary’s products during the thirty-six month period following the transaction closing. We include the fair value of the contingent consideration receivable within prepaid expenses and other current assets on our consolidated balance sheets. As of January 31, 2023, the fair value of the contingent consideration receivable, which was immaterial, was based on actual achievement through the performance period ended January 31, 2023, and was transferred to Level 2 of the fair value hierarchy as the fair value was determined based on other significant observable inputs. We received payments of $0.3 million, and the change in the estimated fair value of this contingent receivable was not material, during the years ended January 31, 2023 and 2022. The estimated fair value of this asset as of January 31, 2022 was $0.3 million. The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the years ended January 31, 2023 and 2022: Year Ended January 31, (in thousands) 2023 2022 Fair value measurement, beginning of year $ — $ 15,704 Contingent consideration liabilities recorded for business combinations 12,184 900 Changes in fair values, recorded in operating expenses 408 883 Payments of contingent consideration — (9,560) Foreign currency translation and other 125 (151) Transfer of contingent consideration liability to Level 2 of the fair value hierarchy — (7,776) Fair value measurement, end of year $ 12,717 $ — Our estimated liability for contingent consideration represents potential payments of additional consideration for business combinations, payable if certain defined performance goals are achieved. Changes in fair value of contingent consideration are recorded in the consolidated statements of operations within selling, general and administrative expenses. As of January 31, 2022, the $7.8 million fair value of the contingent consideration liability was based on actual achievement through the performance periods ended January 31, 2022, and was transferred to Level 2 of the fair value hierarchy as the fair value was determined based on other significant observable inputs. Payments of contingent consideration earned under these agreements were $7.5 million during the year ended January 31, 2023. We recorded a benefit of $0.2 million for changes in the fair values of contingent consideration obligations associated with business combinations and $0.1 million for changes due to foreign currency translation for the year ended January 31, 2023. Fair Value Measurements Money Market Funds - We value our money market funds using quoted active market prices for such funds. Short-term Investments, Corporate Debt Securities, and Commercial Paper - The fair values of short-term investments, as well as corporate debt securities and commercial paper classified as cash equivalents, are estimated using observable market prices for identical securities that are traded in less-active markets, if available. When observable market prices for identical securities are not available, we value these short-term investments using non-binding market price quotes from brokers which we review for reasonableness using observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model. Foreign Currency Forward Contracts - The estimated fair value of foreign currency forward contracts is based on quotes received from the counterparties thereto. These quotes are reviewed for reasonableness by discounting the future estimated cash flows under the contracts, considering the terms and maturities of the contracts and market foreign currency exchange rates using readily observable market prices for similar contracts. Contingent Consideration Assets and Liabilities - Business Combinations and Divestitures - The fair value of the contingent consideration related to business combinations and divestitures is estimated using a probability-adjusted discounted cash flow model. These fair value measurements are based on significant inputs not observable in the market. The key internally developed assumptions used in these models are discount rates and the probabilities assigned to the milestones to be achieved. We remeasure the fair value of the contingent consideration at each reporting period, and any changes in fair value resulting from either the passage of time or events occurring after the acquisition date, such as changes in discount rates, or in the expectations of achieving the performance targets, are recorded within selling, general, and administrative expenses. Increases or decreases in discount rates would have inverse impacts on the related fair value measurements, while favorable or unfavorable changes in expectations of achieving performance targets would result in corresponding increases or decreases in the related fair value measurements. We utilized discount rates ranging from 6.6% to 7.6%, with a weighted average discount rate of 6.9% in our calculations of the estimated fair values of our contingent consideration liabilities as of January 31, 2023. We utilized discount rates ranging from 3.5% to 3.9%, with a weighted average discount rate of 3.7% in our calculation of the estimated fair value of our contingent consideration assets as of January 31, 2022. Other Financial Instruments The carrying amounts of accounts receivable, contract assets, accounts payable, and accrued liabilities and other current liabilities approximate fair value due to their short maturities. The estimated fair value of our Term Loan borrowing was approximately $100 million at January 31, 2023 and 2022. The estimated fair values of the Term Loan borrowings are based upon indicative bid and ask prices as determined by the agent responsible for the syndication of our term loans. We consider these inputs to be within Level 3 of the fair value hierarchy because we cannot reasonably observe activity in the limited market in which participation in our Term Loan trades. The indicative prices provided to us as at each of January 31, 2023 and 2022 did not significantly differ from par value. The estimated fair value of borrowings under our Revolving Credit Facility, if any, is based upon indicative market values provided by one of our lenders. The estimated fair values of our 2021 Notes were approximately $282.0 million and $330.0 million at January 31, 2023 and 2022, respectively. The estimated fair values of the 2021 Notes were determined based on quoted bid and ask prices in the over-the-counter market in which the 2021 Notes traded. We consider these inputs to be within Level 2 of the fair value hierarchy. Assets and Liabilities Not Measured at Fair Value on a Recurring Basis In addition to assets and liabilities that are measured at fair value on a recurring basis, we also measure certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, intangible assets, operating lease right-of-use assets, and property, plant and equipment, are measured at fair value when there is an indication of impairment and the carrying amount exceeds the asset’s projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized. Further details regarding our regular impairment reviews appear in Note 1, “Summary of Significant Accounting Policies”. Assets Held for Sale We initially measure an asset that is classified as held for sale at the lower of its carrying amount or fair value less costs to sell. We assess the fair value of an asset less costs to sell each reporting period that it remains classified as held for sale, and report any subsequent changes as an adjustment to the carrying amount of the asset. Assets are not depreciated or amortized while they are classified as held for sale. During the three months ended July 31, 2022, we commenced plans to sell an approximately 50,000-square foot office building. In November 2022, we completed the sale of the office building and removed the carrying value of approximately $0.9 million from our consolidated balance sheet, which was included within property and equipment, net. We recorded an impairment loss of $2.0 million which adjusted the carrying amount of the asset to its fair value less costs to sell, of which $1.8 million was recorded within selling, general, and administrative expenses and $0.2 million was recorded within other income (expense), net in our consolidated statement of operations for the year ended January 31, 2023. Investments As of January 31, 2023, the carrying amount of our noncontrolling equity investments in privately-held companies without readily determinable fair values was $5.1 million. These investments are included within other assets on the consolidated balance sheets. There were no observable price changes in our investments in privately-held companies during the year ended January 31, 2023. As of January 31, 2022, the carrying amount of our noncontrolling equity investments in privately-held companies without readily determinable fair values was $5.1 million, of which $4.4 million was remeasured to fair value based on an observable transaction during the year ended January 31, 2022. These investments were included within other assets on the consolidated balance sheet as of January 31, 2022. An unrealized gain of $3.1 million, which adjusted the carrying value of a noncontrolling equity investment based on an observable transaction was recorded in other income (expense), net on the consolidated statement of operations for the year ended January 31, 2022. We did not recognize any impairments during the years ended January 31, 2023 and 2022.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	12 Months Ended
	Jan. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS Our primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk and interest rate risk, when deemed appropriate. We enter into these contracts in the normal course of business to mitigate risks and not for speculative purposes. Foreign Currency Forward Contracts Under our risk management strategy, we periodically use foreign currency forward contracts to manage our short-term exposures to fluctuations in operational cash flows resulting from changes in foreign currency exchange rates. These cash flow exposures result from portions of our forecasted operating expenses, primarily compensation and related expenses, which are transacted in currencies other than the U.S. dollar, most notably the Israeli shekel. We also periodically utilize foreign currency forward contracts to manage exposures resulting from forecasted customer collections to be remitted in currencies other than the applicable functional currency, and exposures from cash, cash equivalents and short-term investments denominated in currencies other than the applicable functional currency. These foreign currency forward contracts generally have maturities of no longer than twelve months, although occasionally we will execute a contract that extends beyond twelve months, depending upon the nature of the underlying risk. We held outstanding foreign currency forward contracts with notional amounts of $6.8 million and $7.4 million as of January 31, 2023 and 2022, respectively. Interest Rate Swap Agreement Prior to May 1, 2020, the 2018 Swap was designated as a cash flow hedge for accounting purposes and as such, changes in its fair value were recognized in accumulated other comprehensive income (loss) in the consolidated balance sheet and were reclassified into the consolidated statement of operations within interest expense in the periods in which the hedged transactions affected earnings. On May 1, 2020, which was an interest rate reset date on our Term Loan, we selected an interest rate other than three-month LIBOR. As a result, the 2018 Swap, which was designated specifically to hedge three-month LIBOR interest payments, no longer qualified as a cash flow hedge. Subsequent to May 1, 2020, changes in the fair value of the 2018 Swap were accounted for as a component of other income (expense), net. Accumulated deferred losses on the 2018 Swap of $20.4 million, or $16.0 million after taxes, at May 1, 2020 that were previously recorded as a component of accumulated other comprehensive loss, were being reclassified to the consolidated statement of operations as interest expense over the remaining term of the 2018 Swap, as the previously hedged interest payments occurred. On April 13, 2021, we paid $16.5 million to the counterparty to settle the 2018 Swap agreement prior to its June 2024 maturity. Upon settlement, we recorded an unrealized gain of $1.3 million in other income (expense), net to adjust the 2018 Swap to its fair value at settlement date and reclassified the remaining $15.7 million of pretax accumulated deferred losses from accumulated other comprehensive loss within stockholders’ equity to other income (expense), net on our consolidated statement of operations for the year ended January 31, 2022. The associated $3.7 million deferred tax asset was reclassified from accumulated other comprehensive loss and netted against income taxes receivable during the year ended January 31, 2022. Fair Values of Derivative Financial Instruments The fair values of our derivative financial instruments and their classifications in our consolidated balance sheets as of January 31, 2023 and 2022 were as follows: January 31, (in thousands) Balance Sheet Classification 2023 2022 Derivative assets: Foreign currency forward contracts: Designated as cash flow hedges Prepaid expenses and other current assets $ 19 $ 33 Total derivative assets $ 19 $ 33 Derivative liabilities: Foreign currency forward contracts: Designated as cash flow hedges Accrued expenses and other current liabilities $ 124 $ 91 Total derivative liabilities $ 124 $ 91 Derivative Financial Instruments in Cash Flow Hedging Relationships The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss (“AOCL”) and on the consolidated statement of operations for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Net (losses) gains recognized in AOCL: Foreign currency forward contracts $ (707) $ 85 $ 323 Interest rate swap agreement — — (7,535) $ (707) $ 85 $ (7,212) Net (losses) gains reclassified from AOCL to the consolidated statements of operations: Foreign currency forward contracts $ (660) $ 232 $ 267 Interest rate swap agreement — (16,669) (4,367) $ (660) $ (16,437) $ (4,100) For information regarding the line item locations of the net (losses) gains on derivative financial instruments reclassified out of AOCL into the consolidated statements of operations, see Note 11, “Stockholders’ Equity”. All of the foreign currency forward contracts underlying the net unrealized losses recorded in our accumulated other comprehensive loss at January 31, 2023 mature within twelve months, and therefore we expect all such losses to be reclassified into earnings within the next twelve months. Derivative Financial Instruments Not Designated as Hedging Instruments Losses recognized on derivative financial instruments not designated as hedging instruments in our consolidated statements of operations for the years ended January 31, 2023, 2022, and 2021 were as follows: Classification in Consolidated Statements of Operations Year Ended January 31, (in thousands) 2023 2022 2021 Interest rate swap agreements Other income (expense), net $ — $ (14,374) $ (1,267) $ — $ (14,374) $ (1,267)

STOCK-BASED COMPENSATION AND OT

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS	12 Months Ended
	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS	STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS Stock-Based Compensation Plans Plan Summaries We issue stock-based incentive awards to eligible employees, directors and consultants, including restricted stock units (“RSUs”), performance stock units (“PSUs”), stock options (both incentive and non-qualified), and other awards, under the terms of our outstanding stock benefit plans (the “Plans” or “Stock Plans”) and forms of equity award agreements approved by our board of directors. Awards are generally subject to multi-year vesting periods. We recognize compensation expense for awards on a straight-line basis over the requisite service periods of the awards, which are generally the vesting periods, reduced by estimated forfeitures. Upon issuance of restricted stock, exercise of stock options, or issuance of shares under the Plans, we generally issue new shares of common stock, but may issue treasury shares. Stock-Based Compensation Plans On June 20, 2019, our stockholders approved the Verint Systems Inc. 2019 Long-Term Stock Incentive Plan (the “2019 Plan”). Upon approval of the 2019 Plan, new awards were no longer permitted under our prior stock-based compensation plan (the “2017 Amended Plan”). Awards outstanding at June 20, 2019 under the 2017 Amended Plan or other previous stock-based compensation plans were not impacted by the approval of the 2019 Plan. Collectively, our stock-based compensation plans are referred to herein as the “Plans”. The 2019 Plan authorizes our board of directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, other stock-based awards, and performance compensation awards. Subject to adjustment as provided in the 2019 Plan, up to an aggregate of (i) 9,475,000 shares of our common stock plus (ii) the number of shares of our common stock available for issuance under the 2017 Amended Plan as of June 20, 2019, plus (iii) the number of shares of our common stock that become available for issuance as a result of awards made under the 2017 Amended Plan or the 2019 Plan that are forfeited, cancelled, exchanged, or that terminate or expire, may be issued or transferred in connection with awards under the 2019 Plan. Each stock option or stock-settled stock appreciation right granted under the 2019 Plan will reduce the available plan capacity by one share and each other award denominated in shares that is granted under the 2019 Plan will reduce the available plan capacity by 2.38 shares. In March 2021, our board of directors approved an adjustment of the available plan capacity to the 2019 Plan to 14,239,656 shares based on an adjustment ratio of approximately 1.45 as a result of the Spin-Off. Stock-Based Compensation Expense We recognized stock-based compensation expense in the following line items on the consolidated statements of operations for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Component of income before provision for income taxes: Cost of revenue - recurring $ 2,856 $ 1,999 $ 1,109 Cost of revenue - nonrecurring 2,806 3,029 2,184 Research and development, net 12,576 7,565 3,918 Selling, general and administrative 57,876 52,672 37,989 Total stock-based compensation expense 76,114 65,265 45,200 Income tax benefits related to stock-based compensation (before consideration of valuation allowances) 12,368 10,615 6,684 Total stock-based compensation, net of taxes $ 63,746 $ 54,650 $ 38,516 The following table summarizes stock-based compensation expense by type of award for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Restricted stock units and restricted stock awards $ 68,258 $ 58,678 $ 47,598 Stock bonus program and bonus share program 7,793 6,568 (2,390) Total equity-settled awards 76,051 65,246 45,208 Phantom stock units (cash-settled awards) 63 19 (8) Total stock-based compensation expense $ 76,114 $ 65,265 $ 45,200 Awards under our stock bonus and bonus share programs are accounted for as liability-classified awards, because the obligations are based predominantly on fixed monetary amounts that are generally known at inception of the obligation, to be settled with a variable number of shares of our common stock, which for awards under our stock bonus program is determined using a discounted average price of our common stock. We recorded $0.6 million and $2.5 million of net excess tax benefits for the years ended January 31, 2023 and 2022, respectively, and a $0.9 million net excess tax deficiency for the year ended January 31, 2021 resulting from our Stock Plans as a component of income tax expense. Restricted Stock Units and Performance Stock Units We periodically award RSUs to our directors, officers, and other employees. The fair value of these awards is equivalent to the market value of our common stock on the grant date. RSUs are not shares of our common stock and do not have any of the rights or privileges thereof, including voting or dividend rights. On the applicable vesting date, the holder of an RSU becomes entitled to a share of our common stock. RSUs are subject to certain restrictions and forfeiture provisions prior to vesting. We periodically award PSUs to executive officers and certain employees that vest upon the achievement of specified performance goals or market conditions. We separately recognize compensation expense for each tranche of a PSU award as if it were a separate award with its own vesting date. For certain PSUs, an accounting grant date may be established prior to the requisite service period. Once a performance vesting condition has been defined and communicated, and the requisite service period has begun, our estimate of the fair value of PSUs requires an assessment of the probability that the specified performance criteria will be achieved, which we update at each reporting date and adjust our estimate of the fair value of the PSUs, if necessary. All compensation expense for PSUs with market conditions is recognized if the requisite service period is fulfilled, even if the market condition is not satisfied. RSUs, PSUs, or phantom stock units that are expected to settle with cash payments upon vesting, if any, are reflected as liabilities on our consolidated balance sheets. Such awards were insignificant at January 31, 2023, 2022, and 2021. The following table (“Award Activity Table”) summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, 2023 2022 2021 (in thousands, except grant date fair values) Shares or Units Weighted-Average Grant-Date Fair Value Shares or Units Weighted-Average Grant-Date Fair Value Shares or Units Weighted-Average Grant-Date Fair Value Beginning balance 2,454 $ 42.99 2,950 $ 35.97 1,879 $ 52.96 Granted 1,743 $ 54.98 1,540 $ 48.01 1,469 $ 47.30 Released (1,733) $ 42.13 (1,800) $ 36.14 (1,125) $ 47.53 Forfeited (234) $ 48.86 (236) $ 40.23 (206) $ 52.59 Ending balance 2,230 $ 52.42 2,454 $ 42.99 2,017 $ 51.90 The beginning balance of the outstanding shares for the year ended January 31, 2022 reflects the adjusted shares based on an adjustment ratio of approximately 1.45 as a result of the Spin-Off on February 1, 2021. The related weighted-average grant date fair value for the beginning outstanding shares reflects the adjusted fair value of the awards on the Spin-Off Date. The adjusted shares preserve the same terms and conditions and vesting schedules as the original awards. The beginning balance of the shares and the respective weighted-average grant date fair value for the year ended January 31, 2021 reflects the shares and fair values on the original date of grant without adjustment. With respect to our stock bonus program, activity presented in the table above only includes shares earned and released in consideration of the discount provided under that program. Consistent with the provisions of the Plans under which such shares are issued, other shares issued under the stock bonus program are not included in the table above because they do not reduce available plan capacity (since such shares are deemed to be purchased by the grantee at fair value in lieu of receiving an earned cash bonus). Activity presented in the table above includes all shares awarded and released under the bonus share program. Further details appear below under “Stock Bonus Program” and “Bonus Share Program”. Our RSU and PSU awards may include a provision which allows the awards to be settled with cash payments upon vesting, rather than with delivery of common stock, at the discretion of our board of directors. As of January 31, 2023, for such awards that are outstanding, settlement with cash payments was not considered probable, and therefore these awards have been accounted for as equity-classified awards and are included in the table above. In order to achieve an equitable modification of the existing awards following the Spin-Off, we converted unvested awards as of February 1, 2021 by a factor of approximately 1.45, resulting in additional awards being granted to remaining employees denominated solely in Verint common stock. As noted above, a corresponding adjustment was also made to the available capacity under the 2019 Plan. The following table summarizes PSU activity in isolation under the Plans for the years ended January 31, 2023, 2022, and 2021 (these amounts are also included in the Award Activity Table above for 2023, 2022, and 2021): Year Ended January 31, (in thousands) 2023 2022 2021 Beginning balance 547 743 423 Granted 278 212 297 Released (279) (381) (182) Forfeited (14) (27) (27) Ending balance 532 547 511 Consistent with the table above, the beginning balance of the outstanding shares for the year ended January 31, 2022 reflects the adjusted shares based on an adjustment ratio of approximately 1.45 as a result of the Spin-Off on February 1, 2021. The beginning balance of the outstanding shares of the year ended January 31, 2021 reflects the number of shares on the date of grant without adjustment. Excluding PSUs, we granted 1,465,000 RSUs during the year ended January 31, 2023. As of January 31, 2023, there was approximately $80.1 million of total unrecognized compensation expense, net of estimated forfeitures, related to unvested restricted stock units, which is expected to be recognized over a weighted average period of 1.7 years. Stock Options We did not grant stock options during the years ended January 31, 2023, 2022, and 2021, and activity from stock options awarded in prior periods was not material during these years. Phantom Stock Units We have periodically issued phantom stock units to certain employees that settle, or are expected to settle, with cash payments upon vesting. Like equity-settled awards, phantom stock units are awarded with vesting conditions and are subject to certain forfeiture provisions prior to vesting. Phantom stock unit activity for the years ended January 31, 2023, 2022, and 2021 was not significant. Adjustment in Connection with the Spin-Off In accordance with the terms of our applicable equity incentive plans, following the completion of the Spin-Off on February 1, 2021, we equitably adjusted the number of shares underlying our remaining unvested awards by a factor of approximately 1.45 based on the ratio of the trading prices of our common stock prior to the Spin-Off to the trading prices of our common stock following the Spin-Off. Stock Bonus Program and Bonus Share Program Our stock bonus program permits eligible employees to receive a portion of their earned bonuses, otherwise payable in cash, in the form of discounted shares of our common stock. Executive officers are eligible to participate in this program to the extent that capacity remains available under the program following the enrollment of all other participants. Shares awarded to executive officers with respect to the discount feature of the program are subject to a one-year vesting period. This program is subject to annual funding approval by our board of directors and an annual cap on the number of shares that can be issued. Subject to these limitations, the number of shares to be issued under the program for a given year is determined using a five-day trailing average price of our common stock when the awards are calculated, reduced by a discount determined by the board of directors each year (the “discount”). To the extent that this program is not funded in a given year or the number of shares of common stock needed to fully satisfy employee enrollment exceeds the annual cap, the applicable portion of the employee bonuses will generally revert to being paid in cash. Obligations under this program are accounted for as liabilities, because the obligations are based predominantly on fixed monetary amounts that are generally known at inception of the obligation, to be settled with a variable number of shares of common stock determined using a discounted average price of our common stock. Shares earned under the program are issued after the end of the performance period, in the subsequent fiscal year. Under our bonus share program, we may provide discretionary bonuses to employees or pay earned bonuses that are outside the stock bonus program in the form of shares of common stock. Unlike the stock bonus program, there is no enrollment for this program and no discount feature. Similar to the accounting for the stock bonus program, obligations for these bonuses are accounted for as liabilities, because the obligations are based predominantly on fixed monetary amounts that are generally known, to be settled with a variable number of shares of common stock. As noted above, all shares issued under this program are included in the Award Activity Table above. Like the stock bonus program, shares awarded under the program are issued after the end of the performance period, in the subsequent fiscal year. For bonuses in respect of the year ended January 31, 2020, our board of directors approved the use of up to 305,000 shares of common stock in the aggregate for awards under these two programs, with up to 200,000 shares of common stock, and a discount of 15%, approved for awards under our stock bonus program. We issued 32,000 shares in lieu of cash bonuses and 3,000 shares for the discount feature under the stock bonus program in the year ended January 31, 2021, in respect of the performance period ended January 31, 2020. Approximately 272,000 shares of common stock were awarded and released under the bonus share program during the year ended January 31, 2021, in respect of the performance period ended January 31, 2020. For bonuses in respect of the year ended January 31, 2021, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate for awards under these two programs, with up to 200,000 shares of common stock, and a discount of 15%, for awards under our stock bonus program. However, these two programs were not used for the performance period ended January 31, 2021, and no shares were issued during the year ended January 31, 2022. Bonuses in respect of the year ended January 31, 2021 were paid solely in cash. For bonuses in respect of the year ended January 31, 2022, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate for awards under these two programs, with up to 300,000 shares of common stock, and a discount of 15%, approved for awards under our stock bonus program. We issued approximately 119,000 shares under the stock bonus program during the three months ended July 31, 2022, in respect of the performance period ended January 31, 2022. The bonus share program was not used, and no shares were issued under this program, in respect of the performance period ended January 31, 2022. The following table summarizes activity under the stock bonus program during the years ended January 31, 2023, 2022, and 2021 in isolation from other share activity. As noted above, shares issued in a given fiscal year are in respect of the prior fiscal year’s program period. Also, as noted above, shares issued in respect of the discount feature under the program reduce available plan capacity and are included in the Award Activity Table above. Other shares issued under the program do not reduce available plan capacity and are therefore excluded from the Award Activity Table above. Year Ended January 31, (in thousands) 2023 2022 2021 Shares in lieu of cash bonus — granted and released (not included in the Award Activity Table above) 119 — 32 Shares in respect of discount (included in the Award Activity Table above): Granted 12 — — Released 10 — 3 For bonuses in respect of the year ended January 31, 2023, our board of directors approved the use of up to 300,000 shares of common stock in the aggregate under these two programs, with up to 200,000 shares of common stock, and a discount of 15%, approved for awards under our stock bonus program. Any shares earned under these programs for the performance period ended January 31, 2023 will be issued during the first half of the year ending January 31, 2024. In March 2023, our board of directors approved up to 300,000 shares of common stock in the aggregate under these two programs, with up to 200,000, and a discount of 15%, for awards under our stock bonus program for the performance period ending January 31, 2024. Any shares earned under these programs will be issued during the year ending January 31, 2025. The combined accrued liabilities for the stock bonus program and the bonus share program was $7.9 million and $6.5 million at January 31, 2023 and 2022, respectively. Other Benefit Plans 401(k) Plan and Other Retirement Plans We maintain a 401(k) Plan for our full-time employees in the United States. The plan allows eligible employees who attain the age of 21 beginning with the first of the month following their date of hire to elect to contribute up to 60% of their annual compensation, subject to the prescribed maximum amount. We match employee contributions at a rate of 50%, up to a maximum annual matched contribution of $2,000 per employee. Employee contributions are always fully vested, while our matching contributions for each year vest on the last day of the calendar year provided the employee remains employed with us on that day. Our matching contribution expenses for our 401(k) Plan were $2.7 million, $2.6 million, and $2.6 million for the years ended January 31, 2023, 2022, and 2021, respectively. We provide retirement benefits for non-U.S. employees as required by local laws or to a greater extent as we deem appropriate through plans that function similar to 401(k) plans. Funding requirements for programs required by local laws are determined on an individual country and plan basis and are subject to local country practices and market circumstances. Severance Pay We are obligated to make severance payments for the benefit of certain employees of our foreign subsidiaries. Severance payments made to Israeli employees are considered significant compared to all other subsidiaries with severance payment arrangements. Under Israeli law, we are obligated to make severance payments to employees of our Israeli subsidiary, subject to certain conditions. In most cases, our liability for these severance payments is fully provided for by regular deposits to funds administered by insurance providers and by an accrual for the amount of our liability which has not yet been deposited. Severance expenses for our Israeli employees for the years ended January 31, 2023, 2022, and 2021 were $1.6 million, $1.3 million, and $1.1 million, respectively.

LEASES

LEASES	12 Months Ended
	Jan. 31, 2023
Leases [Abstract]
LEASES	LEASES We have entered into operating leases primarily for corporate offices, research and development facilities, datacenters, and automobiles. Our finance leases primarily relate to infrastructure equipment. Our leases have remaining lease terms of 1 year to 12 years, some of which may include options to extend the leases for up to 10 years, and some of which may include options to terminate the leases within 1 to 3 years. As of January 31, 2023 and 2022, assets recorded under finance leases The components of lease expenses for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Operating lease expenses $ 16,301 $ 24,241 $ 28,617 Finance lease expenses: Amortization of right-of-use assets 3,057 3,223 2,295 Interest on lease liabilities 188 260 312 Total finance lease expenses 3,245 3,483 2,607 Variable lease expenses 6,318 6,344 5,504 Short-term lease expenses 774 1,055 584 Sublease income (267) (1,804) (966) Total lease expenses $ 26,371 $ 33,319 $ 36,346 During the years ended January 31, 2023, 2022, and 2021, we exited certain leased offices primarily due to our workforce operating under remote work environments in certain locations due to the COVID-19 pandemic, which resulted in the recognition of accelerated operating lease costs of $8.3 million, $9.8 million, and $2.4 million, respectively. Operating lease expenses for the year ended January 31, 2021 included $6.9 million of indirect shared facility expenses, which were no longer a component of lease cost subsequent to the completion of the Spin-Off. Other information related to leases was as follows: Year Ended January 31, (dollars in thousands) 2023 2022 2021 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21,261 $ 19,360 $ 21,243 Operating cash flows from finance leases 187 260 312 Financing cash flows from finance leases 2,870 3,189 2,389 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 19,490 $ 11,282 $ 7,619 Finance leases 647 4,041 903 Weighted average remaining lease terms Operating leases 7 years 3 years 6 years Finance leases 2 years 3 years 3 years Weighted average discount rates Operating leases 6.2 % 4.8 % 5.8 % Finance leases 3.6 % 3.8 % 4.0 % Maturities of lease liabilities as of January 31, 2023 were as follows: January 31, 2023 (in thousands) Operating Leases Finance Leases Year Ending January 31, 2024 $ 9,925 $ 1,954 2025 10,419 1,571 2026 8,294 719 2027 7,340 102 2028 9,616 — Thereafter 16,826 — Total future minimum lease payments 62,420 4,346 Less: imputed interest (13,711) (190) Total $ 48,709 $ 4,156 Reported as of January 31, 2023: Accrued expenses and other current liabilities $ 7,965 $ 1,848 Operating lease liabilities 40,744 — Other liabilities — 2,308 Total $ 48,709 $ 4,156 As of January 31, 2023, we have additional operating leases for vehicles that have not yet commenced with future lease obligations of $0.1 million, and an additional finance lease for equipment that has not yet commenced with future lease obligations of $0.2 million. These leases will commence in the year ending January 31, 2024 and have a lease terms of 3 years.
LEASES	LEASES We have entered into operating leases primarily for corporate offices, research and development facilities, datacenters, and automobiles. Our finance leases primarily relate to infrastructure equipment. Our leases have remaining lease terms of 1 year to 12 years, some of which may include options to extend the leases for up to 10 years, and some of which may include options to terminate the leases within 1 to 3 years. As of January 31, 2023 and 2022, assets recorded under finance leases The components of lease expenses for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Operating lease expenses $ 16,301 $ 24,241 $ 28,617 Finance lease expenses: Amortization of right-of-use assets 3,057 3,223 2,295 Interest on lease liabilities 188 260 312 Total finance lease expenses 3,245 3,483 2,607 Variable lease expenses 6,318 6,344 5,504 Short-term lease expenses 774 1,055 584 Sublease income (267) (1,804) (966) Total lease expenses $ 26,371 $ 33,319 $ 36,346 During the years ended January 31, 2023, 2022, and 2021, we exited certain leased offices primarily due to our workforce operating under remote work environments in certain locations due to the COVID-19 pandemic, which resulted in the recognition of accelerated operating lease costs of $8.3 million, $9.8 million, and $2.4 million, respectively. Operating lease expenses for the year ended January 31, 2021 included $6.9 million of indirect shared facility expenses, which were no longer a component of lease cost subsequent to the completion of the Spin-Off. Other information related to leases was as follows: Year Ended January 31, (dollars in thousands) 2023 2022 2021 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21,261 $ 19,360 $ 21,243 Operating cash flows from finance leases 187 260 312 Financing cash flows from finance leases 2,870 3,189 2,389 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 19,490 $ 11,282 $ 7,619 Finance leases 647 4,041 903 Weighted average remaining lease terms Operating leases 7 years 3 years 6 years Finance leases 2 years 3 years 3 years Weighted average discount rates Operating leases 6.2 % 4.8 % 5.8 % Finance leases 3.6 % 3.8 % 4.0 % Maturities of lease liabilities as of January 31, 2023 were as follows: January 31, 2023 (in thousands) Operating Leases Finance Leases Year Ending January 31, 2024 $ 9,925 $ 1,954 2025 10,419 1,571 2026 8,294 719 2027 7,340 102 2028 9,616 — Thereafter 16,826 — Total future minimum lease payments 62,420 4,346 Less: imputed interest (13,711) (190) Total $ 48,709 $ 4,156 Reported as of January 31, 2023: Accrued expenses and other current liabilities $ 7,965 $ 1,848 Operating lease liabilities 40,744 — Other liabilities — 2,308 Total $ 48,709 $ 4,156 As of January 31, 2023, we have additional operating leases for vehicles that have not yet commenced with future lease obligations of $0.1 million, and an additional finance lease for equipment that has not yet commenced with future lease obligations of $0.2 million. These leases will commence in the year ending January 31, 2024 and have a lease terms of 3 years.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Unconditional Purchase Obligations In the ordinary course of business, we enter into certain unconditional purchase obligations, which are agreements to purchase goods or services that are enforceable, legally binding, and that specify all significant terms, including: fixed or minimum quantities to be purchased; fixed, minimum, or variable price provisions; and the approximate timing of the transaction. Our purchase orders are based on current needs and are typically fulfilled by our vendors within a relatively short time horizon. As of January 31, 2023, our unconditional purchase obligations totaled approximately $230.9 million. Licenses and Royalties We license certain technology and pay royalties under such licenses and other agreements entered into in connection with research and development activities. Historically, we have received non-refundable grants from the Israeli Innovation Authority (“IIA”) that funded a portion of our research and development expenditures. The Israeli law under which the IIA grants are made limits our ability to manufacture products, or transfer technologies, developed using these grants outside of Israel. If we were to seek approval to manufacture products, or transfer technologies, developed using these grants outside of Israel, we could be subject to additional royalty requirements or be required to pay certain redemption fees. If we were to violate these restrictions, we could be required to refund any grants previously received, together with interest and penalties, and may be subject to criminal penalties. Funds received from the IIA were recorded as a reduction to research and development expenses and amounts received were not material during the years ended January 31, 2023, 2022 and 2021. Off-Balance Sheet Risk In the normal course of business, we provide certain customers with financial performance guarantees, which are generally backed by standby letters of credit or surety bonds. In general, we would only be liable for the amounts of these guarantees in the event that our nonperformance permits termination of the related contract by our customer, which we believe is remote. At January 31, 2023, we had approximately $1.8 million of outstanding letters of credit and surety bonds relating primarily to these performance guarantees. As of January 31, 2023, we believe we were in compliance with our performance obligations under all contracts for which there is a financial performance guarantee, and the ultimate liability, if any, incurred in connection with these guarantees will not have a material adverse effect on our consolidated results of operations, financial position, or cash flows. Our historical non-compliance with our performance obligations has been insignificant. Indemnifications In the normal course of business, we provide indemnifications of varying scopes to customers against claims of intellectual property infringement made by third parties arising from the use of our products. Historically, costs related to these indemnification provisions have not been significant and we are unable to estimate the maximum potential impact of these indemnification provisions on our future results of operations. To the extent permitted under Delaware law or other applicable law, we indemnify our directors, officers, employees, and agents against claims they may become subject to by virtue of serving in such capacities for us. We also have contractual indemnification agreements with our directors, officers, and certain senior executives. The maximum amount of future payments we could be required to make under these indemnification arrangements and agreements is potentially unlimited; however, we have insurance coverage that limits our exposure and enables us to recover a portion of any future amounts paid. We are not able to estimate the fair value of these indemnification arrangements and agreements in excess of applicable insurance coverage, if any. Legal Proceedings CTI Litigation In March 2009, one of our former employees, Ms. Orit Deutsch, commenced legal actions in Israel against our former primary Israeli subsidiary, Cognyte Technologies Ltd. (formerly known as Verint Systems Limited or “VSL”) (Case Number 4186/09) and against our former affiliate CTI (Case Number 1335/09). Also, in March 2009, a former employee of Comverse Limited (CTI’s primary Israeli subsidiary at the time), Ms. Roni Katriel, commenced similar legal actions in Israel against Comverse Limited (Case Number 3444/09). In these actions, the plaintiffs generally sought to certify class action suits against the defendants on behalf of current and former employees of VSL and Comverse Limited who had been granted stock options in Verint and/or CTI and who were allegedly damaged as a result of a suspension on option exercises during an extended filing delay period that is discussed in our and CTI’s historical public filings. On June 7, 2012, the Tel Aviv District Court, where the cases had been filed or transferred, allowed the plaintiffs to consolidate and amend their complaints against the three defendants: VSL, CTI, and Comverse Limited. On October 31, 2012, CTI distributed all of the outstanding shares of common stock of Comverse, Inc., its principal operating subsidiary and parent company of Comverse Limited, to CTI’s shareholders (the “Comverse Share Distribution”). In the period leading up to the Comverse Share Distribution, CTI either sold or transferred substantially all of its business operations and assets (other than its equity ownership interests in Verint and in its then-subsidiary, Comverse, Inc.) to Comverse, Inc. or to unaffiliated third parties. As the result of these transactions, Comverse, Inc. became an independent company and ceased to be affiliated with CTI, and CTI ceased to have any material assets other than its equity interests in Verint. Prior to the completion of the Comverse Share Distribution, the plaintiffs sought to compel CTI to set aside up to $150.0 million in assets to secure any future judgment, but the District Court did not rule on this motion. In February 2017, Mavenir Inc. became successor-in-interest to Comverse, Inc. On February 4, 2013, Verint acquired the remaining CTI shell company in a merger transaction (the “CTI Merger”). As a result of the CTI Merger, Verint assumed certain rights and liabilities of CTI, including any liability of CTI arising out of the foregoing legal actions. However, under the terms of a Distribution Agreement entered into in connection with the Comverse Share Distribution, we, as successor to CTI, are entitled to indemnification from Comverse, Inc. (now Mavenir) for any losses we may suffer in our capacity as successor to CTI related to the foregoing legal actions. Following an unsuccessful mediation process, on August 28, 2016, the District Court (i) denied the plaintiffs’ motion to certify the suit as a class action with respect to all claims relating to Verint stock options, (ii) dismissed the motion to certify the suit against VSL and Comverse Limited, and (iii) approved the plaintiffs’ motion to certify the suit as a class action against CTI with respect to claims of current or former employees of Comverse Limited (now part of Mavenir) or of VSL who held unexercised CTI stock options at the time CTI suspended option exercises. The court also ruled that the merits of the case would be evaluated under New York law. As a result of this ruling (which excluded claims related to Verint stock options from the case), one of the original plaintiffs in the case, Ms. Deutsch, was replaced by a new representative plaintiff, Mr. David Vaaknin. CTI appealed portions of the District Court’s ruling to the Israeli Supreme Court. On August 8, 2017, the Israeli Supreme Court partially allowed CTI’s appeal and ordered the case to be returned to the District Court to determine whether a cause of action exists under New York law based on the parties’ expert opinions. Following two unsuccessful rounds of mediation in mid to late 2018 and in mid-2019, the proceedings resumed. On April 16, 2020, the District Court accepted plaintiffs’ application to amend the motion to certify a class action and set deadlines for filing amended pleadings by the parties. CTI submitted a motion to appeal the District Court’s decision to the Israeli Supreme Court, as well as a motion to stay the proceedings in the District Court pending the resolution of the appeal. On July 6, 2020, the Israeli Supreme Court granted the motion for a stay. On July 27, 2020, the plaintiffs filed their response on the merits of the motion for leave to appeal. On December 15, 2021, the Israeli Supreme Court rejected CTI’s motion to appeal and the proceedings in the District Court resumed. At the recommendation of the District Court, in June 2022, the parties conducted another round of mediation in New York. On July 10, 2022, the parties reached an agreement to settle the matter on terms set forth in a settlement agreement that was executed by all parties and submitted a motion for approval of the settlement agreement to the District Court. Under the terms of the settlement agreement, subject to full and final waiver, Mavenir Inc. and/or Comverse, Inc. and/or Mavenir Ltd. agreed to pay a total of $16.0 million (such amount to be paid in three phases as set forth in the settlement agreement) as compensation to the plaintiffs and members of the class. The compensation amount is comprehensive, final and absolute and includes within it all the amounts and expenses to be paid in connection with the settlement agreement. Under the terms of an associated guaranty agreement, Verint has guaranteed the payment of the compensation amount in the event it is not paid by the primary obligors. On February 7, 2023, the District Court approved the settlement without material changes. As of the date of this report, the first installment of the compensation amount had been paid by Mavenir, leaving two installments of approximately $4.7 million each to be paid between September 2023 and April 2024. Under the terms of the Separation and Distribution Agreement entered into between Verint and Cognyte, Cognyte has agreed to indemnify Verint for Cognyte’s share of any losses that Verint may suffer related to the foregoing legal actions either in its capacity as successor to CTI, to the extent not indemnified by Mavenir, or due to its former ownership of Cognyte and VSL. As of January 31, 2023, we recorded a liability of $16.0 million, $11.3 million of which is included within accrued expenses and other current liabilities, and $4.7 million of which is included in other liabilities, and an offsetting indemnification receivable of $16.0 million, $11.3 million of which is included in prepaid expenses and other current assets, and $4.7 million of which is included in other assets on our consolidated balance sheets. There was no impact to our consolidated statement of operations. Unfair Competition Litigation and Related Investigation On February 14, 2022, the U.S District Court for the Eastern District of Michigan issued negative partial summary judgment decisions in two cases pending against Verint Americas Inc., as successor to ForeSee Results, Inc. (“ForeSee”). On July 19, 2022, the court also denied ForeSee’s motions for reconsideration of these rulings. We believe that the court’s partial summary judgment decisions were wrongly decided and are contrary to the facts and the law and we intend to appeal those rulings following a final judgment. Furthermore, we believe that the claims asserted by the plaintiffs are without merit, and as explained in our affirmative Delaware litigation described below, that by bringing the claims, plaintiffs breached an agreement not to pursue such claims against ForeSee in an improper attempt by plaintiffs and their founder, Claes Fornell, to extract additional monies from ForeSee. The two Eastern District of Michigan cases are captioned ACSI LLC v. ForeSee Results, Inc. and CFI Group USA LLC v. Verint Americas Inc. The former case was filed on October 24, 2018 against ForeSee Results, Inc. by American Customer Satisfaction Index, LLC (“ACSI LLC”). Case No. 2:18-cv-13319. Verint completed its acquisition of ForeSee on December 19, 2018. In its complaint, ACSI LLC alleged infringement of two federally registered trademarks and common law unfair competition under federal and state law. ACSI LLC asserts that ForeSee, despite cancelling its license to use ACSI LLC’s alleged trademarks in 2013, has continued to use ACSI LLC’s trademarks. The trademark infringement claim was subsequently dismissed, but the common law unfair competition claims have proceeded. The latter case was filed on September 5, 2019 against Verint Americas Inc. (as successor in interest to ForeSee) by CFI Group USA LLC (“CFI”). Case No. 2:19-cv-12602. In its complaint, CFI alleges unfair competition and false advertising under federal and state law, as well as tortious interference with contract. CFI asserts that ForeSee engaged in unfair competition by using ACSI LLC’s trademarks without a license, and that ForeSee engaged in false advertising by mis-describing its customer satisfaction products. ACSI LLC’s and CFI’s complaints seek unspecified damages on their claims. On January 31, 2023, the court orally denied Verint’s request to consolidate the ACSI and CFI trials, and issued a written Order to this effect on February 17, 2023. The court has set the ACSI trial date for April 26, 2023. The court has not provided a revised CFI trial scheduling order, including with respect to setting a trial date. The parties participated in court-ordered mediation on February 28, 2023, but were unable to reach resolution of the matter. ForeSee continues to believe that there are substantial defenses to the claims in the ACSI LLC and CFI litigations and intends to continue to defend them vigorously. While we cannot estimate a possible loss, if any, that may result from the ACSI and CFI complaints against us, as of January 31, 2023, we have accrued $3.5 million, which represents our current estimate of the low end of a range for potential losses associated with these matters. While an ultimate loss in excess of the accrued amount is reasonably possible, a high end of the range cannot be reasonably estimated at this time. We have also recorded a $3.5 million insurance recovery receivable related to these matters, as this probable loss amount would be expected to be covered under one of our existing insurance policies. There was no net impact on our consolidated statements of operations related to these matters. Following the filing of the Eastern District of Michigan litigation, ForeSee filed affirmative litigation in the U.S. District Court for the Northern District of Georgia (Case No. 1:19-cv-02892, Complaint filed on June 25, 2019) against ACSI LLC’s predecessor in interest. ACSI LLC was then substituted as the named defendant. In that action, ForeSee sought cancellation of ACSI LLC’s federally registered trademarks. In response to ASCI LLC’s motion to dismiss the action, on March 15, 2022, the Georgia court issued an order transferring that action to the Eastern District of Michigan. Verint subsequently withdrew the action without prejudice and continues to consider any next actions it may take with respect to this matter. Following the filing of the Eastern District of Michigan litigation, ForeSee also filed affirmative litigation in the U.S. District Court for the District of Delaware (Case No. 1:21-cv-00674, Complaint filed on May 7, 2021) against ACSI LLC, CFI, Claes Fornell, and CFI Software LLC (the “Fornell Group”). Claes Fornell founded both ACSI LLC and CFI, and previously co-founded ForeSee before selling it in December 2013 for a significant gain. The Delaware action asserts claims against ACSI LLC, CFI, Fornell, and CFI Software for their breach of a “Joinder and Waiver Agreement” entered into in connection with the December 2013 sale of ForeSee in which they represented that they had no claims against ForeSee and in which they released any such claims. The Delaware action alleges that the Eastern District of Michigan litigations effectively represent an improper attempt by Fornell and his affiliates to profit off of ForeSee a second time (first by selling it in 2013 as a law-abiding company, only to sue it in 2018 and 2019 claiming violations of law for business practices that began while Fornell owned a significant position in ForeSee (via CFI Software) and during the time that Fornell served as chairman of ForeSee’s board). The Delaware action also asserts fraud claims against Fornell and CFI Software for affirmative statements they made in the December 2013 merger agreement which effectuated the sale and in other contemporaneous materials that ForeSee was not engaging in unfair competition or other violations of law. In the Delaware litigation, we are seeking as damages any amounts recovered by ACSI LLC, CFI or the USAO in the proceedings against ForeSee and/or Verint discussed above, as well as attorneys’ fees. Following the filing of our claims, the Fornell Group moved to dismiss, stay or transfer the Delaware litigation. The motion and ForeSee’s objection are currently pending before the Delaware court. Verint was also informed that the U.S. Attorney’s Office for the Eastern District of Michigan’s Civil Division (“USAO”) is conducting a False Claims Act investigation concerning allegations ForeSee and/or Verint failed to provide the federal government the services described in certain government contracts related to ForeSee’s products inherited by Verint in the acquisition. Verint received a Civil Investigation Demand (“CID”) in connection with this investigation and provided responses. The False Claims Act contains provisions that allow for private persons (“relators”) to initiate actions by filing claims under seal. We believe that this investigation was initiated in coordination with the Eastern District of Michigan litigation discussed above. Verint continues to work cooperatively with the USAO in its review of this matter. In March 2023, Verint and the Assistant U.S. Attorney overseeing this investigation reached an agreement in principle to resolve this matter. The proposed settlement, which would result in the payment by Verint of $7.0 million and would contain a statement of no admission to liability, is subject to definitive documentation as well as review and approval by the USAO, potential objection by any relators, and approval by a court if the investigation is in connection with a lawsuit initiated by a relator. The $7.0 million proposed settlement amount is expected to be covered under one of our existing insurance policies. As further discussed in Note 20, “Subsequent Event”, the settlement in principle with the Department of Justice in March 2023 is a recognizable subsequent event and therefore we recognized a $7.0 million legal settlement liability with a corresponding insurance recovery receivable in our consolidated balance sheet as of January 31, 2023. There was no impact on our consolidated statements of operations related to this settlement. We are a party to various other litigation matters and claims that arise from time to time in the ordinary course of our business. While we believe that the ultimate outcome of any such current matters will not have a material adverse effect on us, their outcomes are not determinable and negative outcomes may adversely affect our financial position, liquidity, or results of operations.

SEGMENT, GEOGRAPHIC, AND SIGNIF

SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION	12 Months Ended
	Jan. 31, 2023
Segment Reporting [Abstract]
SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION	SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION Segment Information Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the enterprise’s chief operating decision maker, or CODM, or decision making group, in deciding how to allocate resources and in assessing performance. Our Chief Executive Officer is our CODM. We are a pure-play customer engagement company that operates as a single reporting segment as our CODM reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Geographic Information Revenue by major geographic region is based upon the geographic location of the customers who purchase our products and services. The geographic locations of distributors, resellers, and systems integrators who purchase and resell our products may be different from the geographic locations of end customers. Revenue in the Americas includes the United States, Canada, Mexico, Brazil, and other countries in the Americas. Revenue in Europe, the Middle East and Africa (“EMEA”) includes the United Kingdom, Germany, Israel, and other countries in EMEA. Revenue in the Asia-Pacific (“APAC”) region includes Australia, India, and other Asia-Pacific countries. The information below summarizes revenue from unaffiliated customers by geographic area for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Americas: United States $ 572,837 $ 552,680 $ 515,480 Other 56,557 48,043 54,470 Total Americas 629,394 600,723 569,950 EMEA: United Kingdom 99,360 100,606 100,855 Other 82,680 79,560 72,361 Total EMEA 182,040 180,166 173,216 APAC 90,811 93,620 87,081 Total revenue $ 902,245 $ 874,509 $ 830,247 Our long-lived assets primarily consist of net property and equipment, operating lease right-of-use assets, goodwill and other intangible assets, and deferred income taxes. We believe that our tangible long-lived assets, which consist of our net property and equipment, are exposed to greater geographic area risks and uncertainties than intangible assets, operating lease right of use assets, and long-term cost deferrals, because these tangible assets are difficult to move and are relatively illiquid. Property and equipment, net by geographic area consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 United States $ 50,917 $ 50,241 United Kingdom 7,244 9,225 Other countries 6,649 4,624 Total property and equipment, net $ 64,810 $ 64,090 Significant Customers No end-customer represented more than 10% of our total revenue during the years ended January 31, 2023, 2022, and 2021. In the year ended January 31, 2021, we had an authorized global reseller of our solutions that represented approximately 10% of our total revenue, but did not represent 10% or greater of our total revenue for the years ended January 31, 2023 or 2022.

SUBSEQUENT EVENT

SUBSEQUENT EVENT	12 Months Ended
	Jan. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENT	SUBSEQUENT EVENTAs discussed in further detail in Note 18, “Commitments and Contingencies”, in March 2023, Verint and the Assistant U.S. Attorney overseeing a False Claims Act investigation (concerning allegations ForeSee and/or Verint failed to provide the federal government the services described in certain government contracts related to ForeSee’s products inherited by Verint in the acquisition) reached an agreement in principle to resolve such matter. The proposed settlement, which would result in the payment by Verint of $7.0 million and would contain a statement of no admission to liability, is subject to definitive documentation as well as review and approval by the USAO, potential objection by any relators, and approval by a court if the investigation is in connection with a lawsuit initiated by a relator. The $7.0 million proposed settlement amount is expected to be covered under one of our existing insurance policies. The proposed settlement was a recognizable subsequent event to the year ended January 31, 2023 in accordance with Topic ASC 855, Subsequent Events . Accordingly, as of January 31, 2023, we recorded a legal settlement liability of $7.0 million reported in accrued expenses and other current liabilities, and a corresponding insurance recovery receivable in prepaid expenses and other current assets on our consolidated balance sheets. The loss accrual and insurance recovery are offset within selling, general and administrative expenses in our consolidated statements of operations for the year ended January 31, 2023 ,

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of Verint Systems Inc., and our wholly owned or otherwise controlled subsidiaries. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders’ equity on our consolidated balance sheet, but separately from our stockholders’ equity. On January 31, 2022, we exercised the option to acquire the noncontrolling interests in two majority owned subsidiaries. Prior to the exercise, we accounted for the option as an in-substance investment in the noncontrolling common stock of each such subsidiary. We included the fair value of the option within accrued expenses and other current liabilities and did not recognize noncontrolling interests in these subsidiaries. Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment. We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all highly liquid investments with original maturities of 90 days or less at the time of purchase to be cash equivalents. For further information regarding our cash and cash equivalents, see Note 5, “Cash, Cash Equivalents, and Short-Term Investments.”
Investments	Investments Our investments generally consist of bank time deposits, and marketable debt securities of corporations, the U.S. government, and agencies of the U.S. government, all with remaining maturities in excess of 90 days at the time of purchase. We held no marketable debt securities at January 31, 2023 and 2022. Investments with maturities in excess of one year are included in other assets.
Accounts Receivable, Net	Accounts Receivable, NetTrade accounts receivable are comprised of invoiced amounts due from customers for which we have an unconditional right to collect and are not interest-bearing. Credit is extended to customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and cash equivalents, bank time deposits, short-term investments, trade accounts receivable, and contract assets. We invest our cash in bank accounts, certificates of deposit, and money market accounts with major financial institutions, in U.S. government and agency obligations, and in debt securities of corporations. By policy, we seek to limit credit exposure on investments through diversification and by restricting our investments to highly rated securities.
Allowance for Credit Losses	Allowance for Credit Losses We adopted Accounting Standard Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments on February 1, 2020 . ASU No. 2016-13 requires us to make judgments as to our ability to collect outstanding receivables and provide allowances for a portion of receivables over the lifetime of the receivables. Our allowance for expected credit losses is estimated based on an analysis of the aging of our accounts receivable and contract assets, historical write-offs, customer payment patterns, individual customer creditworthiness, current economic trends, reasonable and supportable forecasts of future economic conditions, and/or establishment of specific reserves for customers in adverse financial condition. We write-off an account receivable and charge it against its recorded allowance at the point when it is considered uncollectible. We assess the adequacy of the allowance for credit losses on a quarterly basis.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the weighted-average method of inventory accounting. The valuation of our inventories requires us to make estimates regarding excess or obsolete inventories, including making estimates of the future demand for our products. Although we make every effort to ensure the accuracy of our forecasts of future product demand, any significant unanticipated changes in demand, price, or technological developments could have a significant impact on the value of our inventory and reported operating results. Charges for excess and obsolete inventories are included within cost of revenue.
Property and Equipment, net	Property and Equipment, net Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation is computed using the straight-line method based over the estimated useful lives of the assets. The vast majority of equipment, furniture and other is depreciated over periods ranging from three years to seven years. Software is typically depreciated over periods ranging from three years to four years. Buildings are depreciated over ten years. Leasehold improvements are amortized over the shorter of their estimated useful lives or the related lease term. Finance leased assets are amortized over the related lease term. The cost of maintenance and repairs of property and equipment is charged to operations as incurred. When assets are retired or disposed of, the cost and accumulated depreciation or amortization thereon are removed from the consolidated balance sheet and any resulting gain or loss is recognized in the consolidated statement of operations.
Business Segment Information	Business Segment Information Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the enterprise’s chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance.
Goodwill and Other Acquired Intangible Assets	Goodwill and Other Acquired Intangible Assets For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill. We test goodwill for impairment at the reporting unit level, which can be an operating segment or one level below an operating segment, on an annual basis as of November 1, or more frequently if changes in facts and circumstances indicate that impairment in the value of goodwill may exist. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we elect to bypass a qualitative assessment, or if our qualitative assessment indicates that goodwill impairment is more likely than not, we perform quantitative impairment testing. If our quantitative testing determines that the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized in an amount equal to that excess, limited to the total goodwill allocated to the reporting unit. We utilize some or all of three primary approaches to assess the fair value of a reporting unit: (a) an income-based approach, using projected discounted cash flows, (b) a market-based approach, using valuation multiples of comparable companies, and (c) a transaction-based approach, using valuation multiples for recent acquisitions of similar businesses made in the marketplace. Our estimate of fair value of our reporting unit is based on a number of subjective factors, including: (a) appropriate consideration of valuation approaches (income approach, comparable public company approach, and comparable transaction approach), (b) estimates of future growth rates, (c) estimates of our future cost structure, (d) discount rates for our estimated cash flows, (e) selection of peer group companies for the comparable public company and the comparable market transaction approaches, (f) required levels of working capital, (g) assumed terminal value, and (h) time horizon of cash flow forecasts. The valuation methodology to determine the fair value of the reporting units is sensitive to management's forecasts of future revenue, profitability and market conditions. This methodology also considers various macroeconomic, industry-specific, and company-specific factors. Any resulting financial impact cannot be estimated reasonably at this time but may adversely affect our business and financial results. If there were an adverse change in facts and circumstances, then an impairment charge may be necessary in the future. Should the fair value of our reporting unit fall below its carrying amount because of reduced operating performance, market declines, changes in the discount rate, or other conditions, charges for impairment may be necessary. We monitor our reporting unit to determine if there is an indicator of potential impairment. Acquired identifiable intangible assets include identifiable acquired technologies, customer relationships, trade names, distribution networks, non-competition agreements, sales backlog, and in-process research and development. We amortize the cost of finite-lived identifiable intangible assets over their estimated useful lives, which are periods of 10 years or less. Amortization is based on the pattern in which the economic benefits of the intangible asset are expected to be realized, which typically is on a straight-line basis. The fair values assigned to identifiable intangible assets acquired in business combinations are determined primarily by using the income approach, which discounts expected future cash flows attributable to these assets to present value using estimates and assumptions determined by management. The acquired identifiable finite-lived intangible assets are being amortized primarily on a straight-line basis, which we believe approximates the pattern in which the assets are utilized, over their estimated useful lives.
Fair Value Measurements	Fair Value Measurements Accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. This fair value hierarchy consists of three levels of inputs that may be used to measure fair value: • Level 1: quoted prices in active markets for identical assets or liabilities; • Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or • Level 3: unobservable inputs that are supported by little or no market activity. We review the fair value hierarchy classification of our applicable assets and liabilities at each reporting period. Changes in the observability of valuation inputs may result in transfers within the fair value measurement hierarchy. Please refer to Note 14, “Fair Value Measurements”, for further discussion regarding transfers between levels of the fair value measurement hierarchy.
Fair Values of Financial Instruments	Fair Values of Financial InstrumentsOur recorded amounts of cash and cash equivalents, restricted cash and cash equivalents, and restricted bank time deposits, accounts receivable, contract assets, investments, and accounts payable approximate fair value, due to the short-term nature of these instruments. We measure certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants.
Derivative Financial Instruments	Derivative Financial Instruments As part of our risk management strategy, when considered appropriate, we use derivative financial instruments including foreign currency forward contracts and interest rate swap agreements to hedge against certain foreign currency and interest rate exposures. Our intent is to mitigate gains and losses caused by the underlying exposures with offsetting gains and losses on the derivative contracts. By policy, we do not enter into speculative positions with derivative instruments. We record all derivatives as assets or liabilities on our consolidated balance sheets at their fair values. Gains and losses from the changes in values of these derivatives are accounted for based on the use of the derivative and whether it qualifies for hedge accounting. The counterparties to our derivative financial instruments consist of several major international financial institutions. We regularly monitor the financial strength of these institutions. While the counterparties to these contracts expose us to credit-related losses in the event of a counterparty’s non-performance, the risk would be limited to the unrealized gains on such affected contracts. We do not anticipate any such losses and we do not have a material portfolio of derivative financial instruments.
Revenue Recognition	Revenue Recognition We account for revenue in accordance with ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. When an arrangement contains multiple performance obligations, we account for individual performance obligations separately if they are distinct. We recognize revenue through the application of the following five steps: 1) Identify the contract(s) with a customer A contract with a customer exists when (i) we enter into an enforceable contract with the customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance, and (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or in the case of a new customer, published credit and financial information pertaining to the customer. Our customary business practice is to enter into legally enforceable written contracts with our customers. The majority of our contracts are governed by a master agreement between us and the customer, which sets forth the general terms and conditions of any individual contract between the parties, which is then supplemented by a customer purchase order to specify the different goods and services, the associated prices, and any additional terms for an individual contract. Multiple contracts with a single counterparty entered into within a close timeframe are evaluated to determine if the contracts should be combined and accounted for as a single contract. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or services either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods or services, we must apply judgment to determine whether promised goods or services are capable of being distinct and are distinct in the context of the contract. If these criteria are not met the promised goods or services are accounted for as a combined performance obligation. Generally, our contracts do not include non-distinct goods or services. 3) Determine the transaction price The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer. We assess the timing of the transfer of goods and services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, we do not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less, which is the case in the majority of our customer contracts. The primary purpose of our invoicing terms is not to receive or provide financing from or to customers. To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price, if we assessed that it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Typically, our contracts do not provide our customers with any right of return or refund, and we do not constrain the contract price as it is probable that there will not be a significant revenue reversal due to a return or refund. 4) Allocate the transaction price to the performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct goods or services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, we must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. We allocate the variable amount to one or more distinct performance obligations but not all or to one or more distinct services that form a part of a single performance obligation, when the payment terms of the variable amount relate solely to our efforts to satisfy that distinct performance obligation and it results in an allocation that is consistent with the overall allocation objective of the revenue standard. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct good or service that forms part of a single performance obligation. We determine standalone selling price (“SSP”) based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we estimate the SSP taking into account available information such as market conditions, including geographic or regional specific factors, competitive positioning, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation. 5) Recognize revenue when (or as) the entity satisfies a performance obligation We satisfy performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. In the case of contracts that include customer acceptance criteria, revenue is not recognized until we can objectively conclude that the product or service meets the agreed-upon specifications in the contract. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to our customers. Revenue is measured based on consideration specified in a contract with a customer, and excludes taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer. Shipping and handling activities that are billed to the customer and occur after control over a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of revenue. Historically, these expenses have not been material. Nature of Goods and Services We derive and report our revenue in two categories: (a) recurring revenue, which includes bundled SaaS, unbundled SaaS, hosting services, optional managed services, initial and renewal support revenue, and product warranties, and (b) nonrecurring revenue, which primarily consists of perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties. Our bundled SaaS contracts are typically comprised of a right to access our software, maintenance, hosting fees and standard managed services. We do not provide the customer with the contractual right to take possession of the software at any time during the hosting period under these contracts. The customer can only benefit from the SaaS license, maintenance and standard managed services when combined with the hosting service as the hosting service is the only way for the customer to access the software and benefit from the maintenance and managed services. Accordingly, each of the license, maintenance, hosting and standard managed services is not considered a distinct performance obligation in the context of the contract, and are combined into a single performance obligation (“bundled SaaS services”) and recognized ratably over the contract period. Our bundled SaaS customer contracts can consist of fixed, variable, and usage-based fees. Typically, we invoice fees at the outset of the contract, though quarterly or monthly billing terms are included in certain contracts. Certain bundled SaaS contracts include a nonrefundable upfront fee for setup services, which are not distinct from the bundled SaaS services. Non-distinct setup services represent an advanced payment for future bundled SaaS services, and are recognized as revenue when those bundled SaaS services are satisfied, unless the nonrefundable fee is considered to be a material right, in which case the nonrefundable fee is recognized over the expected benefit period, which includes anticipated renewals. We determine SSP for our bundled SaaS services based on the price at which the performance obligation is sold separately, which is observable through past renewal transactions. We satisfy our bundled SaaS services by providing access to our software over time and processing transactions for usage-based contracts. For non-usage based fees, the period of time over which we perform is commensurate with the contract term because that is the period during which we have an obligation to provide the service. The performance obligation is recognized on a time elapsed basis, by day for which the services are provided. Our software licenses either provide our customers a perpetual right to use our software or, in the case of unbundled SaaS, the right to use our software for only a fixed term, in most cases between a one order to maximize the use of observable inputs. Software SSP is established based on an appropriate discount from our established list price, taking into consideration whether there are certain stratifications of the population with different pricing practices. Revenue for hardware is recognized at a point in time, generally upon shipment or delivery. Professional services revenues primarily consist of fees for deployment and optimization services, as well as training, and are generally recognized over time as the customer simultaneously receives and consumes the benefits of the professional services as the services are performed. Professional services that are billed on a time and materials basis are recognized over time as the services are performed. For contracts billed on a fixed price basis, revenue is recognized over time using an input method based on labor hours expended to date relative to the total labor hours expected to be required to satisfy the related performance obligation. We determine SSP for our professional services based on the price at which the performance obligation is sold separately, which is observable through past transactions. Customer support revenue is derived from providing remote technical support services, bug fixes and unspecified software updates and upgrades to customers on a when-and-if-available basis. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract. Each of these distinct performance obligations represent a stand ready obligation to provide service to a customer, which is concurrently delivered and has the same pattern of transfer to the customer, which is why we account for these support services as a single performance obligation. We recognize support services ratably over the contractual term, which typically is one year for perpetual licenses and one Our solutions are generally sold with a warranty of one year to three years for hardware and 90 days for software. These warranties do not represent an additional performance obligation as services beyond assuring that the software license and hardware complies with agreed-upon specifications are not provided.
Cost of Revenue	Cost of Revenue Our cost of revenue includes costs of materials, compensation and benefit costs for operations and service personnel, subcontractor costs, royalties and license fees related to third-party software included in our products, cloud infrastructure costs, depreciation of equipment used in operations and service, amortization of capitalized software development costs and certain purchased intangible assets, and related overhead costs. Costs that relate to satisfied (or partially satisfied) performance obligations in customer contracts (i.e., costs that relate to past performance) are expensed as incurred. Costs to Obtain and Fulfill Contracts We capitalize commissions paid to internal sales personnel and agent commissions that are incremental to obtaining customer contracts. We have determined that these commissions are in fact incremental and would not have occurred absent the customer contract. Deferred commissions also include the associated payroll taxes and fringe benefit costs associated with payments to our sales employees to the extent they are incremental. Sales and agent commissions are primarily deferred and amortized on a straight-line basis over the period the goods or services are transferred to the customer to which the assets relate, which ranges from immediate to as long as six years, if commission amounts paid upon renewal are not commensurate with amounts paid on the initial contract. A portion of the initial commission payable on the majority of our contracts is amortized over the anticipated renewal period, which is generally five
Research and Development, net	Research and Development, net With the exception of certain software development costs, all research and development costs are expensed as incurred, and consist primarily of personnel and consulting costs, travel, depreciation of research and development equipment, and related overhead and other costs associated with research and development activities.
Software Development Costs	Software Development Costs Costs incurred to acquire or develop software to be sold, leased or otherwise marketed are capitalized after technological feasibility is established, and continue to be capitalized through the general release of the related software product. Amortization of capitalized costs begins in the period in which the related product is available for general release to customers and is recorded on a straight-line basis, which approximates the pattern in which the economic benefits of the capitalized costs are expected to be realized, over the estimated economic lives of the related software products, generally five years.
Internal-Use Software Development Costs and Cloud Computing Arrangements	Internal-Use Software Development Costs and Cloud Computing Arrangements We expense costs associated with the assessment stage of software development projects. Capitalization begins when the preliminary project stage has been completed and management with the relevant authority authorizes and commits to the funding of the project. These capitalized costs include external direct costs utilized in developing or obtaining the applications and payroll and payroll-related costs for employees who are directly associated with the development of the applications. We expense the personnel-related costs of training and data conversion. We also expense costs associated with the post-implementation and operation stage, including maintenance and specified upgrades; however, we capitalize internal and external costs associated with significant upgrades to existing systems that result in additional functionality. Cloud computing arrangement costs follow the internal-use software accounting guidance to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized internal-use software development costs are generally amortized over periods ranging from four years to seven years on a straight-line basis, which best represents the pattern of the software’s use. Capitalized implementation costs related to a service contract will be amortized over the term of the hosting arrangement beginning when the component of the hosting arrangement is ready for its intended use. Periodically, we reassess the useful life considering technology, obsolescence, and other factors.
Income Taxes	Income Taxes We account for income taxes under the asset and liability method which includes the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our consolidated financial statements. Under this approach, deferred taxes are recorded for the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus deferred taxes. Deferred taxes result from differences between the financial statement and tax bases of our assets and liabilities, and are adjusted for changes in tax rates and tax laws when changes are enacted. The effects of future changes in income tax laws or rates are not anticipated. We are subject to income taxes in the United States and numerous foreign jurisdictions. The calculation of our income tax provision involves the application of complex tax laws and requires significant judgment and estimates. We evaluate the realizability of our deferred tax assets for each jurisdiction in which we operate at each reporting date, and establish valuation allowances when it is more likely than not that all or a portion of our deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income of the same character and in the same jurisdiction. We consider all available positive and negative evidence in making this assessment, including, but not limited to, the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. In circumstances where there is sufficient negative evidence indicating that our deferred tax assets are not more-likely-than-not realizable, we establish a valuation allowance. We use a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate tax positions taken or expected to be taken in a tax return by assessing whether they are more-likely-than-not sustainable, based solely on their technical merits, upon examination and including resolution of any related appeals or litigation process. The second step is to measure the associated tax benefit of each position as the largest amount that we believe is more-likely-than-not realizable. Differences between the amount of tax benefits taken or expected to be taken in our income tax returns and the amount of tax benefits recognized in our financial statements represent our unrecognized income tax benefits, which we either record as a liability or as a reduction of deferred tax assets. Our policy is to include interest (expense and/or income) and penalties related to unrecognized income tax benefits as a component of the provision for income taxes.
Functional Currencies and Foreign Currency Transaction Gains and Losses	Functional Currencies and Foreign Currency Transaction Gains and Losses The functional currency for most of our foreign subsidiaries is the applicable local currency, although we have some subsidiaries with functional currencies that differ from their local currency, of which the most notable exception is our subsidiary in Israel, whose functional currency is the U.S. dollar. Transactions denominated in currencies other than a functional currency are converted to the functional currency on the transaction date, and any resulting assets or liabilities are further remeasured at each reporting date and at settlement. Gains and losses recognized upon such remeasurements are included within other income (expense), net in the consolidated statements of operations. We recorded net foreign currency gains of $3.5 million for the year ended January 31, 2023, and net foreign currency losses of $1.6 million for each of the years ended January 31, 2022 and 2021. For consolidated reporting purposes, in those instances where a foreign subsidiary has a functional currency other than the U.S. dollar, revenue and expenses are translated into U.S. dollars using average exchange rates for the reporting period, while assets and liabilities are translated into U.S. dollars using period-end rates. The effects of foreign currency translation adjustments are included in stockholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets.
Stock-Based Compensation	Stock-Based Compensation We recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of the award. We recognize the fair value of the award as compensation expense over the period during which an employee is required to provide service in exchange for the award.
Net Income (Loss) Per Common Share Attributable to Verint Systems Inc.	Net Income (Loss) Per Common Share Attributable to Verint Systems Inc. Basic net income (loss) per common share is computed by dividing net income (loss) attributable to common shareholders by the weighted-average common stock outstanding during the respective period. Net income (loss) attributable to common shareholders is computed by deducting both the dividends declared in the period on the Preferred Stock and the dividends accumulated for the period on the Preferred Stock from net income (loss). Shares used in the calculation of basic net income (loss) per common share include vested but unissued shares underlying awards of restricted stock units when all necessary conditions for earning those shares have been satisfied at the award’s vesting date, but exclude unvested shares of restricted stock because they are contingent upon future service conditions. Diluted net income (loss) per common share is computed by dividing net income (loss) attributable to common and common equivalent shareholders by the total of the weighted-average common stock outstanding and common equivalent shares outstanding during the respective period. The number of common equivalent shares outstanding has been determined in accordance with the if-converted method for the Preferred Stock and the treasury stock method for employee stock options and restricted stock units to the extent they are dilutive. Under the treasury stock method, the exercise price paid by the option holder and average future share-based compensation expense that we have not yet recognized are assumed to be used to repurchase shares. Upon conversion of our 0.25% convertible senior notes due April 15, 2026 (the “2021 Notes”), further details for which appear in Note 8, “Long-Term Debt,” we are currently obligated to settle the principal amount of the 2021 Notes in cash upon conversion and as a result, only the amounts payable in excess of the principal amounts of the 2021 Notes, if any, are assumed to be settled with shares of common stock for purposes of computing diluted net income per share. In periods for which we report a net loss, basic net loss per common share and diluted net loss per common share are identical since the effect of potential common shares is anti-dilutive and therefore excluded.
Leases	Leases We determine if an arrangement is a lease at inception. Operating lease assets are presented as operating lease right-of-use (“ROU”) assets, and corresponding operating lease liabilities are presented within accrued expenses and other current liabilities (current portions), and as operating lease liabilities (long-term portions), on our consolidated balance sheets. Finance lease assets are included in property and equipment, and corresponding finance lease liabilities are included within accrued expenses and other current liabilities (current portions), and other liabilities (long-term portions), on our consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the remaining lease payments over the lease term at commencement date. Our leases do not provide an implicit interest rate. We calculate the incremental borrowing rate to reflect the interest rate that we would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term, and consider our historical borrowing activities and market data in this determination. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components, which we account for as a single lease component. Some of our leases contain variable lease payments, which are expensed as incurred unless those payments are based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and included in the measurement of the lease liability; thereafter, changes to lease payments due to rate or index updates are recorded as rent expense in the period incurred. We have elected not to recognize ROU assets and lease liabilities for short-term leases that have a term of twelve months or less. The effect of short-term leases on our ROU assets and lease liabilities was not material. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. In addition, our related party leases and our sublease transactions are de minimis.
Recent Accounting Pronouncements	Recent Accounting Pronouncements New Accounting Pronouncements Recently Adopted In May 2021, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. We adopted this standard as of February 1, 2022, and the adoption did not have any impact on our consolidated financial statements, as the effect will largely depend on the terms of written call options or financings issued or modified in the future. New Accounting Pronouncements Not Yet Effective In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which will require companies to apply the definition of a performance obligation under ASC Topic 606, Revenue from Contracts with Customers , to recognize and measure contract assets and contract liabilities relating to contracts with customers that are acquired in a business combination. Under current GAAP, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 will result in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. ASU No. 2021-08 is effective for fiscal years beginning after December

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Summary of Activity in Allowance for Credit Losses	The following table summarizes the activity in our allowance for credit losses for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Allowance for credit losses, beginning of year $ 1,260 $ 1,609 $ 1,239 Cumulative effect of adoption of ASU No. 2016-13 — — 577 Provisions charged to expense 565 1,242 1,899 Amounts written off (566) (1,666) (1,931) Other, including fluctuations in foreign exchange rates 31 75 (175) Allowance for credit losses, end of year $ 1,290 $ 1,260 $ 1,609

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Jan. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	The following table summarizes the major classes of line items included within discontinued operations in our consolidated statements of operations for the year ended January 31, 2021: Year ended January 31, (in thousands) 2021 Revenue $ 443,458 Cost of revenue 128,043 Operating expenses 264,132 Other income, net 6,604 Income from discontinued operations before benefit from income taxes 57,887 Provision for income taxes 9,393 Net income from discontinued operations 48,494 Net income from discontinued operations attributable to noncontrolling interests 6,107 Net income from discontinued operations attributable to Verint Systems Inc. common shares $ 42,387 The following table summarizes the assets and liabilities that were transferred to Cognyte on February 1, 2021: (in thousands) January 31, 2021 Assets Current Assets: Cash and cash equivalents $ 78,570 Restricted cash and cash equivalents, and restricted bank time deposits 27,042 Short-term investments 4,713 Accounts receivable, net 175,001 Contract assets, net 20,317 Inventories 14,542 Prepaid expenses and other current assets 34,741 Total current assets of discontinued operations 354,926 Property and equipment, net 37,152 Operating lease right-of-use assets 31,040 Goodwill 158,183 Intangible assets, net 5,299 Deferred income taxes 7,202 Other assets 42,076 Total long-term assets of discontinued operations 280,952 Total assets of discontinued operations $ 635,878 Liabilities Current Liabilities: Accounts payable $ 41,512 Accrued expenses and other current liabilities 100,189 Contract liabilities 127,012 Total current liabilities of discontinued operations 268,713 Long-term contract liabilities 22,037 Operating lease liabilities 23,174 Deferred income taxes 3,985 Other liabilities 8,922 Total long-term liabilities of discontinued operations 58,118 Total liabilities of discontinued operations $ 326,831

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	12 Months Ended
	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table provides a disaggregation of our recurring and nonrecurring revenue. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions. • Recurring revenue primarily consists of: ◦ Cloud revenue, which consists primarily of software as a service (“SaaS”) revenue and optional managed services revenue. ▪ SaaS revenue consists predominately of bundled SaaS (software access rights with standard managed services) and unbundled SaaS (software licensing rights accounted for as term-based licenses whereby customers have a license to our software with related support for a specific period). ▪ Bundled SaaS revenue is recognized over time. ▪ Unbundled SaaS revenue is recognized at a point in time, except for the related support which is recognized over time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a one ◦ Support revenue, which consists of initial and renewal support. • Nonrecurring revenue primarily consists of our perpetual licenses, hardware, installation services, business advisory consulting and training services, and patent license royalties. Year Ended January 31, (in thousands) 2023 2022 2021 Recurring revenue Bundled SaaS revenue $ 222,560 $ 183,035 $ 145,962 Unbundled SaaS revenue 221,645 139,729 71,990 Optional managed services revenue 61,388 65,648 59,459 Total cloud revenue 505,593 388,412 277,411 Support revenue 179,944 244,717 298,213 Total recurring revenue 685,537 633,129 575,624 Nonrecurring revenue Perpetual revenue 116,611 138,078 141,840 Professional services revenue 100,097 103,302 112,783 Total nonrecurring revenue 216,708 241,380 254,623 Total revenue $ 902,245 $ 874,509 $ 830,247
Schedule of Contracts with Customers - Assets and Liabilities	The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers: January 31, (in thousands) 2023 2022 Accounts receivable, net $ 188,414 $ 193,831 Contract assets, net $ 60,444 $ 42,688 Long-term contract assets, net (included in other assets) $ 37,950 $ 30,510 Contract liabilities $ 271,476 $ 271,271 Long-term contract liabilities $ 18,047 $ 15,872
Schedule of Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction	The following table provides information about when we expect to recognize our remaining performance obligations: January 31, (in thousands) 2023 2022 RPO: Expected to be recognized within 1 year $ 464,346 $ 447,428 Expected to be recognized in more than 1 year 262,695 274,404 Total RPO $ 727,041 $ 721,832

NET LOSS PER COMMON SHARE ATT_2

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. (Tables)	12 Months Ended
	Jan. 31, 2023
Earnings Per Share [Abstract]
Schedule Of Calculation Of Basic And Diluted Net Loss Per Common Share Attributable To Verint Systems Inc.	The following table summarizes the calculation of basic and diluted net loss per common share attributable to Verint Systems Inc. for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands, except per share amounts) 2023 2022 2021 Net income (loss) from continuing operations $ 15,659 $ 15,651 $ (48,601) Net income from discontinued operations — — 48,494 Net income (loss) 15,659 15,651 (107) Net income attributable to noncontrolling interests from continuing operations 761 1,238 1,053 Net income attributable to noncontrolling interests from discontinued operations — — 6,107 Net income (loss) attributable to Verint Systems Inc. 14,898 14,413 (7,267) Dividends on preferred stock (20,800) (18,922) (7,656) Net loss attributable to Verint Systems Inc. for basic net loss per common share (5,902) (4,509) (14,923) Dilutive effect of dividends on preferred stock — — — Net loss attributable to Verint Systems Inc. for diluted net loss per common share $ (5,902) $ (4,509) $ (14,923) Net (loss) income attributable to Verint Systems Inc. common shares Year Ended January 31, (in thousands, except per share amounts) 2023 2022 2021 Net loss from continuing operations attributable to Verint Systems Inc. common shares (5,902) (4,509) (57,310) Net income from discontinued operations attributable to Verint Systems Inc. common shares — — 42,387 Weighted-average shares outstanding: Basic 65,332 65,591 65,173 Dilutive effect of employee equity award plans — — — Dilutive effect of 2021 Notes — — — Dilutive effect of 2014 Notes — — — Dilutive effect of warrants — — — Dilutive effect of assumed conversion of preferred stock — — — Diluted 65,332 65,591 65,173 Basic net (loss) income per common share attributable to Verint Systems Inc.: Continuing Operations $ (0.09) $ (0.07) $ (0.88) Discontinued Operations — — 0.65 Total basic net loss per common share attributable to Verint Systems Inc. $ (0.09) $ (0.07) $ (0.23) Diluted net (loss) income per common share attributable to Verint Systems Inc.: Continuing operations $ (0.09) $ (0.07) $ (0.88) Discontinued operations — — 0.65 Total diluted net loss per common share attributable to Verint Systems Inc. $ (0.09) $ (0.07) $ (0.23)
Schedule Of Anti-dilutive Securities	We excluded the following weighted-average potential common shares from the calculations of diluted net loss per common share during the applicable periods because their inclusion would have been anti-dilutive: Year Ended January 31, (in thousands) 2023 2022 2021 Common shares excluded from calculation: Stock options and restricted stock-based awards 2,120 1,580 1,337 2014 Notes — 481 6,002 Warrants — 117 6,205 Series A Preferred Stock 5,498 5,498 2,743 Series B Preferred Stock 3,980 3,282 —

CASH, CASH EQUIVALENTS, AND S_2

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Tables)	12 Months Ended
	Jan. 31, 2023
Cash, Cash Equivalents, and Short-Term Investments [Abstract]
Schedule of Cash, Cash Equivalents and Short-term Investments	The following tables summarize our cash, cash equivalents, and short-term investments as of January 31, 2023 and 2022: January 31, 2023 (in thousands) Cost Basis Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash and cash equivalents: Cash and bank time deposits $ 134,289 $ — $ — $ 134,289 Money market funds 96,941 — — 96,941 Commercial paper 50,869 — — 50,869 Total cash and cash equivalents $ 282,099 $ — $ — $ 282,099 Short-term investments: Bank time deposits $ 697 $ — $ — $ 697 Total short-term investments $ 697 $ — $ — $ 697 January 31, 2022 (in thousands) Cost Basis Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash and cash equivalents: Cash and bank time deposits $ 201,769 $ — $ — $ 201,769 Money market funds 127,041 — — 127,041 Commercial paper $ 29,995 $ — $ — 29,995 Total cash and cash equivalents $ 358,805 $ — $ — $ 358,805 Short-term investments: Bank time deposits $ 765 $ — $ — $ 765 Total short-term investments $ 765 $ — $ — $ 765

BUSINESS COMBINATIONS (Tables)

BUSINESS COMBINATIONS (Tables)	12 Months Ended
	Jan. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Purchase Price Allocations	The following table sets forth the components and the allocation of the purchase price for our acquisition of Conversocial, including adjustments identified subsequent to the valuation date none of which were material: (in thousands) Amount Components of Purchase Price: Cash $ 53,409 Other purchase price adjustments (190) Total purchase price $ 53,219 Allocation of Purchase Price: Net tangible assets (liabilities): Accounts receivable $ 1,694 Other current assets, including cash acquired 5,462 Other assets 511 Current and other liabilities (1,945) Contract liabilities - current and long-term (3,410) Deferred income taxes (301) Net tangible assets 2,011 Identifiable intangible assets: Customer relationships 9,800 Developed technology 9,900 Trademarks and trade names 200 Total identifiable intangible assets 19,900 Goodwill 31,308 Total purchase price allocation $ 53,219

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL (Tables)	12 Months Ended
	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquisition-Related Intangible Assets	Acquisition-related intangible assets, excluding certain intangible assets previously acquired that were fully amortized and removed from our consolidated balance sheets, consisted of the following as of January 31, 2023 and 2022: January 31, 2023 (in thousands) Cost Accumulated Net Intangible assets with finite lives: Customer relationships $ 458,013 $ (390,113) $ 67,900 Acquired technology 229,317 (212,065) 17,252 Trade names 4,479 (4,359) 120 Distribution network 2,440 (2,440) — Total intangible assets $ 694,249 $ (608,977) $ 85,272 January 31, 2022 (in thousands) Cost Accumulated Net Intangible assets with finite lives: Customer relationships $ 467,408 $ (375,827) $ 91,581 Acquired technology 229,501 (203,895) 25,606 Trade names 5,677 (4,610) 1,067 Distribution network 2,440 (2,440) — Total intangible assets $ 705,026 $ (586,772) $ 118,254
Schedule of Estimated Future Amortization Expense on Finite-lived Acquisition-related Intangible Assets	Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows: (in thousands) Years Ending January 31, Amount 2024 $ 32,380 2025 16,581 2026 15,219 2027 11,462 2028 6,839 Thereafter 2,791 Total $ 85,272
Schedule of Goodwill Activity	Goodwill activity for the years ended January 31, 2023, and 2022 was as follows: (in thousands) Total Year Ended January 31, 2022: Goodwill, gross, at January 31, 2021 $ 1,383,450 Accumulated impairment losses through January 31, 2021 (56,043) Goodwill, net, at January 31, 2021 1,327,407 Business combinations 36,006 Foreign currency translation and other (9,992) Goodwill, net, at January 31, 2022 $ 1,353,421 Year Ended January 31, 2023: Goodwill, gross, at January 31, 2022 $ 1,409,464 Accumulated impairment losses through January 31, 2022 (56,043) Goodwill, net, at January 31, 2022 1,353,421 Business combinations, including adjustments to prior period acquisitions 25,239 Foreign currency translation and other (31,447) Goodwill, net, at January 31, 2023 $ 1,347,213 Balance at January 31, 2023 Goodwill, gross, at January 31, 2023 $ 1,403,256 Accumulated impairment losses through January 31, 2023 (56,043) Goodwill, net, at January 31, 2023 $ 1,347,213

LONG-TERM DEBT (Tables)

LONG-TERM DEBT (Tables)	12 Months Ended
	Jan. 31, 2023
Debt Disclosure [Abstract]
Summary of Long-term Debt	The following table summarizes our long-term debt at January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 2021 Notes $ 315,000 $ 315,000 Term Loan 100,000 100,000 Less: Unamortized debt discounts and issuance costs (6,092) (8,046) Total debt 408,908 406,954 Less: current maturities — — Long-term debt $ 408,908 $ 406,954
Schedule of Components of Interest Expense	The following table presents the components of interest expense incurred on the 2021 Notes, the 2014 Notes, and on borrowings under our Credit Agreement for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 2021 Notes: Interest expense at 0.25% coupon rate $ 787 $ 639 $ — Amortization of deferred debt issuance costs 1,762 1,416 — Total Interest Expense - 2021 Notes $ 2,549 $ 2,055 $ — 2014 Notes: Interest expense at 1.50% coupon rate $ — $ 1,933 $ 5,887 Amortization of debt discount — — 12,884 Amortization of deferred debt issuance costs — 522 1,215 Total Interest Expense - 2014 Notes $ — $ 2,455 $ 19,986 Borrowings under Credit Agreement: Interest expense at contractual rates $ 4,114 $ 3,366 $ 13,018 Impact of interest rate swap agreement — 1,014 4,368 Amortization of debt discounts 19 18 74 Amortization of deferred debt issuance costs 863 930 1,811 Total Interest Expense - Borrowings under Credit Agreement $ 4,996 $ 5,328 $ 19,271

SUPPLEMENTAL CONSOLIDATED FIN_2

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION (Tables)	12 Months Ended
	Jan. 31, 2023
Condensed Financial Information Disclosure [Abstract]
Schedule of Inventories	Inventories consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Raw materials $ 3,325 $ 3,001 Work-in-process 40 150 Finished goods 9,263 2,186 Total inventories $ 12,628 $ 5,337
Schedule of Property and Equipment, net	Property and equipment, net consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Land and buildings $ 820 $ 7,994 Leasehold improvements 15,026 18,155 Software 73,569 76,152 Equipment, furniture, and other 41,966 64,363 Total cost 131,381 166,664 Less: accumulated depreciation and amortization (66,571) (102,574) Total property and equipment, net $ 64,810 $ 64,090
Schedule of Prepaid Expenses and Other Current Assets	Prepaid and other current assets consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Prepaid expenses $ 24,364 $ 22,639 Other current assets 27,257 31,113 Insurance recovery receivable 12,503 — CTI litigation settlement indemnification asset - current portion 11,250 — Total prepaid expenses and other current assets $ 75,374 $ 53,752
Schedule of Other Assets	Other assets consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Deferred commissions $ 54,512 $ 51,714 Long-term contract assets, net 37,950 30,510 Capitalized software development costs, net 23,527 22,483 Noncontrolling equity investments 5,146 5,146 Long-term deferred cost of revenue 4,951 5,907 CTI litigation settlement indemnification asset - long-term portion 4,750 — Deferred debt issuance costs, net 1,485 1,950 Long-term restricted cash and time deposits 287 409 Other 15,674 8,519 Total other assets $ 148,282 $ 126,638
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Compensation and benefits $ 73,766 $ 86,777 Taxes other than income taxes 16,346 16,313 Preferred Stock dividends payable 10,400 10,400 CTI litigation settlement liability - current portion 11,250 — Operating lease obligations - current portion 7,965 24,551 DOJ legal settlement liability 7,000 — Contingent consideration - current portion 4,496 7,776 Professional and consulting fees 2,635 3,771 Income taxes 443 602 Other 21,643 18,504 Total accrued expenses and other current liabilities $ 155,944 $ 168,694
Schedule of Other Liabilities	Other liabilities consisted of the following as of January 31, 2023 and 2022: January 31 (in thousands) 2023 2022 Unrecognized tax benefits, including interest and penalties $ 52,887 $ 16,345 Contingent consideration - long-term portion 8,221 — CTI litigation settlement liability - long-term portion 4,750 — Finance lease obligations - long-term portion 2,308 3,831 Other 466 1,820 Total other liabilities $ 68,632 $ 21,996
Schedule of Other Income (Expense), Net	Other income (expense), net consisted of the following for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Foreign currency gains (losses), net $ 3,453 $ (1,644) $ (1,584) Losses on derivative financial instruments, net — (14,374) (1,267) Change in fair value of future tranche right — 15,810 (56,146) Other, net (1,471) 5,435 (1,604) Total other income (expense), net $ 1,982 $ 5,227 $ (60,601)
Schedule of Supplemental Information Regarding Consolidated Cash Flows	The following table provides supplemental information regarding our consolidated cash flows for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Cash paid for interest $ 4,661 $ 9,716 $ 24,612 Cash payments of income taxes, net $ 15,886 $ 42,917 $ 21,476 Non-cash investing and financing transactions: Liabilities for contingent consideration in business combinations $ 12,184 $ 900 $ — Preferred Stock dividends declared $ 10,400 $ 10,400 $ 5,200 Finance leases of property and equipment $ 647 $ 4,041 $ 903 Settlement of Future Tranche Right upon issuance of Series B Preferred Stock $ — $ 36,962 $ — Retirement of treasury stock $ 106,146 $ 234,999 $ — Settlement of convertible note premium with common stock $ — $ 59,131 $ — Receipt of common stock from the counterparties under the Note Hedges $ — $ 59,651 $ — Accrued but unpaid purchases of property and equipment $ 2,353 $ 750 $ 2,731 Accrued but unpaid purchases of treasury stock $ 616 $ — $ —

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Jan. 31, 2023
Stockholders' Equity Note [Abstract]
Summary of Components of Accumulated Other Comprehensive Income (Loss)	The following table summarizes changes in the components of our accumulated other comprehensive income (loss) by component for the years ended January 31, 2023 and 2022: (in thousands) Unrealized Gains (Losses) on Foreign Exchange Contracts Designated as Hedges Unrealized Losses on Interest Rate Swap Designated as Hedge Foreign Currency Translation Adjustments Total Accumulated other comprehensive income (loss) at January 31, 2021 $ 634 $ (13,031) $ (124,481) $ (136,878) Distribution of Cognyte Software Ltd. (559) — 17,682 17,123 Other comprehensive income (loss) before reclassifications 70 — (11,668) (11,598) Amounts reclassified out of accumulated other comprehensive income (loss) 193 (1,014) — (821) Amounts reclassified upon partial early retirement of the Term Loan — (12,017) — (12,017) Net other comprehensive (loss) income (682) 13,031 6,014 18,363 Accumulated other comprehensive loss at January 31, 2022 (48) — (118,467) (118,515) Other comprehensive loss before reclassifications (588) — (35,545) (36,133) Amounts reclassified out of accumulated other comprehensive loss (549) — — (549) Net other comprehensive loss (39) — (35,545) (35,584) Accumulated other comprehensive loss at January 31, 2023 $ (87) $ — $ (154,012) $ (154,099)
Schedule of Amounts Reclassified Out of Accumulated Other Comprehensive Income (Loss)	The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of operations, with presentation location, for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, Financial Statement Location (in thousands) 2023 2022 2021 Unrealized (losses) gains on derivative financial instruments: Foreign currency forward contracts $ (1) $ 1 $ 1 Cost of recurring revenue (60) 24 28 Cost of nonrecurring revenue (392) 142 182 Research and development, net (207) 65 56 Selling, general and administrative (660) 232 267 Total, before income taxes 111 (39) (42) Provision for income taxes $ (549) $ 193 $ 225 Total, net of income taxes Interest rate swap agreement $ — $ (1,014) $ (4,367) Interest expense — (15,655) — Other income (expense), net — (16,669) (4,367) Total, before income taxes — 3,638 954 Benefit from income taxes $ — $ (13,031) $ (3,413) Total, net of income taxes

RESEARCH AND DEVELOPMENT, NET (

RESEARCH AND DEVELOPMENT, NET (Tables)	12 Months Ended
	Jan. 31, 2023
Research and Development [Abstract]
Activity of Capitalized Software Development Costs	Activity for our capitalized software development costs for the years ended January 31, 2023, 2022, and 2021 was as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Capitalized software development costs, net, beginning of year $ 22,483 $ 19,250 $ 15,351 Software development costs capitalized during the year 7,595 7,560 7,312 Amortization of capitalized software development costs (6,407) (4,247) (3,304) Write-offs of capitalized software development costs (6) — (129) Foreign currency translation and other (138) (80) 20 Capitalized software development costs, net, end of year $ 23,527 $ 22,483 $ 19,250

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Components of Income (Loss) Before Provision for Income Taxes	The components of income (loss) before provision for income taxes for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Domestic $ (6,676) $ (12,492) $ 127,909 Foreign 61,438 51,996 (169,573) Total income (loss) before provision for income taxes $ 54,762 $ 39,504 $ (41,664)
Schedule of Provision for Income Taxes	The provision for income taxes from continuing operations for the years ended January 31, 2023, 2022, and 2021 consisted of the following: Year Ended January 31, (in thousands) 2023 2022 2021 Current provision for income taxes: Federal $ 30,637 $ 3,215 $ 373 State 2,733 1,121 1,663 Foreign 15,277 30,840 6,299 Total current provision for income taxes 48,647 35,176 8,335 Deferred (benefit from) provision for income taxes: Federal (8,010) 6,714 1,366 State (699) 255 (188) Foreign (835) (18,292) (2,576) Total deferred benefit from income taxes (9,544) (11,323) (1,398) Total provision for income taxes from continuing operations $ 39,103 $ 23,853 $ 6,937
Reconciliation of the U.S. Federal Statutory Rate to the Entity's Effective Tax Rate on Income (Loss) Before Income Taxes	The reconciliation of the U.S. federal statutory rate to our effective tax rate on income (loss) before provision for income taxes from continuing operations for the years ended January 31, 2023, 2022, and 2021 was as follows: Year Ended January 31, (in thousands) 2023 2022 2021 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % Income tax provision (benefit) at the U.S. federal statutory rate $ 11,499 $ 8,296 $ (8,733) State income tax provision (benefit) 2,617 (1,238) 2,017 Foreign tax rate differential 3,244 6,262 5,992 Tax incentives (3,779) (6,378) (2,681) Valuation allowances (292) 2,616 (3,269) Stock-based and other compensation 3,347 897 2,958 Litigation and other non-deductible expenses 1,770 (238) (1,007) Tax credits 321 117 875 Tax contingencies 2,333 2,108 (5,652) Change in fair value of future tranche right — (3,320) 11,791 Changes in tax laws 9 1,552 — U.S. tax effects of foreign operations 18,642 13,480 3,828 Other, net (608) (301) 818 Total provision for income taxes $ 39,103 $ 23,853 $ 6,937 Effective income tax rate 71.4 % 60.4 % (16.6) %
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities consisted of the following at January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 Deferred tax assets: Accrued expenses $ 4,506 $ 4,464 Operating lease liabilities 7,974 9,275 Loss carryforwards 20,483 21,764 Tax credits 5,408 5,780 Stock-based and other compensation 3,963 6,802 Capitalized research and development expenses 18,669 2,253 Other, net 995 1,082 Total deferred tax assets 61,998 51,420 Deferred tax liabilities: Prepaid expenses (2,600) (1,885) Depreciation of property and equipment (2,732) (670) Deferred cost of revenue (9,707) (8,531) Goodwill and other intangible assets (20,607) (23,063) Unremitted earnings of foreign subsidiaries (1,784) (970) Operating lease right-of-use assets (5,241) (4,959) Total deferred tax liabilities (42,671) (40,078) Valuation allowance (20,357) (20,711) Net deferred tax liabilities $ (1,030) $ (9,369) Recorded as: Deferred tax assets $ 10,719 $ 8,091 Deferred tax liabilities (11,749) (17,460) Net deferred tax liabilities $ (1,030) $ (9,369)
Schedule of Valuation Allowance	Activity in the recorded valuation allowance consisted of the following for the years ended January 31, 2023 and 2022: Year Ended January 31, (in thousands) 2023 2022 Valuation allowance, beginning of year $ (20,711) $ (16,761) Income tax benefit (provision) 292 (2,616) Fair value of derivatives and convertible debt instruments — (1,139) Currency translation adjustment and other 62 (195) Valuation allowance, end of year $ (20,357) $ (20,711)
Schedule of Aggregate Changes in the Balance of Gross Unrecognized Tax Benefits	For the years ended January 31, 2023, 2022, and 2021, the aggregate changes in the balance of gross unrecognized tax benefits were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Gross unrecognized tax benefits, beginning of year $ 84,229 $ 84,847 $ 85,327 Increases related to tax positions taken during the current year 645 672 706 Increases related to tax positions taken during prior years 4,260 430 — (Decreases) increases related to foreign currency exchange rates (404) 45 136 Reductions for tax positions of prior years (84) (152) (193) Lapses of statutes of limitations (718) (1,613) (1,129) Gross unrecognized tax benefits, end of year $ 87,928 $ 84,229 $ 84,847
Schedule of Income Tax Returns Under Examination in Major Tax Jurisdictions	As of January 31, 2023, income tax returns are under examination in the following significant tax jurisdictions: Jurisdiction Tax Years United Kingdom December 31, 2006, January 31, 2008 India March 31, 2008, March 31, 2010 - March 31, 2013, March 31, 2017, March 31, 2020 Israel January 31, 2019 - January 31, 2021 Brazil December 31, 2018 United States January 31, 2018

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of January 31, 2023 and 2022: January 31, 2023 Fair Value Hierarchy Category (in thousands) Level 1 Level 2 Level 3 Assets: Money market funds $ 96,941 $ — $ — Commercial paper, classified as cash and cash equivalents — 50,869 — Foreign currency forward contracts — 19 — Contingent consideration receivable — 8 — Total assets $ 96,941 $ 50,896 $ — Liabilities: Foreign currency forward contracts $ — $ 124 $ — Contingent consideration — business combinations — — 12,717 Total liabilities $ — $ 124 $ 12,717 January 31, 2022 Fair Value Hierarchy Category (in thousands) Level 1 Level 2 Level 3 Assets: Money market funds $ 127,041 $ — $ — Commercial paper, classified as cash and cash equivalents — 29,995 $ — Foreign currency forward contracts — 33 — Contingent consideration receivable — — 271 Total assets $ 127,041 $ 30,028 $ 271 Liabilities: Foreign currency forward contracts $ — $ 91 $ — Contingent consideration — business combinations — 7,776 — Total liabilities $ — $ 7,867 $ —
Schedule of Changes in the Estimated Fair Value Using Significant Unobservable Inputs (Level 3)	The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the years ended January 31, 2023 and 2022: Year Ended January 31, (in thousands) 2023 2022 Fair value measurement, beginning of year $ — $ 15,704 Contingent consideration liabilities recorded for business combinations 12,184 900 Changes in fair values, recorded in operating expenses 408 883 Payments of contingent consideration — (9,560) Foreign currency translation and other 125 (151) Transfer of contingent consideration liability to Level 2 of the fair value hierarchy — (7,776) Fair value measurement, end of year $ 12,717 $ —

DERIVATIVE FINANCIAL INSTRUME_2

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Jan. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Financial Instruments	The fair values of our derivative financial instruments and their classifications in our consolidated balance sheets as of January 31, 2023 and 2022 were as follows: January 31, (in thousands) Balance Sheet Classification 2023 2022 Derivative assets: Foreign currency forward contracts: Designated as cash flow hedges Prepaid expenses and other current assets $ 19 $ 33 Total derivative assets $ 19 $ 33 Derivative liabilities: Foreign currency forward contracts: Designated as cash flow hedges Accrued expenses and other current liabilities $ 124 $ 91 Total derivative liabilities $ 124 $ 91
Schedule of the Effects of Derivative Financial Instruments Designated as Cash Flow Hedging Instruments	The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss (“AOCL”) and on the consolidated statement of operations for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Net (losses) gains recognized in AOCL: Foreign currency forward contracts $ (707) $ 85 $ 323 Interest rate swap agreement — — (7,535) $ (707) $ 85 $ (7,212) Net (losses) gains reclassified from AOCL to the consolidated statements of operations: Foreign currency forward contracts $ (660) $ 232 $ 267 Interest rate swap agreement — (16,669) (4,367) $ (660) $ (16,437) $ (4,100)
Schedule of Losses Recognized on Derivative Financial Instruments Not Designated as Hedging Instruments	Losses recognized on derivative financial instruments not designated as hedging instruments in our consolidated statements of operations for the years ended January 31, 2023, 2022, and 2021 were as follows: Classification in Consolidated Statements of Operations Year Ended January 31, (in thousands) 2023 2022 2021 Interest rate swap agreements Other income (expense), net $ — $ (14,374) $ (1,267) $ — $ (14,374) $ (1,267)

STOCK-BASED COMPENSATION AND _2

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS (Tables)	12 Months Ended
	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation Expense	We recognized stock-based compensation expense in the following line items on the consolidated statements of operations for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Component of income before provision for income taxes: Cost of revenue - recurring $ 2,856 $ 1,999 $ 1,109 Cost of revenue - nonrecurring 2,806 3,029 2,184 Research and development, net 12,576 7,565 3,918 Selling, general and administrative 57,876 52,672 37,989 Total stock-based compensation expense 76,114 65,265 45,200 Income tax benefits related to stock-based compensation (before consideration of valuation allowances) 12,368 10,615 6,684 Total stock-based compensation, net of taxes $ 63,746 $ 54,650 $ 38,516
Summary of Stock-based Compensation Expense by Type of Award	The following table summarizes stock-based compensation expense by type of award for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Restricted stock units and restricted stock awards $ 68,258 $ 58,678 $ 47,598 Stock bonus program and bonus share program 7,793 6,568 (2,390) Total equity-settled awards 76,051 65,246 45,208 Phantom stock units (cash-settled awards) 63 19 (8) Total stock-based compensation expense $ 76,114 $ 65,265 $ 45,200
Schedule of RSU Activity	The following table (“Award Activity Table”) summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, 2023 2022 2021 (in thousands, except grant date fair values) Shares or Units Weighted-Average Grant-Date Fair Value Shares or Units Weighted-Average Grant-Date Fair Value Shares or Units Weighted-Average Grant-Date Fair Value Beginning balance 2,454 $ 42.99 2,950 $ 35.97 1,879 $ 52.96 Granted 1,743 $ 54.98 1,540 $ 48.01 1,469 $ 47.30 Released (1,733) $ 42.13 (1,800) $ 36.14 (1,125) $ 47.53 Forfeited (234) $ 48.86 (236) $ 40.23 (206) $ 52.59 Ending balance 2,230 $ 52.42 2,454 $ 42.99 2,017 $ 51.90
Schedule of Performance Share Activity	The following table summarizes PSU activity in isolation under the Plans for the years ended January 31, 2023, 2022, and 2021 (these amounts are also included in the Award Activity Table above for 2023, 2022, and 2021): Year Ended January 31, (in thousands) 2023 2022 2021 Beginning balance 547 743 423 Granted 278 212 297 Released (279) (381) (182) Forfeited (14) (27) (27) Ending balance 532 547 511
Summary of Key Data for Stock Bonus Program	The following table summarizes activity under the stock bonus program during the years ended January 31, 2023, 2022, and 2021 in isolation from other share activity. As noted above, shares issued in a given fiscal year are in respect of the prior fiscal year’s program period. Also, as noted above, shares issued in respect of the discount feature under the program reduce available plan capacity and are included in the Award Activity Table above. Other shares issued under the program do not reduce available plan capacity and are therefore excluded from the Award Activity Table above. Year Ended January 31, (in thousands) 2023 2022 2021 Shares in lieu of cash bonus — granted and released (not included in the Award Activity Table above) 119 — 32 Shares in respect of discount (included in the Award Activity Table above): Granted 12 — — Released 10 — 3

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Jan. 31, 2023
Leases [Abstract]
Schedule of Lease Expenses	The components of lease expenses for the years ended January 31, 2023, 2022, and 2021 were as follows: Year Ended January 31, (in thousands) 2023 2022 2021 Operating lease expenses $ 16,301 $ 24,241 $ 28,617 Finance lease expenses: Amortization of right-of-use assets 3,057 3,223 2,295 Interest on lease liabilities 188 260 312 Total finance lease expenses 3,245 3,483 2,607 Variable lease expenses 6,318 6,344 5,504 Short-term lease expenses 774 1,055 584 Sublease income (267) (1,804) (966) Total lease expenses $ 26,371 $ 33,319 $ 36,346
Schedule of Supplemental Cash Flow Information Related to Leases	Other information related to leases was as follows: Year Ended January 31, (dollars in thousands) 2023 2022 2021 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21,261 $ 19,360 $ 21,243 Operating cash flows from finance leases 187 260 312 Financing cash flows from finance leases 2,870 3,189 2,389 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 19,490 $ 11,282 $ 7,619 Finance leases 647 4,041 903 Weighted average remaining lease terms Operating leases 7 years 3 years 6 years Finance leases 2 years 3 years 3 years Weighted average discount rates Operating leases 6.2 % 4.8 % 5.8 % Finance leases 3.6 % 3.8 % 4.0 %
Schedule of Maturities of Operating Lease Liabilities	Maturities of lease liabilities as of January 31, 2023 were as follows: January 31, 2023 (in thousands) Operating Leases Finance Leases Year Ending January 31, 2024 $ 9,925 $ 1,954 2025 10,419 1,571 2026 8,294 719 2027 7,340 102 2028 9,616 — Thereafter 16,826 — Total future minimum lease payments 62,420 4,346 Less: imputed interest (13,711) (190) Total $ 48,709 $ 4,156 Reported as of January 31, 2023: Accrued expenses and other current liabilities $ 7,965 $ 1,848 Operating lease liabilities 40,744 — Other liabilities — 2,308 Total $ 48,709 $ 4,156
Schedule of Maturities of Finance Lease Liabilities	Maturities of lease liabilities as of January 31, 2023 were as follows: January 31, 2023 (in thousands) Operating Leases Finance Leases Year Ending January 31, 2024 $ 9,925 $ 1,954 2025 10,419 1,571 2026 8,294 719 2027 7,340 102 2028 9,616 — Thereafter 16,826 — Total future minimum lease payments 62,420 4,346 Less: imputed interest (13,711) (190) Total $ 48,709 $ 4,156 Reported as of January 31, 2023: Accrued expenses and other current liabilities $ 7,965 $ 1,848 Operating lease liabilities 40,744 — Other liabilities — 2,308 Total $ 48,709 $ 4,156

SEGMENT, GEOGRAPHIC, AND SIGN_2

SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION (Tables)	12 Months Ended
	Jan. 31, 2023
Segment Reporting [Abstract]
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	The information below summarizes revenue from unaffiliated customers by geographic area for the years ended January 31, 2023, 2022, and 2021: Year Ended January 31, (in thousands) 2023 2022 2021 Americas: United States $ 572,837 $ 552,680 $ 515,480 Other 56,557 48,043 54,470 Total Americas 629,394 600,723 569,950 EMEA: United Kingdom 99,360 100,606 100,855 Other 82,680 79,560 72,361 Total EMEA 182,040 180,166 173,216 APAC 90,811 93,620 87,081 Total revenue $ 902,245 $ 874,509 $ 830,247 Property and equipment, net by geographic area consisted of the following as of January 31, 2023 and 2022: January 31, (in thousands) 2023 2022 United States $ 50,917 $ 50,241 United Kingdom 7,244 9,225 Other countries 6,649 4,624 Total property and equipment, net $ 64,810 $ 64,090

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details) organization in Thousands	12 Months Ended
	Jan. 31, 2023 professional country office organization
Accounting Policies [Abstract]
Percentage of fortune 100 companies as customers	85%
Number of organizations as customer | organization	10
Number of countries customers located | country	175
Number of offices | office	30
Entity number of employees | professional	4,300

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Spin-Off, Apax Convertible Preferred Stock Investment and Principles of Consolidation (Details) $ / shares in Units, $ in Millions					12 Months Ended
	Apr. 06, 2021 USD ($)	Feb. 01, 2021 $ / shares shares	May 07, 2020 USD ($)	Dec. 04, 2019 USD ($)	Jan. 31, 2022 subsidiary $ / shares	Jan. 31, 2023 $ / shares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock, par value (in dollars per share) | $ / shares		$ 0.001			$ 0.001	$ 0.001
Spin-off transaction, number of shares received (in shares) | shares		1
Number of majority owned subsidiaries acquired | subsidiary					2
Apax
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Percentage ownership of outstanding shares						13%
Convertible Preferred Stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Sale of stock, consideration received on transaction				$ 400
Series A Preferred Stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Sale of stock, consideration received on transaction			$ 200
Series B Preferred Stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Sale of stock, consideration received on transaction	$ 200

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Minimum maturity period of short term investments in time deposits (in days)	90 days

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations Of Credit Risk (Details)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Accounts Receivable | Customer Concentration Risk | Partner A
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%	14%
Accounts Receivable | Customer Concentration Risk | Partner B
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%
Contract Assets | Customer Concentration Risk | Partner A
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%	14%
Contract Assets | Customer Concentration Risk | Partner B
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%
Total Revenue | Revenue from Rights Concentration Risk | Partner A
Concentration Risk [Line Items]
Concentrations of credit risk, percentage			10%

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance For Credit Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses, beginning of year	$ 1,260	$ 1,609	$ 1,239
Provisions charged to expense	565	1,242	1,899
Amounts written off	(566)	(1,666)	(1,931)
Other, including fluctuations in foreign exchange rates	31	75	(175)
Allowance for credit losses, end of year	1,290	1,260	1,609
Estimated expected credit losses	100	0	0
Cumulative Effect, Period of Adoption, Adjustment
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses, beginning of year	$ 0	0	577
Allowance for credit losses, end of year		$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property And Equipment, Net (Details)	12 Months Ended
	Jan. 31, 2023
Equipment, furniture, and other | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives, (in years)	3 years
Equipment, furniture, and other | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives, (in years)	7 years
Software | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives, (in years)	3 years
Software | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives, (in years)	4 years
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives, (in years)	10 years

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Business Segment Information (Details)	12 Months Ended
	Jan. 31, 2023 segment
Accounting Policies [Abstract]
Number of reportable segments	1

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill And Other Acquired Intangible Assets (Details)	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Estimated useful lives of finite-lived intangible assets (in years)	10 years

SUMMARY OF SIGNIFICANT ACCOU_12

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Costs to Obtain and Fulfill Contracts (Details)	12 Months Ended
	Jan. 31, 2023
Minimum
Disaggregation of Revenue [Line Items]
Sales and agent commissions, amortization period	0 years
Customer engagement contracts renewal period	5 years
Maximum
Disaggregation of Revenue [Line Items]
Sales and agent commissions, amortization period	6 years
Customer engagement contracts renewal period	6 years

SUMMARY OF SIGNIFICANT ACCOU_13

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Software Development Costs (Details)	12 Months Ended
	Jan. 31, 2023
Software Development Costs
Software Development Costs
Estimated useful lives, (in years)	5 years
Internal-Use Software | Minimum
Software Development Costs
Estimated useful lives, (in years)	4 years
Internal-Use Software | Maximum
Software Development Costs
Estimated useful lives, (in years)	7 years

SUMMARY OF SIGNIFICANT ACCOU_14

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Foreign Currency Transaction Gains And Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Accounting Policies [Abstract]
Foreign currency gains (losses), net	$ 3,453	$ (1,644)	$ (1,584)

SUMMARY OF SIGNIFICANT ACCOU_15

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details)	Apr. 09, 2021
2021 Notes
Debt Conversion
Coupon interest rate	0.25%

DISCONTINUED OPERATIONS - Addit

DISCONTINUED OPERATIONS - Additional Information (Details) - Discontinued Operations - Cognyte - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Feb. 01, 2021	Jan. 29, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transition Services Agreement, amount invoiced to other party		$ 5,900,000
Transition Services Agreement, amount invoiced from other party		1,100,000
Total assets of discontinued operations	$ 0	0	$ 635,878,000
Total liabilities of discontinued operations		0	326,831,000
Costa and expenses of discontinued operations	0	0
Revenue of discontinued operations	$ 0	$ 0	443,458,000
Accumulated other comprehensive income, net of tax transferred				$ 17,100,000
Dividends receivable					$ 35,000,000
Cash and cash equivalents			$ 78,570,000

DISCONTINUED OPERATIONS - Summa

DISCONTINUED OPERATIONS - Summary of Discontinued Operations in Condensed Consolidated Statement of Operations (Details) - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net income from discontinued operations	$ 0	$ 0	$ 48,494,000
Discontinued Operations | Cognyte
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	$ 0	$ 0	443,458,000
Cost of revenue			128,043,000
Operating expenses			264,132,000
Other income, net			6,604,000
Income from discontinued operations before benefit from income taxes			57,887,000
Provision for income taxes			9,393,000
Net income from discontinued operations			48,494,000
Net income from discontinued operations attributable to noncontrolling interests			6,107,000
Net income from discontinued operations attributable to Verint Systems Inc. common shares			$ 42,387,000

DISCONTINUED OPERATIONS - Sum_2

DISCONTINUED OPERATIONS - Summary of Assets and Liabilities Transferred (Details) - Discontinued Operations - Cognyte - USD ($)	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Current Assets:
Cash and cash equivalents			$ 78,570,000
Restricted cash and cash equivalents, and restricted bank time deposits			27,042,000
Short-term investments			4,713,000
Accounts receivable, net			175,001,000
Contract assets, net			20,317,000
Inventories			14,542,000
Prepaid expenses and other current assets			34,741,000
Total current assets of discontinued operations			354,926,000
Long-term Assets
Property and equipment, net			37,152,000
Operating lease right-of-use assets			31,040,000
Goodwill			158,183,000
Intangible assets, net			5,299,000
Deferred income taxes			7,202,000
Other assets			42,076,000
Total long-term assets of discontinued operations			280,952,000
Total assets of discontinued operations	$ 0	$ 0	635,878,000
Current Liabilities:
Accounts payable			41,512,000
Accrued expenses and other current liabilities			100,189,000
Contract liabilities			127,012,000
Total current liabilities of discontinued operations			268,713,000
Long-term Liabilities
Long-term contract liabilities			22,037,000
Operating lease liabilities			23,174,000
Deferred income taxes			3,985,000
Other liabilities			8,922,000
Total long-term liabilities of discontinued operations			58,118,000
Total liabilities of discontinued operations		$ 0	$ 326,831,000

REVENUE RECOGNITION - Additiona

REVENUE RECOGNITION - Additional Information (Details)	12 Months Ended
	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Software maintenance, period	1 year
Software
Disaggregation of Revenue [Line Items]
Warranty period (in days/years)	90 days
Minimum
Disaggregation of Revenue [Line Items]
Unbundled contracts renewal term	1 year
Minimum | Hardware
Disaggregation of Revenue [Line Items]
Warranty period (in days/years)	1 year
Maximum
Disaggregation of Revenue [Line Items]
Unbundled contracts renewal term	3 years
Maximum | Hardware
Disaggregation of Revenue [Line Items]
Warranty period (in days/years)	3 years

REVENUE RECOGNITION - Disaggreg

REVENUE RECOGNITION - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 902,245	$ 874,509	$ 830,247
Bundled SaaS revenue
Disaggregation of Revenue [Line Items]
Total revenue	222,560	183,035	145,962
Unbundled SaaS revenue
Disaggregation of Revenue [Line Items]
Total revenue	221,645	139,729	71,990
Optional managed services revenue
Disaggregation of Revenue [Line Items]
Total revenue	61,388	65,648	59,459
Total cloud revenue
Disaggregation of Revenue [Line Items]
Total revenue	505,593	388,412	277,411
Support revenue
Disaggregation of Revenue [Line Items]
Total revenue	179,944	244,717	298,213
Recurring
Disaggregation of Revenue [Line Items]
Total revenue	685,537	633,129	575,624
Perpetual revenue
Disaggregation of Revenue [Line Items]
Total revenue	116,611	138,078	141,840
Professional services revenue
Disaggregation of Revenue [Line Items]
Total revenue	100,097	103,302	112,783
Nonrecurring
Disaggregation of Revenue [Line Items]
Total revenue	$ 216,708	$ 241,380	$ 254,623
Minimum
Disaggregation of Revenue [Line Items]
Unbundled contracts renewal term	1 year
Maximum
Disaggregation of Revenue [Line Items]
Unbundled contracts renewal term	3 years

REVENUE RECOGNITION - Contract

REVENUE RECOGNITION - Contract Balances (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 188,414	$ 193,831
Contract assets, net	60,444	42,688
Long-term contract assets, net (included in other assets)	37,950	30,510
Contract liabilities	271,476	271,271
Long-term contract liabilities	$ 18,047	$ 15,872

REVENUE RECOGNITION - Contrac_2

REVENUE RECOGNITION - Contract Balances Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Concentration Risk [Line Items]
Accounts receivable from contract assets recognized at the beginning of each period	$ 43.2	$ 37.7
Contract Assets recognized in current period	69.9	57.4
Current period revenue recognized from beginning balance of contract liabilities	$ 242.4	$ 247.9
Accounts Receivable | Customer Concentration Risk | Partner A
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%	14%
Accounts Receivable | Customer Concentration Risk | Partner B
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%
Contract Assets | Customer Concentration Risk | Partner A
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%	14%
Contract Assets | Customer Concentration Risk | Partner B
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	15%

REVENUE RECOGNITION - Remaining

REVENUE RECOGNITION - Remaining Performance Obligations (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation	$ 727,041	$ 721,832
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period		1 year
Revenue performance obligation		$ 447,428
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period	1 year
Revenue performance obligation	$ 464,346	$ 274,404
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period
Revenue performance obligation	$ 262,695
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue performance obligation, period	3 years

REVENUE RECOGNITION - Costs To

REVENUE RECOGNITION - Costs To Obtain And Fulfill Contracts (Details) - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Sales Commission
Capitalized Contract Cost [Line Items]
Capitalized contract cost, net	$ 58,600,000	$ 55,800,000
Capitalized contract cost, amortization	33,100,000	33,100,000	$ 26,100,000
Capitalized contract cost, impairment losses	0	0	0
Sales Commission | Prepaid expenses and other current assets
Capitalized Contract Cost [Line Items]
Capitalized contract cost, net	3,700,000	3,900,000
Sales Commission | Other assets
Capitalized Contract Cost [Line Items]
Capitalized contract cost, net	54,900,000	51,900,000
Costs to Fulfill
Capitalized Contract Cost [Line Items]
Capitalized contract cost, net	5,100,000	6,100,000
Capitalized contract cost, amortization	3,000,000	3,200,000	$ 2,700,000
Costs to Fulfill | Prepaid expenses and other current assets
Capitalized Contract Cost [Line Items]
Capitalized contract cost, net	200,000	200,000
Costs to Fulfill | Other assets
Capitalized Contract Cost [Line Items]
Capitalized contract cost, net	$ 4,900,000	$ 5,900,000

NET LOSS PER COMMON SHARE ATT_3

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. - Calculation of Basic And Diluted Net Loss Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Net Income Attributable to Verint Systems Inc. [Abstract]
Net income (loss) from continuing operations	$ 15,659	$ 15,651	$ (48,601)
Net income from discontinued operations	0	0	48,494
Net income (loss)	15,659	15,651	(107)
Net income (loss) attributable to Verint Systems Inc.	14,898	14,413	(7,267)
Dividends on preferred stock	(20,800)	(18,922)	(7,656)
Net loss attributable to Verint Systems Inc. for basic net loss per common share	(5,902)	(4,509)	(14,923)
Dilutive effect of dividends on preferred stock	0	0	0
Net loss attributable to Verint Systems Inc. for diluted net loss per common share	(5,902)	(4,509)	(14,923)
Net (loss) income attributable to Verint Systems Inc. common shares:
Net loss from continuing operations attributable to Verint Systems Inc. common shares	(5,902)	(4,509)	(57,310)
Net income from discontinued operations attributable to Verint Systems Inc. common shares	$ 0	$ 0	$ 42,387
Weighted-average shares outstanding:
Basic (in shares)	65,332	65,591	65,173
Dilutive effect of employee equity award plans (in shares)	0	0	0
Dilutive effect of warrants (in shares)	0	0	0
Dilutive effect of assumed conversion of preferred stock (in shares)	0	0	0
Diluted (in shares)	65,332	65,591	65,173
Basic net (loss) income per common share attributable to Verint Systems Inc.:
Continuing operations (in dollars per share)	$ (0.09)	$ (0.07)	$ (0.88)
Discontinued operations (in dollars per share)	0	0	0.65
Total basic net loss per common share attributable to Verint Systems Inc. (in dollars per share)	(0.09)	(0.07)	(0.23)
Diluted net (loss) income per common share attributable to Verint Systems Inc.:
Continuing operations (in dollars per share)	(0.09)	(0.07)	(0.88)
Discontinued operations (in dollars per share)	0	0	0.65
Total diluted net loss per common share attributable to Verint Systems Inc. (in dollars per share)	$ (0.09)	$ (0.07)	$ (0.23)
2021 Notes
Weighted-average shares outstanding:
Dilutive effect of convertible senior notes (in shares)	0	0	0
2014 Notes
Weighted-average shares outstanding:
Dilutive effect of convertible senior notes (in shares)	0	0	0
Continuing Operations
Net Income Attributable to Verint Systems Inc. [Abstract]
Net income attributable to noncontrolling interests	$ 761	$ 1,238	$ 1,053
Discontinued Operations
Net Income Attributable to Verint Systems Inc. [Abstract]
Net income attributable to noncontrolling interests	$ 0	$ 0	$ 6,107

NET LOSS PER COMMON SHARE ATT_4

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. - Schedule of Anti-dilutive Securities (Details) - shares shares in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Stock options and restricted stock-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,120	1,580	1,337
2014 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	481	6,002
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	117	6,205
Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,498	5,498	2,743
Series B Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	3,980	3,282	0

NET LOSS PER COMMON SHARE ATT_5

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC. - Additional Information (Details) - $ / shares	5 Months Ended
	Jan. 21, 2022	Apr. 09, 2021	Apr. 06, 2021	Feb. 01, 2021	Jun. 18, 2014
2021 Notes
Class of Stock [Line Items]
Conversion price (in dollars per share)		$ 62.08	$ 62.08
Capped calls, initial cap price (in dollars per share)			$ 100
2014 Notes
Class of Stock [Line Items]
Conversion price (in dollars per share)				$ 40.55
Exercise price of warrants (in dollars per share)				$ 47.18	$ 75
Number of shares of common stock upon conversion (in shares)				9,541,000
Warrants, number of underlying common shares (in shares)				9,865,000	6,205,000
Warrants issued (in shares)	293,143
Warrants exercised on a cashless basis (in shares)	5,031,000

CASH, CASH EQUIVALENTS, AND S_3

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, cost basis	$ 282,099	$ 358,805	$ 663,843
Cash and cash equivalents, fair value	282,099	358,805
Maturities and sales of investments	10,700	46,300	$ 69,800
Bank time deposits
Debt Securities, Available-for-sale [Line Items]
Cost Basis	697	765
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	697	765
Total short-term investments
Debt Securities, Available-for-sale [Line Items]
Cost Basis	697	765
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	697	765
Cash and bank time deposits
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, cost basis	134,289	201,769
Cash and cash equivalents, fair value	134,289	201,769
Money market funds
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, cost basis	96,941	127,041
Cash and cash equivalents, fair value	96,941	127,041
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, cost basis	50,869	29,995
Cash and cash equivalents, fair value	$ 50,869	$ 29,995

BUSINESS COMBINATIONS - Busines

BUSINESS COMBINATIONS - Business Combinations For Year Ended January 31, 2023 (Details) $ in Thousands	12 Months Ended
	Jan. 31, 2023 USD ($) professional employee business_combination	Jan. 31, 2022 USD ($)	Aug. 31, 2022 employee	Jan. 31, 2021 USD ($)
Business Acquisition [Line Items]
Number of businesses acquired | business_combination	2
Entity number of employees | professional	4,300
Goodwill	$ 1,347,213	$ 1,353,421		$ 1,327,407
Liability for contingent consideration
Business Acquisition [Line Items]
Contingent consideration liabilities recorded for business combinations	12,184	$ 900
Business Combinations Year Ended January 31 2023
Business Acquisition [Line Items]
Total purchase prices	38,300
Cash	26,100
Cash acquired from acquisition	4,200
Business combination, contingent consideration (up to)	21,400
Contingent consideration obligations, fair value	12,200
Goodwill	25,500
Business acquisition, goodwill deductible for income tax purposes	5,100
Business acquisition, goodwill not deductible for income tax purposes	20,400
Business acquisition related costs	1,100
Business Combinations Year Ended January 31 2023 | Developed technology
Business Acquisition [Line Items]
Identifiable intangible assets	6,000
Business Combinations Year Ended January 31 2023 | Customer relationships
Business Acquisition [Line Items]
Identifiable intangible assets	4,200
Business Combinations Year Ended January 31 2023 | Trade names
Business Acquisition [Line Items]
Identifiable intangible assets	$ 100
August 2022 Acquisition
Business Acquisition [Line Items]
Entity number of employees | employee			6
January 2023 Acquisition
Business Acquisition [Line Items]
Entity number of employees | employee	20

BUSINESS COMBINATIONS - Convers

BUSINESS COMBINATIONS - Conversocial Limited (Details) - USD ($) $ in Thousands		12 Months Ended
	Aug. 23, 2021	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Business Acquisition [Line Items]
Cash paid for business combinations, including adjustments, net of cash acquired	$ 50,200	$ 21,928	$ 57,024	$ 0
Goodwill		$ 1,347,213	1,353,421	$ 1,327,407
Finite-lived intangible asset, useful life (in years)		10 years
Conversocial Limited
Business Acquisition [Line Items]
Cash	53,409
Cash acquired from acquisition	3,200
Other purchase price adjustments	(190)
Goodwill	31,308
Business acquisition, goodwill deductible for income tax purposes	500
Business acquisition, goodwill not deductible for income tax purposes	30,800
Current and long-term contract liabilities	3,410
Component of the purchase price allocation	$ 1,200
Business acquisition related costs		$ 1,200	$ 3,400
Weighted-average estimated useful life of all finite-lived identifiable intangible assets (in years)	5 years 10 months 24 days
Conversocial Limited | Customer relationships
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life (in years)	7 years
Conversocial Limited | Developed technology
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life (in years)	5 years
Conversocial Limited | Trademarks and trade names
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life (in years)	1 year
Conversocial Limited | Prepaid expenses and other current assets
Business Acquisition [Line Items]
Component of the purchase price allocation	$ 700
Conversocial Limited | Other assets
Business Acquisition [Line Items]
Component of the purchase price allocation	$ 500

BUSINESS COMBINATIONS - Conve_2

BUSINESS COMBINATIONS - Conversocial Limited - Schedule of Purchase Price allocation (Details) - USD ($) $ in Thousands	Aug. 23, 2021	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 1,347,213	$ 1,353,421	$ 1,327,407
Conversocial Limited
Business Acquisition [Line Items]
Cash	$ 53,409
Other purchase price adjustments	(190)
Total purchase price	53,219
Accounts receivable	1,694
Other current assets, including cash acquired	5,462
Other assets	511
Current and other liabilities	(1,945)
Contract liabilities - current and long-term	(3,410)
Deferred income taxes	(301)
Net tangible assets	2,011
Identifiable intangible assets	19,900
Goodwill	31,308
Total purchase price allocation	53,219
Conversocial Limited | Customer relationships
Business Acquisition [Line Items]
Identifiable intangible assets	9,800
Conversocial Limited | Developed technology
Business Acquisition [Line Items]
Identifiable intangible assets	9,900
Conversocial Limited | Trademarks and trade names
Business Acquisition [Line Items]
Identifiable intangible assets	$ 200

BUSINESS COMBINATIONS - Other B

BUSINESS COMBINATIONS - Other Business Combination Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Business Acquisition [Line Items]
Changes in the fair values of contingent consideration obligations associated with business combinations	$ 200	$ 900	$ (800)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling, general and administrative	Selling, general and administrative	Selling, general and administrative
Payments of contingent consideration earned	$ 7,500	$ 9,600	$ 15,200
Recurring | Level 3
Business Acquisition [Line Items]
Contingent consideration obligations, fair value	12,717	$ 0
Recurring | Level 3 | Accrued expenses and other current liabilities
Business Acquisition [Line Items]
Contingent consideration obligations, fair value	4,500
Recurring | Level 3 | Other Noncurrent Liabilities
Business Acquisition [Line Items]
Contingent consideration obligations, fair value	$ 8,200

INTANGIBLE ASSETS AND GOODWIL_2

INTANGIBLE ASSETS AND GOODWILL - Schedule of Acquisition-Related Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	$ 694,249	$ 705,026
Accumulated Amortization	(608,977)	(586,772)
Net	85,272	118,254
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	458,013	467,408
Accumulated Amortization	(390,113)	(375,827)
Net	67,900	91,581
Acquired technology
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	229,317	229,501
Accumulated Amortization	(212,065)	(203,895)
Net	17,252	25,606
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	4,479	5,677
Accumulated Amortization	(4,359)	(4,610)
Net	120	1,067
Distribution network
Acquired Finite-Lived Intangible Assets [Line Items]
Cost	2,440	2,440
Accumulated Amortization	(2,440)	(2,440)
Net	$ 0	$ 0

INTANGIBLE ASSETS AND GOODWIL_3

INTANGIBLE ASSETS AND GOODWILL - Additional Information (Details)	12 Months Ended
	Jan. 31, 2023 USD ($) Reporting_Unit	Jan. 31, 2022 USD ($)	Jan. 31, 2021 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 39,400,000	$ 46,800,000	$ 47,700,000
Impairment of intangible assets, finite-lived	$ 0		0
Number of reporting units | Reporting_Unit	1
Impairments of goodwill	$ 0	$ 0	$ 0
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]		Selling, general and administrative
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets, finite-lived		$ 400,000

INTANGIBLE ASSETS AND GOODWIL_4

INTANGIBLE ASSETS AND GOODWILL - Schedule of Estimated Future Amortization Expense on Finite-lived Acquisition-related Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Intangible Assets - Future Amortization [Abstract]
2024	$ 32,380
2025	16,581
2026	15,219
2027	11,462
2028	6,839
Thereafter	2,791
Net	$ 85,272	$ 118,254

INTANGIBLE ASSETS AND GOODWIL_5

INTANGIBLE ASSETS AND GOODWILL - Goodwill Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Goodwill [Roll Forward]
Goodwill, gross at the beginning of the period	$ 1,403,256	$ 1,409,464	$ 1,383,450
Accumulated impairment losses	(56,043)	(56,043)	$ (56,043)
Goodwill, net at the beginning of the period	1,353,421	1,327,407
Business combinations	25,239	36,006
Foreign currency translation and other	(31,447)	(9,992)
Goodwill, net, at the end of the period	$ 1,347,213	$ 1,353,421

LONG-TERM DEBT - Schedule of Lo

LONG-TERM DEBT - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022	Apr. 30, 2021
Debt Instrument [Line Items]
Less: Unamortized debt discounts and issuance costs	$ (6,092)	$ (8,046)
Total debt	408,908	406,954
Less: current maturities	0	0
Long-term debt	408,908	406,954
2021 Notes
Debt Instrument [Line Items]
Long-term debt outstanding	315,000	315,000
Term Loan
Debt Instrument [Line Items]
Long-term debt outstanding	$ 100,000	$ 100,000	$ 100,000

LONG-TERM DEBT - 2021 Notes (De

LONG-TERM DEBT - 2021 Notes (Details)			12 Months Ended
	Apr. 09, 2021 USD ($) $ / shares	Apr. 06, 2021 USD ($) $ / shares	Jan. 31, 2023 USD ($)	Jan. 31, 2022 USD ($)	Jan. 31, 2021 USD ($)
Debt Instrument [Line Items]
Payments of debt issuance costs			$ 224,000	$ 10,708,000	$ 2,287,000
Series B Preferred Stock
Debt Instrument [Line Items]
Sale of stock, consideration received on transaction		$ 200,000,000
Series B Preferred Stock | Series B Private Placement
Debt Instrument [Line Items]
Sale of stock, consideration received on transaction		$ 200,000,000
2021 Notes
Debt Instrument [Line Items]
Debt principal amount	$ 315,000,000
Coupon interest rate	0.25%
Convertible debt, conversion ratio	0.0161092
Conversion price (in dollars per share) | $ / shares	$ 62.08	$ 62.08
Payments of debt issuance costs	$ 8,900,000
Effective interest rate (as a percent)			0.83%

LONG-TERM DEBT - 2014 Notes (De

LONG-TERM DEBT - 2014 Notes (Details) - USD ($) shares in Thousands			3 Months Ended		12 Months Ended
	Jun. 01, 2021	Jun. 18, 2014	Jul. 31, 2021	Jul. 31, 2020	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Feb. 01, 2021	Jan. 31, 2020
Debt Instrument [Line Items]
Losses on early retirements of debt					$ 0	$ 2,474,000	$ 143,000
Common stock issued upon settlement of Warrants							218,000
Increase (decrease) to stockholders' equity					858,149,000	954,579,000	1,282,564,000		$ 1,242,437,000
Decrease to temporary equity					(436,321,000)	(436,321,000)
Increase to current maturities of long-term debt					0	0
Decrease to deferred tax liabilities					(1,030,000)	(9,369,000)
Payment for debt extinguishment, principal					0	386,887,000	0
Additional Paid-in Capital
Debt Instrument [Line Items]
Common stock issued upon settlement of Warrants							218,000
Increase (decrease) to stockholders' equity					1,055,157,000	1,125,152,000	1,726,166,000		1,660,889,000
Accumulated Deficit
Debt Instrument [Line Items]
Increase (decrease) to stockholders' equity					$ (45,333,000)	$ (54,509,000)	(113,797,000)		(105,590,000)
Cumulative Effect, Period of Adoption, Adjustment
Debt Instrument [Line Items]
Increase (decrease) to stockholders' equity							1,430,000		(940,000)
Decrease to temporary equity								$ 4,800,000
Increase to current maturities of long-term debt								4,400,000
Decrease to deferred tax liabilities								900,000
Increase to debt issuance costs								100,000
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital
Debt Instrument [Line Items]
Increase (decrease) to stockholders' equity							(43,445,000)	(43,400,000)
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
Debt Instrument [Line Items]
Increase (decrease) to stockholders' equity							44,875,000	$ 44,900,000	$ (940,000)
2014 Notes
Debt Instrument [Line Items]
Debt principal amount		$ 400,000,000
Coupon interest rate		1.50%
Proceeds from issuance of convertible notes, net of underwriting discounts		$ 391,900,000
Repurchased amount in cash				$ 13,100,000
Principal amount - repurchased notes				13,000,000
Losses on early retirements of debt				100,000
Common stock issued upon settlement of Warrants				$ 200,000
Payment for debt extinguishment	$ 389,800,000
Payment for debt extinguishment, principal	386,900,000
Payment for debt extinguishment, interest	2,900,000
Incremental conversion value	$ 57,700,000
Treasury stock reissued (in shares)			1,250
2014 Notes | Cumulative Effect, Period of Adoption, Adjustment
Debt Instrument [Line Items]
Equity component of currently redeemable convertible notes							$ 78,000,000

LONG-TERM DEBT - Capped Calls,

LONG-TERM DEBT - Capped Calls, Note Hedges and Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands					5 Months Ended	12 Months Ended
	Jun. 01, 2021	Apr. 06, 2021	Feb. 01, 2021	Jun. 18, 2014	Jan. 21, 2022	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Apr. 09, 2021
Debt Instrument [Line Items]
Purchases of capped calls, net of taxes		$ 41,100				$ 0	$ 41,060	$ 0
2021 Notes
Debt Instrument [Line Items]
Conversion price (in dollars per share)		$ 62.08							$ 62.08
Capped calls, initial cap price (in dollars per share)		$ 100
2014 Notes
Debt Instrument [Line Items]
Conversion price (in dollars per share)			$ 40.55
Exercise price of warrants (in dollars per share)			$ 47.18	$ 75
Note Hedges, number of shares with right to acquire from counterparties			9,865,000	6,205,000
Note Hedges, Shares With Right To Acquire From Counterparties, Price			$ 40.55	$ 64.46
Payment For Note Hedges				$ 60,800
Note hedges, shares received upon settlement (in shares)	1,250,000
Note hedges, number of shares received pertaining to reimbursement	42,000
Warrants, number of underlying common shares (in shares)			9,865,000	6,205,000
Proceeds from issuance of warrants				$ 45,200
Warrants issued (in shares)					293,143
Warrants exercised on a cashless basis (in shares)					5,031,000

LONG-TERM DEBT - Credit Agreeme

LONG-TERM DEBT - Credit Agreement (Details) - USD ($)			3 Months Ended
	Jan. 31, 2018	Jun. 29, 2017	Apr. 30, 2021	Jan. 31, 2023	Jan. 31, 2022	Apr. 09, 2021
Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 725,000,000
Credit Agreement | Eurodollar
Debt Instrument [Line Items]
Interest rate margin (as a percent)		2.25%
Credit Agreement | ABR Rate
Debt Instrument [Line Items]
Interest rate margin (as a percent)		1.25%
Term Loan
Debt Instrument [Line Items]
Debt face amount		$ 425,000,000
Long-term debt outstanding			$ 100,000,000	$ 100,000,000	$ 100,000,000
Unamortized debt discount		500,000			200,000
Required quarterly principal payment			1,100,000
Repayments of debt			$ 309,000,000
Increase to debt issuance costs					$ 1,800,000
Interest rate at end of period (as a percent)				6.37%	2.10%
Effective interest rate (as a percent)				6.58%
Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 300,000,000				$ 300,000,000
Credit facility outstanding				$ 0	$ 0
Debt covenant, leverage ratio				4.50
Prior Revolving Credit Facility
Debt Instrument [Line Items]
Increase to debt issuance costs						$ 1,300,000
2018 Amendment | Eurodollar
Debt Instrument [Line Items]
Interest rate margin (as a percent)	2%
2018 Amendment | ABR Rate
Debt Instrument [Line Items]
Interest rate margin (as a percent)	1%

LONG-TERM DEBT - Credit Agree_2

LONG-TERM DEBT - Credit Agreement Issuance and Amendment Costs (Details) - USD ($) $ in Millions		12 Months Ended
	Apr. 09, 2021	Jan. 31, 2021	Jan. 31, 2022
2020 Amendment
Debt Instrument [Line Items]
Debt restructuring costs incurred during period		$ 2.1
Payments of debt restructuring costs		1.2
Deferred debt restructuring costs		0.9
Term Loan
Debt Instrument [Line Items]
Deferred debt restructuring costs		0.5
Deferred debt issuance costs			$ 1.8
Prior Revolving Credit Facility
Debt Instrument [Line Items]
Deferred debt restructuring costs		$ 0.4
Deferred debt issuance costs	$ 1.3
Deferred debt issuance costs, associated with commitments	0.8
Write off of deferred debt issuance cost	0.5
2021 Amendment
Debt Instrument [Line Items]
Debt restructuring costs incurred during period	$ 1.5

LONG-TERM DEBT - Components of

LONG-TERM DEBT - Components of Interest Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Apr. 09, 2021	Jun. 18, 2014
2021 Notes
Debt Instrument [Line Items]
Interest expense at coupon or contractual rate	$ 787	$ 639	$ 0
Amortization of deferred debt issuance costs	1,762	1,416	0
Total interest expense	2,549	2,055	0
Coupon interest rate				0.25%
2014 Notes
Debt Instrument [Line Items]
Interest expense at coupon or contractual rate	0	1,933	5,887
Amortization of debt discounts	0	0	12,884
Amortization of deferred debt issuance costs	0	522	1,215
Total interest expense	0	2,455	19,986
Coupon interest rate					1.50%
Credit Agreement
Debt Instrument [Line Items]
Interest expense at coupon or contractual rate	4,114	3,366	13,018
Impact of interest rate swap agreement	0	1,014	4,368
Amortization of debt discounts	19	18	74
Amortization of deferred debt issuance costs	863	930	1,811
Total interest expense	$ 4,996	$ 5,328	$ 19,271

SUPPLEMENTAL CONSOLIDATED FIN_3

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Inventories (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Raw materials	$ 3,325	$ 3,001
Work-in-process	40	150
Finished goods	9,263	2,186
Total inventories	$ 12,628	$ 5,337

SUPPLEMENTAL CONSOLIDATED FIN_4

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Property and equipment, net (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 131,381	$ 166,664
Less: accumulated depreciation and amortization	(66,571)	(102,574)
Total property and equipment, net	64,810	64,090
Land and buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	820	7,994
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	15,026	18,155
Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	73,569	76,152
Equipment, furniture, and other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 41,966	$ 64,363

SUPPLEMENTAL CONSOLIDATED FIN_5

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Depreciation expense	$ 18.6	$ 20.7	$ 30.6

SUPPLEMENTAL CONSOLIDATED FIN_6

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Loss Contingencies [Line Items]
Prepaid expenses	$ 24,364	$ 22,639
Other current assets	27,257	31,113
Total prepaid expenses and other current assets	75,374	53,752
CTI Litigation
Loss Contingencies [Line Items]
CTI litigation settlement indemnification asset - current portion	11,250	0
Other
Loss Contingencies [Line Items]
Insurance recovery receivable	$ 12,503	$ 0

SUPPLEMENTAL CONSOLIDATED FIN_7

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Other assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Deferred commissions	$ 54,512	$ 51,714
Long-term contract assets, net	37,950	30,510
Capitalized software development costs, net	23,527	22,483	$ 19,250	$ 15,351
Noncontrolling equity investment in privately-held companies without readily determinable fair values	5,146	5,146
Long-term deferred cost of revenue	4,951	5,907
CTI litigation settlement indemnification asset - long-term portion	4,750	0
Deferred debt issuance costs, net	1,485	1,950
Long-term restricted cash and time deposits	287	409
Other	15,674	8,519
Total other assets	$ 148,282	$ 126,638

SUPPLEMENTAL CONSOLIDATED FIN_8

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Accrued expenses and other current liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Loss Contingencies [Line Items]
Compensation and benefits	$ 73,766	$ 86,777
Taxes other than income taxes	16,346	16,313
Preferred Stock dividends payable	10,400	10,400
Operating lease obligations - current portion	7,965	24,551
Contingent consideration - current portion	4,496	7,776
Professional and consulting fees	2,635	3,771
Income taxes	443	602
Other	21,643	18,504
Total accrued expenses and other current liabilities	155,944	168,694
CTI Litigation
Loss Contingencies [Line Items]
Litigation settlement liability	11,250	0
DOJ False Claims Act Litigation
Loss Contingencies [Line Items]
Litigation settlement liability	$ 7,000	$ 0

SUPPLEMENTAL CONSOLIDATED FIN_9

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Other liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Unrecognized tax benefits, including interest and penalties	$ 52,887	$ 16,345
Contingent consideration - long-term portion	8,221	0
CTI litigation settlement liability - long-term portion	4,750	0
Finance lease obligations - long-term portion	2,308	3,831
Other	466	1,820
Total other liabilities	$ 68,632	$ 21,996

SUPPLEMENTAL CONSOLIDATED FI_10

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Foreign currency gains (losses), net	$ 3,453	$ (1,644)	$ (1,584)
Losses on derivative financial instruments, net	0	(14,374)	(1,267)
Change in fair value of future tranche right	0	15,810	(56,146)
Other, net	(1,471)	5,435	(1,604)
Total other income (expense), net	$ 1,982	$ 5,227	$ (60,601)

SUPPLEMENTAL CONSOLIDATED FI_11

SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION - Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Cash paid for interest	$ 4,661	$ 9,716	$ 24,612
Cash payments of income taxes, net	15,886	42,917	21,476
Non-cash investing and financing transactions:
Liabilities for contingent consideration in business combinations	12,184	900	0
Preferred Stock dividends declared	10,400	10,400	5,200
Finance leases of property and equipment	647	4,041	903
Settlement of Future Tranche Right upon issuance of Series B Preferred Stock	0	36,962	0
Retirement of treasury stock	106,146	234,999	0
Settlement of convertible note premium with common stock	0	59,131	0
Receipt of common stock from the counterparties under the Note Hedges	0	59,651	0
Accrued but unpaid purchases of property and equipment	2,353	750	2,731
Accrued but unpaid purchases of treasury stock	$ 616	$ 0	$ 0

CONVERTIBLE PREFERRED STOCK - A

CONVERTIBLE PREFERRED STOCK - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	Apr. 06, 2021	May 07, 2020	Dec. 04, 2019
Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction			$ 400
Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction		$ 200
Series A Preferred Stock | Series A Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction		$ 200
Sale of stock, number of shares issued (in shares)		200,000
Sale of stock, price per share (in dollars per share)		$ 1,000
Payments of stock issuance costs		$ 2.7
Series B Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 200
Series B Preferred Stock | Series B Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 200
Sale of stock, number of shares issued (in shares)	200,000
Sale of stock, price per share (in dollars per share)	$ 1,000
Payments of stock issuance costs	$ 1.3

CONVERTIBLE PREFERRED STOCK - V

CONVERTIBLE PREFERRED STOCK - Voting Rights, Dividends and Liquidation Rights (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	May 07, 2020	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Dec. 04, 2019
Subsidiary, Sale of Stock [Line Items]
Holders of preferred stock voting rights, as percentage of voting power of common stock outstanding					19.90%
Payments of preferred stock dividends		$ 20,800	$ 12,856	$ 1,589
Accrued dividends on preferred stock			10,400
Preferred stock dividends, unpaid and undeclared		12,100
Dividends declared and recorded		10,400
Dividends on preferred stock		$ 20,800	$ 18,922	$ 7,656
Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, liquidation preference (in dollars per share)	$ 1,000
Preferred Stock | Minimum
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate, increase percentage each year	1%
Preferred Stock | Maximum
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate, increase percentage each year	10%
Preferred Stock | Dividend for the first 48-month anniversary of closing date
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate	5.20%
Preferred Stock | Dividend after the first 48-month anniversary of closing date
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate	4%
Preferred Stock | Dividend increase term in event
Subsidiary, Sale of Stock [Line Items]
Preferred stock, dividend rate	6%

CONVERTIBLE PREFERRED STOCK - C

CONVERTIBLE PREFERRED STOCK - Conversion And Future Tranche Right (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended	12 Months Ended
	Apr. 06, 2021	May 07, 2020	Apr. 30, 2021	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Feb. 01, 2021
Class of Stock [Line Items]
Shares issuable upon conversion (in shares)				9,800,000
Common stock, trading days		30 days
Convertible preferred stock, threshold percentage of conversion trigger		175%
Preferred stock, redemption price in percentage		100%
Internal rate of return		8%
Preferred stock dividends, unpaid and undeclared				$ 12,100
Future tranche right, fair value		$ 3,400
Carrying value of preferred stock				436,321	$ 436,321
Change in fair value of future tranche right				$ 0	$ (15,810)	$ 56,146
Apax
Class of Stock [Line Items]
Percentage ownership of outstanding shares				13%
Series A Preferred Stock
Class of Stock [Line Items]
Conversion price (in dollars per share)		$ 53.50					$ 36.38
Conversion premium		17.10%
Common stock, consecutive trading days		45 days
Preferred stock, liquidation preference value				$ 200,000
Preferred stock dividends, unpaid and undeclared				6,100
Carrying value of preferred stock		$ 203,400
Series B Preferred Stock
Class of Stock [Line Items]
Conversion price (in dollars per share)	$ 50.25
Conversion price, trading days	20 days
Preferred stock, liquidation preference value				200,000
Preferred stock dividends, unpaid and undeclared				$ 6,100
Carrying value of preferred stock	$ 237,000
Change in fair value of future tranche right			$ 15,800
Future tranche right	$ 37,000
Series B Preferred Stock | Series B Private Placement
Class of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	200,000

STOCKHOLDERS' EQUITY - Common S

STOCKHOLDERS' EQUITY - Common Stock Dividends (Details) - USD ($)		12 Months Ended
	Feb. 01, 2021	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Stockholders' Equity Note [Abstract]
Dividends on common stock		$ 0	$ 0	$ 0
Spin-off transaction, number of shares received (in shares)	1

STOCKHOLDERS' EQUITY - Treasury

STOCKHOLDERS' EQUITY - Treasury Stock (Details) - shares	Jan. 31, 2023	Jan. 31, 2022
Stockholders' Equity Note [Abstract]
Treasury stock outstanding (in shares)	0	0

STOCKHOLDERS' EQUITY - Stock Re

STOCKHOLDERS' EQUITY - Stock Repurchase Programs (Details) - USD ($)		2 Months Ended	3 Months Ended		12 Months Ended
	Jun. 01, 2021	Mar. 27, 2023	Jul. 31, 2021	Apr. 30, 2021	Jan. 31, 2023	Jan. 31, 2022	Dec. 07, 2022
Class of Stock [Line Items]
Stock repurchased during period (in shares)					2,659,000	1,613,000
Stock repurchased during period, value					$ 129,600,000	$ 76,000,000
Common stock repurchased and retired (in shares)					2,659,000	5,000,786
Treasury stock retired					$ 0	$ 0
Common stock repurchased and retired					23,456,000	49,581,000
Settlement of conversion premium upon maturity of 2014 Notes						(8,000)
2014 Notes
Class of Stock [Line Items]
Settlement of conversion premium upon maturity of 2014 Notes (in shares)			1,250,000
Treasury stock reissued, average cost per share (in dollars per share)			$ 47.30
Settlement of conversion premium upon maturity of 2014 Notes			$ 59,100,000
Common stock received from exercise of Note Hedges (in shares)	1,250,000
Note hedges, shares received upon settlement, value	$ 57,700,000
Common stock received from exercise of Note Hedges related to repurchased 2014 Notes (in shares)	42,000
Note hedges, common stock value pertaining to reimbursement	$ 2,000,000
Common Stock Including Additional Paid in Capital
Class of Stock [Line Items]
Treasury stock retired					129,600,000	$ 235,000,000
December 2022 Share Repurchase Program
Class of Stock [Line Items]
Stock repurchase program, authorized amount							$ 200,000,000
Stock repurchased during period, value					23,500,000
December 2022 Share Repurchase Program | Subsequent Event
Class of Stock [Line Items]
Stock repurchased during period (in shares)		472,000
Stock repurchased during period, value		$ 17,400,000
December 2021 Share Repurchase Program
Class of Stock [Line Items]
Stock repurchased during period, value					$ 105,700,000
March 2021 Share Repurchase Program
Class of Stock [Line Items]
Stock repurchased during period, value				$ 75,400,000
2021 Share Repurchase Program
Class of Stock [Line Items]
Common stock repurchased and retired (in shares)						1,058,300
Common stock repurchased and retired						$ 49,600,000

STOCKHOLDERS' EQUITY - Issuance

STOCKHOLDERS' EQUITY - Issuance of Convertible Preferred Stock (Details) - USD ($) $ in Millions	Apr. 06, 2021	May 07, 2020	Dec. 04, 2019	Jan. 31, 2023
Apax
Class of Stock [Line Items]
Percentage ownership of outstanding shares				13%
Convertible Preferred Stock
Class of Stock [Line Items]
Sale of stock, consideration received on transaction			$ 400
Series A Preferred Stock
Class of Stock [Line Items]
Sale of stock, consideration received on transaction		$ 200
Series A Preferred Stock | Series A Private Placement
Class of Stock [Line Items]
Sale of stock, consideration received on transaction		$ 200
Series B Preferred Stock
Class of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 200
Series B Preferred Stock | Series B Private Placement
Class of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 200

STOCKHOLDERS' EQUITY - Summary

STOCKHOLDERS' EQUITY - Summary of Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Class of Stock [Line Items]
Beginning balances	$ 954,579	$ 1,282,564	$ 1,242,437
Distribution of Cognyte Software Ltd.		(277,412)
Other comprehensive (loss) income	(35,584)	18,363	15,299
Ending balances	858,149	954,579	1,282,564
Foreign Currency Translation Adjustments
Class of Stock [Line Items]
Beginning balances	(118,467)	(124,481)
Distribution of Cognyte Software Ltd.		17,682
Other comprehensive income (loss) before reclassifications	(35,545)	(11,668)
Amounts reclassified out of accumulated other comprehensive income (loss)	0	0
Amounts reclassified upon partial early retirement of the Term Loan		0
Other comprehensive (loss) income	(35,545)	6,014
Ending balances	(154,012)	(118,467)	(124,481)
AOCI Attributable to Parent
Class of Stock [Line Items]
Beginning balances	(118,515)	(136,878)	(151,865)
Distribution of Cognyte Software Ltd.		17,123
Other comprehensive income (loss) before reclassifications	(36,133)	(11,598)
Amounts reclassified out of accumulated other comprehensive income (loss)	(549)	(821)
Amounts reclassified upon partial early retirement of the Term Loan		(12,017)
Other comprehensive (loss) income	(35,584)		14,987
Ending balances	(154,099)	(118,515)	(136,878)
Unrealized Gains (Losses) on Foreign Exchange Contracts Designated as Hedges | Unrealized gains (losses) on derivative financial instruments designated as hedges
Class of Stock [Line Items]
Beginning balances	(48)	634
Distribution of Cognyte Software Ltd.		(559)
Other comprehensive income (loss) before reclassifications	(588)	70
Amounts reclassified out of accumulated other comprehensive income (loss)	(549)	193
Amounts reclassified upon partial early retirement of the Term Loan		0
Other comprehensive (loss) income	(39)	(682)
Ending balances	(87)	(48)	634
Unrealized Losses on Interest Rate Swap Designated as Hedge | Unrealized gains (losses) on derivative financial instruments designated as hedges
Class of Stock [Line Items]
Beginning balances	0	(13,031)
Distribution of Cognyte Software Ltd.		0
Other comprehensive income (loss) before reclassifications	0	0
Amounts reclassified out of accumulated other comprehensive income (loss)	0	(1,014)
Amounts reclassified upon partial early retirement of the Term Loan		(12,017)
Other comprehensive (loss) income	0	13,031
Ending balances	$ 0	$ 0	$ (13,031)

STOCKHOLDERS' EQUITY - AMOUNTS

STOCKHOLDERS' EQUITY - AMOUNTS RECLASSIFIED OUT OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Class of Stock [Line Items]
Research and development, net	$ (130,644)	$ (123,291)	$ (128,152)
Selling, general and administrative	(392,939)	(376,808)	(327,345)
Interest Expense	(7,877)	(10,325)	(39,803)
Total, before income taxes	54,762	39,504	(41,664)
Provision for income taxes	(39,103)	(23,853)	(6,937)
Net income (loss) from continuing operations	15,659	15,651	(48,601)
Recurring
Class of Stock [Line Items]
Cost of revenue	(162,347)	(156,569)	(139,044)
Nonrecurring
Class of Stock [Line Items]
Cost of revenue	(119,530)	(124,226)	(130,545)
Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income
Class of Stock [Line Items]
Research and development, net	(392)	142	182
Selling, general and administrative	(207)	65	56
Total, before income taxes	(660)	232	267
Provision for income taxes	111	(39)	(42)
Net income (loss) from continuing operations	(549)	193	225
Foreign currency forward contracts | Recurring | Reclassification out of Accumulated Other Comprehensive Income
Class of Stock [Line Items]
Cost of revenue	(1)	1	1
Foreign currency forward contracts | Nonrecurring | Reclassification out of Accumulated Other Comprehensive Income
Class of Stock [Line Items]
Cost of revenue	(60)	24	28
Interest rate swap agreement | Reclassification out of Accumulated Other Comprehensive Income
Class of Stock [Line Items]
Interest Expense	0	(1,014)	(4,367)
Other income (expense), net	0	(15,655)	0
Total, before income taxes	0	(16,669)	(4,367)
Provision for income taxes	0	3,638	954
Net income (loss) from continuing operations	$ 0	$ (13,031)	$ (3,413)

RESEARCH AND DEVELOPMENT, NET -

RESEARCH AND DEVELOPMENT, NET - R&D Expenses And Grants (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Research and Development [Abstract]
Gross research and development expenses	$ 130,600	$ 123,300	$ 128,200
Capitalized computer software, impairments	$ 6	$ 0	$ 129

RESEARCH AND DEVELOPMENT, NET_2

RESEARCH AND DEVELOPMENT, NET - Capitalized Software Development Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Movement in Capitalized Computer Software, Net [Roll Forward]
Beginning of the period	$ 22,483	$ 19,250	$ 15,351
Software development costs capitalized during the year	7,595	7,560	7,312
Amortization of capitalized software development costs	(6,407)	(4,247)	(3,304)
Write-offs of capitalized software development costs	(6)	0	(129)
Foreign currency translation and other	(138)	(80)	20
End of the period	$ 23,527	$ 22,483	$ 19,250

INCOME TAXES - Income (Loss) Be

INCOME TAXES - Income (Loss) Before Provision before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
Domestic	$ (6,676)	$ (12,492)	$ 127,909
Foreign	61,438	51,996	(169,573)
Income (loss) from continuing operations before provision for income taxes	$ 54,762	$ 39,504	$ (41,664)

INCOME TAXES - Provision For In

INCOME TAXES - Provision For Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Current provision for income taxes:
Federal	$ 30,637	$ 3,215	$ 373
State	2,733	1,121	1,663
Foreign	15,277	30,840	6,299
Total current provision for income taxes	48,647	35,176	8,335
Deferred (benefit from) provision for income taxes:
Federal	(8,010)	6,714	1,366
State	(699)	255	(188)
Foreign	(835)	(18,292)	(2,576)
Total deferred benefit from income taxes	(9,544)	(11,323)	(1,398)
Total provision for income taxes from continuing operations	$ 39,103	$ 23,853	$ 6,937

INCOME TAXES - Effective Tax Ra

INCOME TAXES - Effective Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
U.S. federal statutory income tax rate	21%	21%	21%
Income tax provision (benefit) at the U.S. federal statutory rate	$ 11,499	$ 8,296	$ (8,733)
State income tax provision (benefit)	2,617	(1,238)	2,017
Foreign tax rate differential	3,244	6,262	5,992
Tax incentives	(3,779)	(6,378)	(2,681)
Valuation allowances	(292)	2,616	(3,269)
Stock-based and other compensation	3,347	897	2,958
Litigation and other non-deductible expenses	1,770	(238)	(1,007)
Tax credits	321	117	875
Tax contingencies	2,333	2,108	(5,652)
Change in fair value of future tranche right	0	(3,320)	11,791
Changes in tax laws	9	1,552	0
U.S. tax effects of foreign operations	18,642	13,480	3,828
Other, net	(608)	(301)	818
Total provision for income taxes from continuing operations	$ 39,103	$ 23,853	$ 6,937
Effective income tax rate	71.40%	60.40%	(16.60%)

INCOME TAXES - Additional Infor

INCOME TAXES - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Operating Loss Carryforwards [Line Items]
Effective income tax rate, increase (decrease) due to tax incentive	(6.90%)	(16.10%)	6.40%
Tax credit carryforward, amount	$ 8,400
Tax credit carryforward amount indefinite carryforward	2,700
Tax credit carryforward amount subject to expiration	5,700
Taxes withholding with respect to certain cash may be repatriated	2,000
Unrecognized tax benefits	87,928	$ 84,229	$ 84,847	$ 85,327
Unrecognized tax benefits, income tax penalties and interest expense	1,400	500	400
Unrecognized tax benefits, income tax penalties and interest accrued	5,200	3,400
Decrease in unrecognized tax benefits is reasonably possible	7,200
Discontinued Operations | Cognyte
Operating Loss Carryforwards [Line Items]
Unrecognized tax benefits	4,700
Adjustment to additional paid-in capital, uncertain tax position indemnified amount	5,700
Valuation Allowance of Deferred Tax Assets
Operating Loss Carryforwards [Line Items]
Valuation allowances amount	20,357	$ 20,711	$ 16,761
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	162,300
Operating loss carryforwards, not subject to expiration	13,600
State and Local Jurisdictions
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	172,000
Operating loss carryforwards, not subject to expiration	4,500
Foreign Countries
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	38,600
Operating loss carryforwards, subject to expiration	$ 2,400

INCOME TAXES - Deferred Tax Ass

INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Deferred tax assets:
Accrued expenses	$ 4,506	$ 4,464
Operating lease liabilities	7,974	9,275
Loss carryforwards	20,483	21,764
Tax credits	5,408	5,780
Stock-based and other compensation	3,963	6,802
Capitalized research and development expenses	18,669	2,253
Other, net	995	1,082
Total deferred tax assets	61,998	51,420
Deferred tax liabilities:
Prepaid expenses	(2,600)	(1,885)
Depreciation of property and equipment	(2,732)	(670)
Deferred cost of revenue	(9,707)	(8,531)
Goodwill and other intangible assets	(20,607)	(23,063)
Unremitted earnings of foreign subsidiaries	(1,784)	(970)
Operating lease right-of-use assets	(5,241)	(4,959)
Total deferred tax liabilities	(42,671)	(40,078)
Valuation allowance	(20,357)	(20,711)
Net deferred tax liabilities	(1,030)	(9,369)
Recorded as:
Deferred tax assets	10,719	8,091
Deferred tax liabilities	(11,749)	(17,460)
Net deferred tax liabilities	$ (1,030)	$ (9,369)

INCOME TAXES - Valuation Allowa

INCOME TAXES - Valuation Allowances (Details) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Recorded valuation allowance
Balance at beginning of year	$ (20,711)	$ (16,761)
Balance at end of year	(20,357)	(20,711)
Income tax benefit (provision)
Recorded valuation allowance
Adjustments to valuation allowances	292	(2,616)
Fair value of derivatives and convertible debt instruments
Recorded valuation allowance
Adjustments to valuation allowances	0	(1,139)
Currency translation adjustment and other
Recorded valuation allowance
Adjustments to valuation allowances	$ 62	$ (195)

INCOME TAXES - Unrecognized Tax

INCOME TAXES - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Changes in the balance of gross unrecognized tax benefits
Gross unrecognized tax benefits, beginning of year	$ 84,229	$ 84,847	$ 85,327
Increases related to tax positions taken during the current year	645	672	706
Increases related to tax positions taken during prior years	4,260	430	0
(Decreases) increases related to foreign currency exchange rates	(404)	45	136
Reductions for tax positions of prior years	(84)	(152)	(193)
Lapses of statutes of limitations	(718)	(1,613)	(1,129)
Gross unrecognized tax benefits, end of year	$ 87,928	$ 84,229	$ 84,847

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - Recurring - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Level 1
Assets:
Money market funds	$ 96,941	$ 127,041
Commercial paper, classified as cash and cash equivalents	0	0
Foreign currency forward contracts	0	0
Contingent consideration receivable	0	0
Total assets	96,941	127,041
Liabilities:
Foreign currency forward contracts	0	0
Contingent consideration — business combinations	0	0
Total liabilities	0	0
Level 2
Assets:
Money market funds	0	0
Commercial paper, classified as cash and cash equivalents	50,869	29,995
Foreign currency forward contracts	19	33
Contingent consideration receivable	8	0
Total assets	50,896	30,028
Liabilities:
Foreign currency forward contracts	124	91
Contingent consideration — business combinations	0	7,776
Total liabilities	124	7,867
Level 3
Assets:
Money market funds	0	0
Commercial paper, classified as cash and cash equivalents	0	0
Foreign currency forward contracts	0	0
Contingent consideration receivable	0	271
Total assets	0	271
Liabilities:
Foreign currency forward contracts	0	0
Contingent consideration — business combinations	12,717	0
Total liabilities	$ 12,717	$ 0

FAIR VALUE MEASUREMENTS - ADDIT

FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) ft² in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Jan. 31, 2020	Jul. 31, 2022 ft²	Jan. 31, 2023 USD ($)	Jan. 31, 2022 USD ($)	Jan. 31, 2021 USD ($)	Nov. 30, 2022 USD ($)
Assets and Liabilities Measured at Fair Value on Recurring Basis
Contingent consideration, measurement period	36 months
Payments of contingent consideration earned			$ 7,500,000	$ 9,600,000	$ 15,200,000
Benefit for changes in the fair values of contingent consideration obligations associated with business combinations			(200,000)	(900,000)	$ 800,000
Impairment loss of assets to be disposed of			2,000,000
Noncontrolling equity investment in privately-held companies without readily determinable fair values			5,146,000	5,146,000
Noncontrolling equity investment in privately-held companies without readily determinable fair values, remeasured to fair value				4,400,000
Unrealized gain on noncontrolling equity investment				3,100,000
Noncontrolling equity investment in privately-held companies, impairments			0	$ 0
Selling, general and administrative
Assets and Liabilities Measured at Fair Value on Recurring Basis
Impairment loss of assets to be disposed of			1,800,000
Other income (expense), net
Assets and Liabilities Measured at Fair Value on Recurring Basis
Impairment loss of assets to be disposed of			$ 200,000
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Office Building Held For Sale
Assets and Liabilities Measured at Fair Value on Recurring Basis
Area of assets held for sale | ft²		50
Assets held for sale, carrying value						$ 900,000
Minimum | Discount Rate
Assets and Liabilities Measured at Fair Value on Recurring Basis
Contingent consideration, liability, measurement input			0.066
Contingent consideration, asset, measurement input				0.035
Maximum | Discount Rate
Assets and Liabilities Measured at Fair Value on Recurring Basis
Contingent consideration, liability, measurement input			0.076
Contingent consideration, asset, measurement input				0.039
Weighted Average | Discount Rate
Assets and Liabilities Measured at Fair Value on Recurring Basis
Contingent consideration, liability, measurement input			0.069
Contingent consideration, asset, measurement input				0.037
Level 3 | Term Loan
Assets and Liabilities Measured at Fair Value on Recurring Basis
Long-term debt			$ 100,000,000	$ 100,000,000
Level 3 | Recurring
Assets and Liabilities Measured at Fair Value on Recurring Basis
Contingent consideration payments received			300,000	300,000
Contingent consideration receivable			0	271,000
Contingent consideration — business combinations			12,717,000	0
Level 2 | 2021 Notes
Assets and Liabilities Measured at Fair Value on Recurring Basis
Fair value of term loans			282,000,000	330,000,000
Level 2 | Recurring
Assets and Liabilities Measured at Fair Value on Recurring Basis
Contingent consideration receivable			8,000	0
Contingent consideration — business combinations			0	$ 7,776,000
Payments of contingent consideration earned			7,500,000
Benefit for changes in the fair values of contingent consideration obligations associated with business combinations			200,000
Changes due to foreign currency translation			$ 100,000

FAIR VALUE MEASUREMENTS - CONTI

FAIR VALUE MEASUREMENTS - CONTINGENT CONSIDERATION TABLE (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Changes in the estimated fair value of liability for contingent consideration measured using significant unobservable inputs (Level 3)
Changes in fair values, recorded in operating expenses	$ (200)	$ (900)	$ 800
Liability for contingent consideration
Changes in the estimated fair value of liability for contingent consideration measured using significant unobservable inputs (Level 3)
Fair value measurement, beginning of year	0	15,704
Contingent consideration liabilities recorded for business combinations	12,184	900
Changes in fair values, recorded in operating expenses	408	883
Payments of contingent consideration	0	(9,560)
Foreign currency translation and other	125	(151)
Transfer of contingent consideration liability to Level 2 of the fair value hierarchy	0	(7,776)
Fair value measurement, end of year	$ 12,717	$ 0	$ 15,704

DERIVATIVE FINANCIAL INSTRUME_3

DERIVATIVE FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($) $ in Thousands			12 Months Ended
	Apr. 13, 2021	May 01, 2020	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Sep. 06, 2019
Derivative [Line Items]
Payments for derivative instrument			$ 0	$ 16,502	$ 0
Unrealized gain on derivatives			$ 0	(14,374)	$ (1,267)
Deferred tax asset reclassified upon derivative settlement				3,700
Foreign currency forward contracts
Derivative [Line Items]
Derivative, term			12 months
Derivative - notional amount			$ 6,800	$ 7,400
Maximum maturity of foreign currency derivatives			12 months
2018 Interest Rate Swap
Derivative [Line Items]
Derivative - notional amount						$ 200,000
Derivative - fixed interest rate						2.949%
Derivative - index interest rate floor						0%
Reclassification of cash flow hedge loss, before tax	$ 15,700	$ 20,400
Reclassification of cash flow hedge loss, after tax		$ 16,000
Payments for derivative instrument	16,500
Unrealized gain on derivatives	$ 1,300

DERIVATIVE FINANCIAL INSTRUME_4

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of Fair Values of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Fair Values of Derivative Financial Instruments
Assets, fair value	$ 19	$ 33
Liabilities, fair value	124	91
Prepaid expenses and other current assets | Foreign currency forward contracts | Designated as cash flow hedges
Fair Values of Derivative Financial Instruments
Assets, fair value	19	33
Accrued expenses and other current liabilities | Foreign currency forward contracts | Designated as cash flow hedges
Fair Values of Derivative Financial Instruments
Liabilities, fair value	$ 124	$ 91

DERIVATIVE FINANCIAL INSTRUME_5

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of the Effects of Derivative Financial Instruments Designated as Cash Flow Hedging Instruments (Details) - Designated as cash flow hedges - Cash flow hedging - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
DERIVATIVE FINANCIAL INSTRUMENTS
Net (losses) gains recognized in AOCL	$ (707)	$ 85	$ (7,212)
Net (losses) gains reclassified from AOCL to the consolidated statements of operations	(660)	(16,437)	(4,100)
Foreign currency forward contracts
DERIVATIVE FINANCIAL INSTRUMENTS
Net (losses) gains recognized in AOCL	(707)	85	323
Net (losses) gains reclassified from AOCL to the consolidated statements of operations	(660)	232	267
Interest rate swap agreement
DERIVATIVE FINANCIAL INSTRUMENTS
Net (losses) gains recognized in AOCL	0	0	(7,535)
Net (losses) gains reclassified from AOCL to the consolidated statements of operations	$ 0	$ (16,669)	$ (4,367)

DERIVATIVE FINANCIAL INSTRUME_6

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of Losses Recognized on Derivative Financial Instruments Not Designated As Hedging Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Losses on derivative financial instruments, net	$ 0	$ (14,374)	$ (1,267)
Not designated as cash flow hedges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Losses on derivative financial instruments, net	0	(14,374)	(1,267)
Interest rate swap agreement | Not designated as cash flow hedges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Losses on derivative financial instruments, net	$ 0	$ (14,374)	$ (1,267)

STOCK-BASED COMPENSATION AND _3

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Stock-Based Compensation Plans (Details) - 2019 Long-Term Stock Incentive Plan	Jan. 31, 2023 shares	Mar. 31, 2021 shares	Feb. 01, 2021
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	9,475,000	14,239,656
Reduction of available plan capacity for each stock option or stock-settled stock appreciation right (in shares)	1
Reduction of available plan capacity for each other award (in shares)	2.38
Unvested awards conversion factor			1.45

STOCK-BASED COMPENSATION AND _4

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Stock-Based Compensation Plans
Share-based payment arrangement, expense	$ 76,114	$ 65,265	$ 45,200
Income tax benefits related to stock-based compensation (before consideration of valuation allowances)	12,368	10,615	6,684
Total stock-based compensation, net of taxes	63,746	54,650	38,516
Cost of revenue - recurring
Stock-Based Compensation Plans
Share-based payment arrangement, expense	2,856	1,999	1,109
Cost of revenue - nonrecurring
Stock-Based Compensation Plans
Share-based payment arrangement, expense	2,806	3,029	2,184
Research and development, net
Stock-Based Compensation Plans
Share-based payment arrangement, expense	12,576	7,565	3,918
Selling, general and administrative
Stock-Based Compensation Plans
Share-based payment arrangement, expense	$ 57,876	$ 52,672	$ 37,989

STOCK-BASED COMPENSATION AND _5

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Schedule of Stock-Based Compensation Expense by Type of Award (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Stock-based compensation expense
Share-based payment arrangement, expense	$ 76,114	$ 65,265	$ 45,200
Net excess tax deficiency (benefit) resulting from Stock Plans	(600)	(2,500)	900
Total equity-settled awards
Stock-based compensation expense
Share-based payment arrangement, expense	76,051	65,246	45,208
Restricted stock units and restricted stock awards | Total equity-settled awards
Stock-based compensation expense
Share-based payment arrangement, expense	68,258	58,678	47,598
Stock Bonus Program | Total equity-settled awards
Stock-based compensation expense
Share-based payment arrangement, expense	7,793	6,568	(2,390)
Phantom stock units (cash-settled awards) | Phantom stock units (cash-settled awards)
Stock-based compensation expense
Share-based payment arrangement, expense	$ 63	$ 19	$ (8)

STOCK-BASED COMPENSATION AND _6

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Restricted Stock Units and Performance Stock Units (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Shares or Units
Beginning balance (in shares)	2,454	2,017	1,879
Beginning balance, adjusted for Spin-Off (in shares)			2,950
Granted (in shares)	1,743	1,540	1,469
Released (in shares)	(1,733)	(1,800)	(1,125)
Forfeited (in shares)	(234)	(236)	(206)
Ending balance (in shares)	2,230	2,454	2,017
Weighted-Average Grant-Date Fair Value
Beginning balance (in dollars per share)	$ 42.99	$ 51.90	$ 52.96
Beginning balance, adjusted for Spin-Off (in dollars per share)			35.97
Granted (in dollars per share)	54.98	48.01	47.30
Released (in dollars per share)	42.13	36.14	47.53
Forfeited (in dollars per share)	48.86	40.23	52.59
Ending balance (in dollars per share)	$ 52.42	$ 42.99	$ 51.90
Additional disclosures
Granted (in shares)	1,743	1,540	1,469
RSUs
Shares or Units
Granted (in shares)	1,465
Additional disclosures
Granted (in shares)	1,465
Unrecognized compensation expense	$ 80.1
Remaining weighted-average vesting period over which expense is expected to be recognized (in years)	1 year 8 months 12 days

STOCK-BASED COMPENSATION AND _7

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Schedule of PSU Activity (Details) - shares shares in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Shares or Units
Beginning balance (in shares)	2,454	2,017	1,879
Beginning balance, adjusted for Spin-Off (in shares)			2,950
Granted (in shares)	1,743	1,540	1,469
Released (in shares)	(1,733)	(1,800)	(1,125)
Forfeited (in shares)	(234)	(236)	(206)
Ending balance (in shares)	2,230	2,454	2,017
Performance based RSU's
Shares or Units
Beginning balance (in shares)	547	511	423
Beginning balance, adjusted for Spin-Off (in shares)			743
Granted (in shares)	278	212	297
Released (in shares)	(279)	(381)	(182)
Forfeited (in shares)	(14)	(27)	(27)
Ending balance (in shares)	532	547	511

STOCK-BASED COMPENSATION AND _8

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Adjustment in Connection with the Spin-Off (Details)	Feb. 01, 2021
2019 Long-Term Stock Incentive Plan
Stock-Based Compensation Plans
Unvested awards conversion factor	1.45

STOCK-BASED COMPENSATION AND _9

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Stock Bonus Program and Bonus Share Program (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Mar. 29, 2023	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Stock Bonus Program
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, award vesting period		1 year
Share-based compensation arrangement by share-based payment award, determination of shares issuable trailing period of average price of common stock		5 days
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)		200,000	300,000	200,000	200,000
Discount from market price (as a percent)		15%	15%	15%	15%
Shares in lieu of cash bonus - granted and released (in shares)		119,000	0	32,000
Shares released in respect of discount (in shares)		10,000	0	3,000
Stock Bonus Program | Subsequent Event
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	200,000
Discount from market price (as a percent)	15%
Stock bonus program and bonus share program
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)		300,000	300,000	300,000	305,000
Shares in lieu of cash bonus - granted and released (in shares)			0
Accrued bonuses		$ 7.9	$ 6.5
Stock bonus program and bonus share program | Subsequent Event
Stock-Based Compensation Plans
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)	300,000
Bonus Share Program
Stock-Based Compensation Plans
Shares in lieu of cash bonus - granted and released (in shares)			0	272,000

STOCK-BASED COMPENSATION AND_10

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Activities Of Stock Bonus Program (Details) - Stock Bonus Program - shares shares in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Stock-Based Compensation Plans
Shares in lieu of cash bonus - granted and released (in shares)	119	0	32
Shares granted in respect of discount (in shares)	12	0	0
Shares released in respect of discount (in shares)	10	0	3

STOCK-BASED COMPENSATION AND_11

STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS - Other Benefit Plans (Details) - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
401(k) Plan and Other Retirement Plans
Employee contribution limit (as a percentage of compensation)	60%
Company's matching contribution as percentage of employee's annual compensation (as a percentage of compensation)	50%
Matching contribution per employee maximum amount	$ 2,000
Matching contribution expense	2,700,000	$ 2,600,000	$ 2,600,000
Liability for Severance Pay
Severance expenses	$ 1,600,000	$ 1,300,000	$ 1,100,000

LEASES - Additional Information

LEASES - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Lessee, Lease, Description [Line Items]
Lessee operating and finance leases options to extend lease terms	10 years
Finance lease, right-of-use asset	$ 10.7	$ 14.4
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property and equipment, net	Property and equipment, net
Finance lease, accumulated depreciation	$ 4.9	$ 5
Accelerated operating lease costs	8.3	$ 9.8	$ 2.4
Operating ease expense, indirect shared facility expenses			$ 6.9
Operating leases, not yet commenced with future lease obligations, amount	0.1
Finance leases, not yet commenced with future lease obligations, amount	$ 0.2
Operating leases, not yet commenced with future lease obligations, term	3 years
Minimum
Lessee, Lease, Description [Line Items]
Lessee operating and finance leases remaining lease term	1 year
Lessee operating and finance leases options to terminate leases term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lessee operating and finance leases remaining lease term	12 years
Lessee operating and finance leases options to terminate leases term	3 years

LEASES - Component Of Lease Exp

LEASES - Component Of Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Leases [Abstract]
Operating lease expenses	$ 16,301	$ 24,241	$ 28,617
Amortization of right-of-use assets	3,057	3,223	2,295
Interest on lease liabilities	188	260	312
Total finance lease expenses	3,245	3,483	2,607
Variable lease expenses	6,318	6,344	5,504
Short-term lease expenses	774	1,055	584
Sublease income	(267)	(1,804)	(966)
Total lease expenses	$ 26,371	$ 33,319	$ 36,346

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information Related To Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 21,261	$ 19,360	$ 21,243
Operating cash flows from finance leases	187	260	312
Financing cash flows from finance leases	2,870	3,189	2,389
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	19,490	11,282	7,619
Finance leases	$ 647	$ 4,041	$ 903
Weighted average remaining lease terms
Operating leases	7 years	3 years	6 years
Finance leases	2 years	3 years	3 years
Weighted average discount rates
Operating leases	6.20%	4.80%	5.80%
Finance leases	3.60%	3.80%	4%

LEASES - Maturities Of Lease Li

LEASES - Maturities Of Lease Liabilities (Details) $ in Thousands	Jan. 31, 2023 USD ($)
Operating Leases
2024	$ 9,925
2025	10,419
2026	8,294
2027	7,340
2028	9,616
Thereafter	16,826
Total future minimum lease payments	62,420
Less: imputed interest	(13,711)
Total	48,709
Finance Leases
2024	1,954
2025	1,571
2026	719
2027	102
2028	0
Thereafter	0
Total future minimum lease payments	4,346
Less: imputed interest	(190)
Total	$ 4,156

LEASES - Supplemental Balance S

LEASES - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Operating Leases
Operating lease obligations - current portion	$ 7,965	$ 24,551
Operating lease liabilities, noncurrent	40,744	$ 28,457
Total	$ 48,709
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Finance Leases
Finance lease liability, current	$ 1,848
Finance lease obligations - long-term portion	2,308	$ 3,831
Total	$ 4,156
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other liabilities	Other liabilities

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Purchase Obligations And Off-Balance Sheet Risk (Details) $ in Millions	Jan. 31, 2023 USD ($)
Unconditional Purchase Obligations (Excluding Capital Stock Redemptions) [Abstract]
Unconditional purchase obligations	$ 230.9
Concentration Risks, Types, No Concentration Percentage [Abstract]
Outstanding letters of credit and surety bonds	$ 1.8

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Legal Proceedings (Details)				1 Months Ended	12 Months Ended
	Jul. 10, 2022 USD ($) phase	Oct. 31, 2012 USD ($)	Jun. 07, 2012 defendant	Mar. 29, 2023 USD ($)	Jan. 31, 2023 USD ($) installment	Jun. 30, 2019 round	Feb. 14, 2022 Claim	Jan. 31, 2022 USD ($)
CTI Litigation
Loss Contingencies [Line Items]
Number of defendants | defendant			3
Loss contingency, damages sought, value		$ 150,000,000
Number of rounds of mediation | round						2
Litigation settlement liability					$ 11,250,000			$ 0
CTI Litigation | Settled Litigation
Loss Contingencies [Line Items]
Litigation settlement, amount	$ 16,000,000
Litigation settlement, number of payment phases | phase	3
Litigation settlement, number of payment installments remaining | installment					2
Litigation liability					$ 16,000,000
Loss contingency, insurance recovery receivable					16,000,000
CTI Litigation | Settled Litigation | Accrued expenses and other current liabilities
Loss Contingencies [Line Items]
Litigation liability					11,300,000
CTI Litigation | Settled Litigation | Accrued expenses and other current liabilities | Subsequent Event
Loss Contingencies [Line Items]
Litigation liability				$ 4,700,000
CTI Litigation | Settled Litigation | Other liabilities
Loss Contingencies [Line Items]
Litigation liability					4,700,000
CTI Litigation | Settled Litigation | Other liabilities | Subsequent Event
Loss Contingencies [Line Items]
Litigation liability				4,700,000
CTI Litigation | Settled Litigation | Prepaid expenses and other current assets
Loss Contingencies [Line Items]
Loss contingency, insurance recovery receivable					11,300,000
CTI Litigation | Settled Litigation | Other assets
Loss Contingencies [Line Items]
Loss contingency, insurance recovery receivable					4,700,000
ACSI and CFI Complaints
Loss Contingencies [Line Items]
Litigation settlement, income statement impact					0
ACSI and CFI Complaints | Pending Litigation
Loss Contingencies [Line Items]
Number of pending cases | Claim							2
Loss contingency accrual					3,500,000
Loss contingency, insurance recovery receivable					3,500,000
DOJ False Claims Act Litigation
Loss Contingencies [Line Items]
Litigation settlement, income statement impact					0
Litigation settlement liability					$ 7,000,000			$ 0
DOJ False Claims Act Litigation | Pending Litigation | Subsequent Event
Loss Contingencies [Line Items]
Loss contingency, insurance recovery receivable				7,000,000
Litigation settlement, proposed amount				$ 7,000,000

SEGMENT, GEOGRAPHIC, AND SIGN_3

SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION - Reportable Operating Segments (Details)	12 Months Ended
	Jan. 31, 2023 segment
Segment Reporting [Abstract]
Number of reportable segments	1

SEGMENT, GEOGRAPHIC, AND SIGN_4

SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION - Revenue by Geography (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Revenues from External Customers and Long-Lived Assets
Total revenue	$ 902,245	$ 874,509	$ 830,247
Americas:
Revenues from External Customers and Long-Lived Assets
Total revenue	629,394	600,723	569,950
United States
Revenues from External Customers and Long-Lived Assets
Total revenue	572,837	552,680	515,480
Other
Revenues from External Customers and Long-Lived Assets
Total revenue	56,557	48,043	54,470
EMEA:
Revenues from External Customers and Long-Lived Assets
Total revenue	182,040	180,166	173,216
United Kingdom
Revenues from External Customers and Long-Lived Assets
Total revenue	99,360	100,606	100,855
Other
Revenues from External Customers and Long-Lived Assets
Total revenue	82,680	79,560	72,361
APAC
Revenues from External Customers and Long-Lived Assets
Total revenue	$ 90,811	$ 93,620	$ 87,081

SEGMENT, GEOGRAPHIC, AND SIGN_5

SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION - Property and equipment, net (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 64,810	$ 64,090
United States
Property, Plant and Equipment [Line Items]
Property and equipment, net	50,917	50,241
United Kingdom
Property, Plant and Equipment [Line Items]
Property and equipment, net	7,244	9,225
Other countries
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 6,649	$ 4,624

SEGMENT, GEOGRAPHIC, AND SIGN_6

SEGMENT, GEOGRAPHIC, AND SIGNIFICANT CUSTOMER INFORMATION - Significant Customers (Details)	12 Months Ended
	Jan. 31, 2021
Total Revenue | Revenue from Rights Concentration Risk | Partner A
Concentration Risk [Line Items]
Concentrations of credit risk, percentage	10%

SUBSEQUENT EVENT (Details)

SUBSEQUENT EVENT (Details) - DOJ False Claims Act Litigation - USD ($)	1 Months Ended	12 Months Ended
	Mar. 29, 2023	Jan. 31, 2023	Jan. 31, 2022
Subsequent Event [Line Items]
Litigation settlement liability		$ 7,000,000	$ 0
Litigation settlement, income statement impact		$ 0
Pending Litigation | Subsequent Event
Subsequent Event [Line Items]
Litigation settlement, proposed amount	$ 7,000,000

Uncategorized Items - vrnt-2023

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]